var title_f29_63_30704="Gram stain vagina 2";
var content_f29_63_30704=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F69669&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F69669&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gram stain vagina 2",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 364px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_63_30704=[""].join("\n");
var outline_f29_63_30704=null;
var title_f29_63_30705="Long axis echo HCM";
var content_f29_63_30705=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/65618/palaxhcm_conv.mp4?title=Long+axis+echo+HCM\" style=\"width:383px;height:276px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Parasternal long axis echocardiogram in a patient with hypertrophic cardiomyopathy (HCM)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 430px; height: 226px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The parasternal view from a 2 dimensional echocardiogram of a patient with a hypertrophic cardiomyopathy shows a very thick interventricular septum (IVS) and thickened mitral valve (MV) leaflets. During systole there is systolic anterior movement of MV leaflet, which is in contact with the septum and obstructs left ventricular (LV) outflow.",
"    <div class=\"footnotes\">",
"     Ao: aortic root; LV: left ventricle; LA: left atrium.",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas Binder, MD. University of Vienna.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_63_30705=[""].join("\n");
var outline_f29_63_30705=null;
var title_f29_63_30706="Sulfonated phenolics in aqueous solution: Drug information";
var content_f29_63_30706=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Sulfonated phenolics in aqueous solution: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F136225\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Debacterol&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F136230\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Aphthous Ulcer Treatment Agent",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F14477728\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Oral ulcers:",
"     </b>",
"     Topical: Apply 1 coated applicator swab to ulcer for 5-10 seconds.",
"     <b>",
"      Note:",
"     </b>",
"     Not recommended to apply more than 1 treatment to each ulcer; however, if ulcer pain returns shortly after rinsing with water, 1 repeat application may be used.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F14477727\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F14477729\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F136219\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Solution, topical [for oral mucosa]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Debacterol&reg;: Sulfonated phenolics 50% and sulfuric acid 30% (1.5 mL) [for professional use only]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Swab, topical [for oral mucosa]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Debacterol&reg;: Sulfonated phenolics 50% and sulfuric acid 30% (12s) (0.2 mL) [for professional use only]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F136212\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F136220\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     For external use only; avoid contact with eyes. Prior to application/treatment, the ulcerated mucosal area should be thoroughly dried with a cotton-tipped applicator or similar method. After drying, apply solution coated applicator swab directly to the ulcerated area (most patients experience a brief stinging sensation immediately) and hold the applicator in contact with the ulcer for at least 5-10 seconds. The patient should then thoroughly rinse out the mouth with water and spit out the rinse water. The stinging sensation and ulcer pain will subside almost immediately after the rinse.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F14477706\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of ulcerating oral lesions such as recurrent aphthous stomatitis (canker sores)",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F136229\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined: Local: Irritation upon administration",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F136221\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no contraindications listed in the manufacturer's labeling.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F136215\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Irritation: If excess irritation occurs, rinse with a sodium bicarbonate (baking soda) solution (",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     teaspoonful mixed in 120 mL [4 oz] water); if irritation persists, contact healthcare provider.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sulfur: Do not use if allergic to sulfur in any form.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Accidental ingestion: If ingested, do not induce vomiting; rinse out mouth and immediately dilute liquids (no more than 8 ounces in adults and 4 ounces in children) and get medical help or contact a Poison Control Center.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: For topical use only. Debacterol&reg; is not intended for the treatment of cold sores and fever blisters. Prolonged use of Debacterol&reg; on normal tissue should be avoided.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Eye exposure: Avoid contact with eyes. If eye exposure occurs, immediately remove contact lenses, irrigate eyes for at least 15 minutes with lukewarm water, and contact a physician.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300097\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6223151\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16322996\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Debacterol Mouth/Throat)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     30-50% (1): $5.79",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     30-50% (1.5 mL): $39.00",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F136214\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Semiviscous, chemical cautery agent which provides controlled, focal debridement and sterilization of necrotic tissues; relieving pain, sealing damaged tissue, and providing local antiseptic action",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Rhodus NL and Bereuter J, &ldquo;An Evaluation of a Chemical Cautery Agent and an Anti-inflammatory Ointment for the Treatment of Recurrent Aphthous Stomatitis: A Pilot Study,&rdquo;",
"      <i>",
"       Quintessence Int",
"      </i>",
"      , 1998, 29(12):769-73.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?29/63/30706/abstract-text/10196853/pubmed\" id=\"10196853\" target=\"_blank\">",
"        10196853",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9882 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-61.234.146.186-71A5527948-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_63_30706=[""].join("\n");
var outline_f29_63_30706=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136225\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136230\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14477728\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14477727\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14477729\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136219\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136212\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136220\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14477706\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136229\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136221\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136215\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300097\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6223151\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16322996\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136214\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9882\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9882|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f29_63_30707="Cystic hygroma CXR III";
var content_f29_63_30707=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F63237&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F63237&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cystic hygroma in adult presenting as left apical mass",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A chest radiograph shows a left apical mass.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_63_30707=[""].join("\n");
var outline_f29_63_30707=null;
var title_f29_63_30708="Parkinson disease treatment options — medications";
var content_f29_63_30708=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Parkinson disease treatment options ��������� medications (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?29/63/30708/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?29/63/30708/contributors\" id=\"au1659\">",
"       Daniel Tarsy, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?29/63/30708/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?29/63/30708/contributors\" id=\"se6959\">",
"       Howard I Hurtig, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?29/63/30708/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?29/63/30708/contributors\" id=\"de6967\">",
"       John F Dashe, MD, PhD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"mobipreview.htm?29/63/30708?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      PARKINSON DISEASE OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     There are a wide variety of medical and surgical treatments available for Parkinson disease (PD). Medical treatment includes medications, education, support, exercise, physical and speech therapy, and nutrition. For some people with advanced Parkinson disease, surgical treatment with deep brain stimulation is another option. The optimal combination of treatments depends upon the person's signs and symptoms, age, stage and severity of disease, and their level of physical activity.",
"    </p>",
"    <p>",
"     The information that follows can help patients and family members to better understand the potential risks and benefits of medications. Other types of treatment are discussed separately. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/50/28449?source=see_link\">",
"      \"Patient information: Parkinson disease treatment options &mdash; education, support, and therapy (Beyond the Basics)\"",
"     </a>",
"     .) The symptoms and diagnosis of PD are also discussed separately. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?5/4/5188?source=see_link\">",
"      \"Patient information: Parkinson disease symptoms and diagnosis (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      WHEN TO START PARKINSON DISEASE TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     The decision to start medication for Parkinson disease depends upon the severity of symptoms. The most important consideration is how much the symptoms interfere with the person's ability to perform daily activities. Another important factor is the person's personal philosophy about the use of medications. The healthcare provider, patient, and family (if applicable) should share in the decision making process.",
"    </p>",
"    <p>",
"     There are six main types of medications available to treat symptoms of Parkinson disease: levodopa, dopamine agonists (DAs), inhibitors of enzymes that inactivate dopamine (MAO B inhibitors and COMT inhibitors), anticholinergics, and amantadine. Estrogen may be recommended for postmenopausal women with PD.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      LEVODOPA",
"     </span>",
"    </p>",
"    <p>",
"     Levodopa is the most effective drug for the treatment of symptoms of Parkinson disease. It is most effective for reducing difficulties moving all or part of the body (akinesia) and rigidity. Tremor is less likely to get better with levodopa, while problems with standing and coordination are even less likely to improve.",
"    </p>",
"    <p>",
"     There are several formulations of levodopa. In all forms, it is combined in various concentrations with another compound (carbidopa) to improve the efficiency of levodopa and reduce side effects. Carbidopa alone has no benefit.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       In the United States, carbidopa-levodopa is called Sinemet&reg; or Parcopa&reg;. Sinemet&reg; is a pill that is swallowed, while Parcopa&reg; is a tablet that dissolves on the tongue. Carbidopa-levodopa is available in three different quick-acting formulations:",
"       <span class=\"nowrap\">",
"        10/100,",
"       </span>",
"       <span class=\"nowrap\">",
"        25/100",
"       </span>",
"       and",
"       <span class=\"nowrap\">",
"        25/250",
"       </span>",
"       (the numerator is the carbidopa dose in milligrams and the denominator is the levodopa dose). Two slow-release formulations are available: Controlled release carbidopa-levodopa (or CR Sinemet)",
"       <span class=\"nowrap\">",
"        25/100",
"       </span>",
"       and",
"       <span class=\"nowrap\">",
"        50/200.",
"       </span>",
"      </li>",
"      <li>",
"       In Canada and Europe, levodopa is combined with benserazide (Madopar&reg; or Prolopa&reg;).",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Dosing",
"     </span>",
"     &nbsp;&mdash;&nbsp;Treatment is usually started with a small dose of the quick-acting pill two to three times per day with a meal or snack (to minimize nausea, the most common early side effect). The dose is then slowly increased over several days, depending on the person's tolerance, to the lowest dose that controls symptoms. In some cases, a slow-release pill can then be substituted to reduce the number of doses required per day.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Side effects",
"     </span>",
"     &nbsp;&mdash;&nbsp;The most common side effects of levodopa are nausea, sleepiness, dizziness, and headache. More serious side effects can include confusion, hallucinations, delusions, agitation, and psychosis; these are more common in older people. Side effects can usually be avoided or minimized by starting with a low dose and increasing gradually.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h3\">",
"      Motor complications",
"     </span>",
"     &nbsp;&mdash;&nbsp;In many cases, long-term (5 to 10 years) use of levodopa is associated with complications called motor fluctuations and dyskinesias. Motor fluctuations are a group of symptoms that include the \"wearing off\" or \"on-off\" effect (when the medication wears off before the next scheduled dose). Dyskinesias consist of abnormal involuntary movements that cause rapid jerking or slow and extended muscle spasms. Motor fluctuations and dyskinesia develop in at least one-half of people who take levodopa long-term.",
"    </p>",
"    <p>",
"     For years, there were concerns that levodopa could potentially speed the breakdown and death of dopamine-producing neurons in the brain. However, the evidence is not strong enough to justify avoiding a treatment that is highly effective for most people. As a result, most experts continue to recommend levodopa when symptoms compromise quality of life. Clinical trials are underway to further investigate the benefits versus risks of levodopa. (See",
"     <a class=\"local\" href=\"#H27\">",
"      'Clinical trials'",
"     </a>",
"     below.)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H7\">",
"     <span class=\"h1\">",
"      MAO B INHIBITORS",
"     </span>",
"    </p>",
"    <p>",
"     Selegiline (Eldepryl&reg;, Emsam&reg;, Zelapar&reg;) and rasagiline (Azilect&reg;) are monoamine oxidase B (MAO B) inhibitors. These work by blocking the effect of proteins that inactivate dopamine. They are long-acting and modestly reduce symptoms of Parkinson disease. They may help to protect dopamine-producing neurons. However, the benefit is usually small, and some people do not notice any improvement. MAO B inhibitors can be taken alone or in combination with levodopa or other antiparkinson drugs.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Dosing",
"     </span>",
"     &nbsp;&mdash;&nbsp;Selegiline is a pill that is usually taken by mouth once per day (in the morning or at noon to avoid insomnia). Zelapar&reg; dissolves on the tongue. Rasagiline is taken by mouth once per day.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Side effects",
"     </span>",
"     &nbsp;&mdash;&nbsp;Side effects of MAO B inhibitors can include nausea, headache, and difficulty falling asleep. In older people with Parkinson disease, selegiline often causes confusion, which may prevent it from being useful in this group. &nbsp;People who take antidepressants and MAO B inhibitors at the same time can sometimes develop severe high blood pressure, but fortunately this complication is rare.",
"    </p>",
"    <p>",
"     Nonspecific MAO inhibitors are sometimes used to treat depression and must not be taken with foods that contain tyramine, such as aged cheeses and red wine. However, selegiline and rasagiline are",
"     <strong>",
"      specific",
"     </strong>",
"     MAO inhibitors, which means that they do not require dietary changes or restrictions.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H10\">",
"     <span class=\"h1\">",
"      DOPAMINE AGONISTS",
"     </span>",
"    </p>",
"    <p>",
"     Dopamine agonists (DAs) work by directly stimulating dopamine receptors in the brain. There are several DAs available in the United States, including bromocriptine (Parlodel&reg;), pramipexole (Mirapex&reg;), ropinirole (Requip&reg;), transdermal rotigotine (Neupro&reg;), and apomorphine given by injection (Apokyn&reg;).",
"    </p>",
"    <p>",
"     Clinical trials have found that dopamine agonists are effective for controlling the symptoms of Parkinson disease. However, they are slightly less effective than levodopa and have more side effects, particularly sedation, swelling of the legs, and visual hallucinations.",
"    </p>",
"    <p>",
"     Dopamine agonists may be used alone as an initial treatment for some people with early Parkinson disease, especially those who develop symptoms before age 65. In this group, early use of dopamine agonists may postpone the need for levodopa until later in the course of the disease. The use of dopamine agonists rather than levodopa appears to reduce or postpone the onset of motor complications and dyskinesias.",
"    </p>",
"    <p>",
"     While dopamine agonists may control symptoms in the early stages of the disease, most people with worsening symptoms require levodopa within a few years. In addition, initial symptom control is usually not as good with dopamine agonists as with levodopa. Thus, when deciding which medication to use initially, patients and clinicians must consider the potential benefits of dopamine agonists (fewer levodopa-related motor complications if levodopa can be delayed) as well as the risks (possibly less effective control of Parkinson disease symptoms and more side effects).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Dosing",
"     </span>",
"     &nbsp;&mdash;&nbsp;Dopamine agonists are generally taken by mouth at least three times per day. Apomorphine is only available by injection or continuous IV infusion. Rotigotine (Neupro&reg;) is a dopamine agonist administered with a once daily skin patch.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Side effects",
"     </span>",
"     &nbsp;&mdash;&nbsp;Common side effects of dopamine agonists include sleepiness, nausea, vomiting, low blood pressure after standing up, confusion, hallucinations, and swelling in the lower legs and feet. In some cases, side effects are so bothersome that the person cannot tolerate them. Starting with a low dose and increasing slowly over a period of several weeks may help to minimize side effects.",
"    </p>",
"    <p>",
"     The manufacturer of pramipexole has issued a warning that \"sleep attacks\" can occur suddenly and without warning in people who take the medication, particularly when the dose is greater than 1.5",
"     <span class=\"nowrap\">",
"      mg/day.",
"     </span>",
"     Ropinirole probably carries the same risk. People who drive should be aware of this risk and other factors that can increase drowsiness, such as sleep disorders (insomnia, sleep apnea) and certain other medications (sleeping, anxiety medications).",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Dopaminergic dysregulation syndrome &mdash; A small number of people with Parkinson disease use levodopa compulsively. Overuse can lead to mood disorders, such as mania (irrational and elevated mood and energy, unusual thoughts). Impulsive behaviors, such as compulsive gambling or sexual behaviors, can also occur. Treatment with antipsychotic medications may be recommended to control these symptoms.",
"      </li>",
"      <li>",
"       Impulse control disorders &mdash; Treatment with dopamine agonists, even at appropriate doses, increases the risk of impulse control disorders, such as pathologic gambling, compulsive sexual behavior, or compulsive buying. Decreasing or discontinuing the dopamine agonist quickly resolves the behavior in nearly all cases.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H13\">",
"     <span class=\"h1\">",
"      COMT INHIBITORS",
"     </span>",
"    </p>",
"    <p>",
"     The catechol-O-methyl transferase (COMT) inhibitors tolcapone (Tasmar&reg;) and entacapone (Comtan&reg;) may be used to prolong and enhance the effect of levodopa. The treatment is primarily used for people with motor fluctuations who have \"wearing off\" periods at the end of their dose of levodopa. The medication has no effect on its own.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h2\">",
"      Dosing",
"     </span>",
"     &nbsp;&mdash;&nbsp;Tolcapone is usually taken by mouth three times per day while entacapone is taken with each dose of levodopa, up to eight times per day.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      Side effects",
"     </span>",
"     &nbsp;&mdash;&nbsp;The most common side effects of entacapone and tolcapone include dyskinesia, hallucinations, confusion, nausea, diarrhea, orange discoloration of the urine, and low blood pressure after standing up. Tolcapone may increase liver enzymes; blood testing may be recommended to monitor these levels.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H16\">",
"     <span class=\"h1\">",
"      ANTICHOLINERGICS",
"     </span>",
"    </p>",
"    <p>",
"     An anticholinergic medication may be recommended to reduce symptoms of bothersome tremor in people with Parkinson disease under age 70 who do not have significant akinesia or difficulty walking. Anticholinergics may be given alone, or with levodopa or dopamine agonists in people with more advanced disease who have a persistent tremor.",
"    </p>",
"    <p>",
"     There are several anticholinergic drugs available for people with Parkinson disease, including trihexyphenidyl, benztropine, orphenadrine, procyclidine, and biperiden. These medications are believed to be equally effective.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17\">",
"     <span class=\"h2\">",
"      Dosing",
"     </span>",
"     &nbsp;&mdash;&nbsp;Trihexyphenidyl and benztropine are usually taken by mouth two or three times per day.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18\">",
"     <span class=\"h2\">",
"      Side effects",
"     </span>",
"     &nbsp;&mdash;&nbsp;The most common side effects of anticholinergics include dry mouth, blurred vision, constipation, nausea, difficulty emptying the bladder, impaired sweating, and rapid heart rate. Other side effects can be especially bothersome for older adults and anyone with difficulty thinking clearly. These can include difficulty with memory, confusion, and hallucinations.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H19\">",
"     <span class=\"h1\">",
"      AMANTADINE",
"     </span>",
"    </p>",
"    <p>",
"     Amantadine (Symmetrel&reg;) is an antiviral drug that was developed to prevent influenza, but was found to improve mild symptoms (tremor, akinesia, rigidity) in people with Parkinson disease. Its benefit appears to be temporary in some people. When combined with levodopa, amantadine may help to reduce motor fluctuations and dyskinesia in people with advanced Parkinson disease.",
"    </p>",
"    <p>",
"     Amantadine is usually taken by mouth two to three times per day.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H20\">",
"     <span class=\"h2\">",
"      Side effects",
"     </span>",
"     &nbsp;&mdash;&nbsp;Possible side effects of amantadine include visual hallucinations and confusion, livedo reticularis (blotchy, purple-colored areas of skin, usually found on the wrists and legs), and swelling of the ankles.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H21\">",
"     <span class=\"h1\">",
"      TREATMENT FOR NON-MOTOR SYMPTOMS",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H22\">",
"     <span class=\"h2\">",
"      Depression",
"     </span>",
"     &nbsp;&mdash;&nbsp;Depression is one of the most common mental health problems experienced by people with Parkinson disease. However, effective medications are available to treat depression. Although the best medication depends upon an individual's situation, a class of medications called SSRIs (selective serotonin reuptake inhibitors) is commonly used. Although less often used, tricyclic antidepressants such as nortriptyline are also effective. The treatment of depression is discussed separately. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?21/24/21894?source=see_link\">",
"      \"Patient information: Depression treatment options for adults (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H23\">",
"     <span class=\"h2\">",
"      Sleep disorders",
"     </span>",
"     &nbsp;&mdash;&nbsp;Daytime sleepiness and fatigue are frequent problems in people with Parkinson disease, and are often a result of nighttime sleeping problems. Treatment options include improving sleep habits, recognizing and treating problems that disrupt sleep (such as pain or the need to urinate frequently), and use of a stimulant (such as caffeine or modafinil) to decrease sleepiness during the day. Other treatments for insomnia are discussed separately. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?2/16/2306?source=see_link\">",
"      \"Patient information: Insomnia (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H24\">",
"     <span class=\"h2\">",
"      Dementia",
"     </span>",
"     &nbsp;&mdash;&nbsp;Difficulties with memory and thinking (dementia) are a common problem for people with Parkinson disease, especially as the disease progresses and the person ages. A class of medications known as cholinesterase inhibitors, which were originally developed to treat Alzheimer disease, may help to improve these symptoms. Examples include rivastigmine (Exelon&reg;), donepezil (Aricept&reg;), galantamine (Razadyne&reg;), and memantine (Namenda&reg;). (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?14/37/14934?source=see_link\">",
"      \"Patient information: Dementia (including Alzheimer disease) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H25\">",
"     <span class=\"h2\">",
"      Psychosis and hallucinations",
"     </span>",
"     &nbsp;&mdash;&nbsp;The treatment of psychosis and hallucinations in people with Parkinson disease often includes stopping or decreasing the dose of one or more of the medications used to treat motor symptoms of Parkinson disease. It is sometimes possible to decrease the dose slightly and improve the symptoms of psychosis and hallucinations with little to no worsening of tremors and other movement problems of Parkinson disease.",
"    </p>",
"    <p>",
"     If adjusting medications does not improve symptoms adequately, an antipsychotic medication such as quetiapine (Seroquel&reg;) or clozapine (Clozaril&reg;) may be used in low doses. However, people who take clozapine must have frequent blood counts (once per week) due to a potentially serious (but preventable) risk of a drug-induced decrease in the number of white blood cells.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H26\">",
"     <span class=\"h1\">",
"      TREATMENT TO SLOW THE PROGRESSION OF PARKINSON DISEASE",
"     </span>",
"    </p>",
"    <p>",
"     There is great interest in finding a treatment that could help to slow the progression of Parkinson disease. The idea is based upon the concept that dopamine-producing neurons could be protected from early death and depletion of dopamine.",
"    </p>",
"    <p>",
"     No treatment has been proven to be neuroprotective. Many treatments have been studied, including MAO B inhibitors, dopamine agonists, coenzyme Q10, and vitamin E. However, there is not enough evidence to know if these treatments are effective and they are not currently recommended to slow the progression of Parkinson disease. Several clinical trials are underway. (See",
"     <a class=\"local\" href=\"#H27\">",
"      'Clinical trials'",
"     </a>",
"     below.)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H27\">",
"     <span class=\"h1\">",
"      CLINICAL TRIALS",
"     </span>",
"    </p>",
"    <p>",
"     Progress in treating Parkinson disease requires that better treatments be identified through clinical trials, which are conducted all over the world. A clinical trial is a carefully controlled way to study the effectiveness of new treatments or new combinations of known therapies. Ask for more information about clinical trials, or read about clinical trials at:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       <a class=\"external\" href=\"file://www.cancer.gov/clinicaltrials/learning/\">",
"        www.cancer.gov/clinicaltrials/learning/",
"       </a>",
"      </li>",
"      <li>",
"       <a class=\"external\" href=\"file://www.cancer.gov/clinicaltrials/\">",
"        www.cancer.gov/clinicaltrials/",
"       </a>",
"      </li>",
"      <li>",
"       <a class=\"external\" href=\"file://clinicaltrials.gov/\">",
"        file://clinicaltrials.gov/",
"       </a>",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H28\">",
"     <span class=\"h1\">",
"      SUMMARY",
"     </span>",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       In most cases, medication for Parkinson disease is recommended once the symptoms are severe enough to interfere with daily living. All decisions regarding the use of antiparkinson medications should be made jointly by the patient, caregivers, family, and the healthcare provider. (See",
"       <a class=\"local\" href=\"#H2\">",
"        'When to start Parkinson disease treatment'",
"       </a>",
"       above.)",
"      </li>",
"      <li>",
"       Currently, no treatment has been proven to slow, stop, or change the progression of Parkinson disease. However, medications for Parkinson disease are usually effective in controlling the symptoms of the disease.",
"      </li>",
"      <li>",
"       Either levodopa or a dopamine agonist can be used initially for patients who require treatment for symptoms of Parkinson disease. One goal of therapy is try to find the lowest effective dose of medication. It is reasonable to use a dopamine agonist as initial treatment for people with Parkinson disease who are under age 65, and to use levodopa as initial treatment for people age 65 and older. However, there are often exceptions to these general rules, and all treatments should be individualized. Levodopa is the drug of choice if symptoms of Parkinson disease seriously threaten the patient's lifestyle.",
"      </li>",
"      <li>",
"       Levodopa is usually taken three times per day, and the dose may be slowly increased over time, depending upon the patient's response. (See",
"       <a class=\"local\" href=\"#H3\">",
"        'Levodopa'",
"       </a>",
"       above.)",
"      </li>",
"      <li>",
"       Dopamine agonist medications include bromocriptine (Parlodel&reg;), pramipexole (Mirapex&reg;), ropinirole (Requip&reg;), rotigotine (Neupro&reg;), and apomorphine (Apokyn&reg;). Other PD medications may be taken with a dopamine agonist, if necessary. (See",
"       <a class=\"local\" href=\"#H10\">",
"        'Dopamine agonists'",
"       </a>",
"       above.)",
"      </li>",
"      <li>",
"       Selegiline (Symmetrel&reg;) and Rasagiline (Azilect&reg;) are MAO B inhibitors that may help to relieve mild symptoms of Parkinson disease in some people with early Parkinson disease. (See",
"       <a class=\"local\" href=\"#H7\">",
"        'MAO B inhibitors'",
"       </a>",
"       above.)",
"      </li>",
"      <li>",
"       Anticholinergic drugs are usually reserved for younger patients in whom tremor is the predominant problem. (See",
"       <a class=\"local\" href=\"#H16\">",
"        'Anticholinergics'",
"       </a>",
"       above.)",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H285803789\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H2287310627\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11171566\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?13/40/13954?source=see_link\">",
"      Patient information: Parkinson disease (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?34/8/34947?source=see_link\">",
"      Patient information: Medicines for Parkinson disease (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?13/14/13538?source=see_link\">",
"      Patient information: Tremor (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11171583\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/50/28449?source=see_link\">",
"      Patient information: Parkinson disease treatment options &mdash; education, support, and therapy (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?5/4/5188?source=see_link\">",
"      Patient information: Parkinson disease symptoms and diagnosis (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?21/24/21894?source=see_link\">",
"      Patient information: Depression treatment options for adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?2/16/2306?source=see_link\">",
"      Patient information: Insomnia (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?14/37/14934?source=see_link\">",
"      Patient information: Dementia (including Alzheimer disease) (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H30\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/36/15943?source=see_link\">",
"      Bradykinetic movement disorders in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/13/14554?source=see_link\">",
"      Clinical manifestations of Parkinson disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/30/26089?source=see_link\">",
"      Diagnosis of Parkinson disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/6/36970?source=see_link\">",
"      Etiology and pathogenesis of Parkinson disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/17/21784?source=see_link\">",
"      Management of comorbid problems associated with Parkinson disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/26/18857?source=see_link\">",
"      Motor fluctuations and dyskinesia in Parkinson disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/31/15863?source=see_link\">",
"      Neuroprotective therapy for Parkinson disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/11/4277?source=see_link\">",
"      Nonpharmacologic management of Parkinson disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/46/10984?source=see_link\">",
"      Overview of tremor",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/36/15946?source=see_link\">",
"      Parkinson disease dementia",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/63/32762?source=see_link\">",
"      Pharmacologic treatment of Parkinson disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/22/32105?source=see_link\">",
"      Surgical treatment of Parkinson disease",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"        MedlinePlus",
"       </a>",
"      </li>",
"      <li>",
"       <a class=\"external\" href=\"file://www.parkinson.org/\">",
"        National Parkinson Foundation",
"       </a>",
"      </li>",
"      <li>",
"       <a class=\"external\" href=\"file://www.ninds.nih.gov/disorders/parkinsons_disease/detail_parkinsons_disease.htm\">",
"        National Institute of Neurological Disorders and stroke",
"       </a>",
"      </li>",
"      <li>",
"       <a class=\"external\" href=\"file://www.pdf.org/\">",
"        Parkinson's Disease Foundation",
"       </a>",
"      </li>",
"      <li>",
"       <a class=\"external\" href=\"file://wemove.org/\">",
"        WE MOVE",
"       </a>",
"      </li>",
"     </ul>",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 20, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"mobipreview.htm?29/63/30708?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f29_63_30708=[""].join("\n");
var outline_f29_63_30708=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           PARKINSON DISEASE OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           WHEN TO START PARKINSON DISEASE TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           LEVODOPA",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H7\">",
"           MAO B INHIBITORS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H10\">",
"           DOPAMINE AGONISTS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H13\">",
"           COMT INHIBITORS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H16\">",
"           ANTICHOLINERGICS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H19\">",
"           AMANTADINE",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H21\">",
"           TREATMENT FOR NON-MOTOR SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H26\">",
"           TREATMENT TO SLOW THE PROGRESSION OF PARKINSON DISEASE",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H27\">",
"           CLINICAL TRIALS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H28\">",
"           SUMMARY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H285803789\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f29_63_30709="Ibuprofen and diphenhydramine: Drug information";
var content_f29_63_30709=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Ibuprofen and diphenhydramine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?16/41/17045?source=see_link\">",
"    see \"Ibuprofen and diphenhydramine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F12864215\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Advil&reg; PM Caplets [OTC];",
"     </li>",
"     <li>",
"      Advil&reg; PM Liqui-Gels&reg; [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F15035996\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Analgesic, Miscellaneous;",
"     </li>",
"     <li>",
"      Ethanolamine Derivative;",
"     </li>",
"     <li>",
"      Histamine H;",
"      <sub>",
"       1",
"      </sub>",
"      Antagonist",
"     </li>",
"     <li>",
"      Histamine H;",
"      <sub>",
"       1",
"      </sub>",
"      Antagonist, First Generation",
"     </li>",
"     <li>",
"      Nonsteroidal Anti-inflammatory Drug (NSAID), Oral",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F15039009\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Insomnia and pain:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Diphenhydramine citrate 38 mg and ibuprofen 200 mg per caplet: Two caplets at bedtime (maximum: 2 caplets/24 hours)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Diphenhydramine hydrochloride 25 mg and ibuprofen 200 mg per capsule: Two capsules at bedtime (maximum: 2 capsule/24 hours)",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F15039008\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Insomnia and pain:",
"     </b>",
"     Children &ge;12 years and Adolescents: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F15039070\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Caplet, oral, as citrate: Diphenhydramine citrate 38 mg and ibuprofen 200 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Advil&reg; PM Caplet: Diphenhydramine citrate 38 mg and ibuprofen 200 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral, as hydrochloride:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Advil&reg; PM Liqui-Gels&reg;: Diphenhydramine hydrochloride 25 mg and ibuprofen 200 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F15035886\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Excludes capsule",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F15039011\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     May be administered with food or milk if stomach upset occurs.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F15035998\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Aid in the relief of insomnia accompanied by minor aches and pains",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F15038998\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F15035999\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to diphenhydramine, ibuprofen, or any component of the formulation; perioperative pain in the setting of coronary artery bypass graft (CABG) surgery",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F15036147\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anaphylactoid reactions: Even in patients without prior exposure anaphylactoid reactions may occur; patients with \"aspirin triad\" (bronchial asthma, aspirin intolerance, rhinitis) may be at increased risk. Do not use in patients who experience bronchospasm, asthma, rhinitis, or urticaria with NSAID or aspirin therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular events: NSAIDs are associated with an increased risk of adverse cardiovascular events and may interfere with aspirin&rsquo;s cardioprotective effect; use with caution.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depression: May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gastrointestinal events: NSAIDs may increase risk of gastrointestinal irritation, inflammation, ulceration, bleeding, and perforation; use caution with a history of GI disease (bleeding or ulcers), concurrent therapy with aspirin, anticoagulants, and/or corticosteroids, smoking, use of alcohol (&ge;3 alcoholic beverages/day), the elderly or debilitated patients. Use the lowest effective dose for the shortest duration of time.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Skin reactions: NSAIDs may cause serious skin adverse events; discontinue at the first sign of skin rash or hypersensitivity.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Aseptic meningitis: Ibuprofen may increase the risk of aseptic meningitis, especially in patients with systemic lupus erythematosus (SLE) and mixed connective tissue disorders.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Asthma: Do not administer to patients with aspirin-sensitive asthma; severe bronchospasm may occur. Use caution in patients with other forms of asthma.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use ibuprofen with caution in patients with cardiovascular disease. Use the lowest effective dose for the shortest duration of time to reduce risk of cardiovascular events. NSAIDs may cause fluid retention; use caution in patients taking a diuretic.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Increased intraocular pressure/glaucoma: Use with caution in patients with increased intraocular pressure or angle-closure glaucoma.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with decreased hepatic function.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypertension: Use with caution; NSAIDs may cause new-onset hypertension or worsening of existing hypertension. Response to ACE inhibitors, thiazides, or loop diuretics may be impaired with concurrent use of NSAIDs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Prostatic hyperplasia/urinary obstruction: Use with caution in patients with prostatic hyperplasia and/or GU obstruction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pyloroduodenal obstruction: Use with caution in patients with pyloroduodenal obstruction (including stenotic peptic ulcer).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: NSAID use may compromise existing renal function; use with caution.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Respiratory disease: Use with caution in patients with emphysema or chronic bronchitis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thyroid dysfunction: Use with caution in patients with thyroid dysfunction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Ibuprofen or diphenhydramine (including topical) containing products: Concurrent use with other ibuprofen- or diphenhydramine-containing products should be avoided or used with caution.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sedatives: Effects may be potentiated when used with other sedative drugs or ethanol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Avoid use in the elderly; diphenhydramine is a potent anticholinergic agent which may increase the risk of confusion, dry mouth, constipation, and other anticholinergic effects. Ibuprofen, a nonselective NSAID, is associated with an increased risk of GI bleeding in older adults.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Self-medication (OTC use): Should only be used when a full night&rsquo;s sleep is anticipated. Avoid use if not experiencing pain in addition to insomnia. Consult a healthcare provider if pain lasts &gt;10 days or insomnia lasts &gt;14 days. Consuming &ge;3 alcoholic beverages/day or taking longer than recommended may increase the risk of GI bleeding.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299210\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to individual components.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F13120039\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors (Central): Anticholinergics may diminish the therapeutic effect of Acetylcholinesterase Inhibitors (Central). Acetylcholinesterase Inhibitors (Central) may diminish the therapeutic effect of Anticholinergics. If the anticholinergic action is a side effect of the agent, the result may be beneficial.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aclidinium: May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: May diminish the sedative effect of Antihistamines.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergics: May enhance the adverse/toxic effect of other Anticholinergics.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP2D6 Inhibitors (Moderate) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Benzylpenicilloyl Polylysine: Antihistamines may diminish the diagnostic effect of Benzylpenicilloyl Polylysine.  Management: Suspend systemic H1 antagonists for benzylpenicilloyl-polylysine skin testing and delay testing until systemic antihistaminic effects have dissipated. A histamine skin test may be used to assess persistent antihistaminic effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Betahistine: Antihistamines may diminish the therapeutic effect of Betahistine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Codeine: CYP2D6 Inhibitors (Moderate) may diminish the therapeutic effect of Codeine. These CYP2D6 inhibitors may prevent the metabolic conversion of codeine to its active metabolite morphine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Substrates: CYP2D6 Inhibitors (Moderate) may decrease the metabolism of CYP2D6 Substrates.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Tamoxifen.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fesoterodine: CYP2D6 Inhibitors may increase serum concentrations of the active metabolite(s) of Fesoterodine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Highest Risk QTc-Prolonging Agents: QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying) may enhance the QTc-prolonging effect of Highest Risk QTc-Prolonging Agents.  Management: Avoid such combinations when possible.  Use should be accompanied by close monitoring for evidence of QT prolongation or other alterations of cardiac rhythm.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: Antihistamines may diminish the therapeutic effect of Hyaluronidase.  Management: Patients receiving antihistamines (particularly at larger doses) may not experience the desired clinical response to standard doses of hyaluronidase.  Larger doses of hyaluronidase may be required.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ipratropium (Oral Inhalation): May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metoprolol: CYP2D6 Inhibitors may increase the serum concentration of Metoprolol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May enhance the QTc-prolonging effect of QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying). Management: Though the drugs listed here have uncertain QT-prolonging effects, they all have some possible association with QT prolongation and should generally be avoided when possible.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Moderate Risk QTc-Prolonging Agents: QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying) may enhance the QTc-prolonging effect of Moderate Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nebivolol: CYP2D6 Inhibitors (Moderate) may increase the serum concentration of Nebivolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramlintide: May enhance the anticholinergic effect of Anticholinergics. These effects are specific to the GI tract.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Propafenone: May increase the serum concentration of CYP2D6 Inhibitors (Moderate).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tamoxifen: CYP2D6 Inhibitors (Moderate) may decrease serum concentrations of the active metabolite(s) of Tamoxifen. Specifically, CYP2D6 inhibitors may decrease the metabolic formation of highly potent active metabolites.  Management: Consider alternatives with less of an inhibitory effect on CYP2D6 activity when possible.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thioridazine: CYP2D6 Inhibitors may decrease the metabolism of Thioridazine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiotropium: Anticholinergics may enhance the anticholinergic effect of Tiotropium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     TraMADol: CYP2D6 Inhibitors (Moderate) may diminish the therapeutic effect of TraMADol. These CYP2D6 inhibitors may prevent the metabolic conversion of tramadol to its active metabolite that accounts for much of its opioid-like effects.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F15039001\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F15039010\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Some products may contain potassium.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16570431\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Ibuprofen-Diphenhydramine HCl Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     200-25 mg (16): $2.51",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F15039004\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Bhatt DL, Scheiman J, Abraham NS, et al, &ldquo;ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risk of Antiplatelet Therapy and NSAID Use. A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents,&rdquo;",
"      <i>",
"       J Am Coll Cardiol",
"      </i>",
"      , 2008, 52(18):1502-17.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?29/63/30709/abstract-text/19017521/pubmed\" id=\"19017521\" target=\"_blank\">",
"        19017521",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Catella-Lawson F, Reilly MP, Kapoor SC, et al, &ldquo;Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2001, 345(25):1809-17.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?29/63/30709/abstract-text/11752357/pubmed\" id=\"11752357\" target=\"_blank\">",
"        11752357",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 86869 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-85.214.214.87-4FABCF92AE-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_63_30709=[""].join("\n");
var outline_f29_63_30709=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12864215\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15035996\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15039009\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15039008\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15039070\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15035886\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15039011\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15035998\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15038998\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15035999\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15036147\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299210\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13120039\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15039001\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15039010\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16570431\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15039004\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/86869\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/86869|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?16/41/17045?source=related_link\">",
"      Ibuprofen and diphenhydramine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f29_63_30710="Adenoid cystic carcinoma CXR";
var content_f29_63_30710=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F81685%7EPULM%2F68760&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F81685%7EPULM%2F68760&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Adenoid cystic carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 320px; height: 322px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Lateral view of the neck shows a posterior cervical tracheal wall lesion. The patient had been treated for atypical asthma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Adenoid cystic carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 389px; height: 525px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Computed tomographic scans often reveal an irregular tracheal mass that originates from the posterior wall.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_63_30710=[""].join("\n");
var outline_f29_63_30710=null;
var title_f29_63_30711="Technique of hip disarticulation";
var content_f29_63_30711=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F71192&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F71192&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 538px\">",
"   <div class=\"ttl\">",
"    Technique of hip disarticulation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 518px; height: 671px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_63_30711=[""].join("\n");
var outline_f29_63_30711=null;
var title_f29_63_30712="Alopecia areata 5";
var content_f29_63_30712=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F70996%7EDERM%2F63538&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F70996%7EDERM%2F63538&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Alopecia areata",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 380px; height: 272px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This child has smooth, well-demarcated, noninflammatory, asymptomatic patches of alopecia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Alopecia areata",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 350px; height: 330px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFKAV4DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDpUGeQOenNJIAwyfz9aWPDAgjvSucj5cEdfWugyMy7GCc9+OaybkHnjPNbFwOCc54/KsmfjO3lsc1ky0UzgfhU8HBzg7faon65BOc1PFyTuJB6n3qRl2EEAnpz29a1LcfKOtZtuOoyOPStS35wO30q47iZeh5A/wAasp055AqtH7/WrcXA57du1akk6jnI9PrVlB0HFV48Y/pVpCC2cj6GriJko4Xc+eOT7UvkLIP36hz/AHWGQPw6UjfcweclQfzFWO/PerEMWBEx5SiMj+58vH06VGzENsk5z91hwD7exq1UM6K6EPyCaYGfc9Tnkdeazbg4c5zwK0Zt20iT7wyM4xu96zZ8knhfzrGRSK5ODkgYznrT9+47RjOM5IqLAwCcsc55FB3GcKOPlyfUfTtUDLCIXb5sgDt71OzeTEWbZtPtyT7e9UTM0eUDOxyNpODnPTA71ct4zGrTXLGSQ++Qv09KALcKXLISxEUfXOfm/PtVq2JKhVDOcYJcA5/HHIqKCTe6rJguo4HUe3SpRcJJdSR+bGQgXzARjOegrRCJGuZIgdwULgnK5I49P8/SnQpJD5r7zJIAMKq/fx1xz0zwPpTGcMkrKBlwYkBGRgDk/T/61NExsrITQbZY1Xewz83vj29qYjRBLx+azKqkZDZyaHMrBWKqycY9fqa5KHxVbTRttlVViYqFIzuGTjH6VuaL4gtNStEMUqPLjDKp5yOtNTT0uFjZj+XGQDn0qbcvQjn6VmrdETBBsBHLDeM+3FWhI7Dd5i5PHyncBVpiLQVSegyaQqQOCfxquLko4EqHB5DAVOkvmLuiO5c457UxkErdyMMKpT8gggVduIy6/wCsYHsVwMVmzsyfeIPOM0pCsUpMcj39KRO/0/CnSYPT9KYnP41h1GTDvj8vWl7cgZPrSg8fXpSoMk8VVhD4wBgZyRVqIYFV0OOB0HFWYx696pATJjJHr6VMKjjHpUg6HmrQg7ZyaXHr+lC9MClHt1pjPPosFe5AJHNK4zz0Hr/OiInoOuKcwOOMjmucozrkEg4x755rKuBuXqCf5Gti46c1k3C/NyOB7d6ykUii/U54Pcg1PAAADxnr+FRsMP04x61ZtwM84x39qkZcgJ9s9TitKAcgdaoQD5lB+taEPDZ9fariSy9DjB7kds1aj+6M+n51WiPIxx7kdaspxt7Z/nWgiygwARj6VZQDjPPbjtVdBk4PTvmrUY9O/StIiY6QbkwuM9fyOf6VZU5AxxUcY9RxTrcYjAPVTt/KrSES4wMDpUcoyMk8VKB71HIABziiwGbdsREzdEyCf8f1rLlVmc4zkjitO9ZS2wh3yPuKOv58dKyrmVobcF15AwdrqSSODnnpWUlqUiF0ZOQoxjgZ/PnsKgeeNS6ROFfq74JC56n68cCqU10hWR2DtJgfIqY2joOvv3rDutYnhuZIbOCaW7QfvicvHEvYvjoM4wucn9axlJItRb2OmuLgWiRsxdJJTsQffkI9FA6k9cfTJGKUQ3kgM004gUYCwKVwp9XbHzMPyHT3rlI1uhI9w2HnkDB53lyWyR8oUEhfXA+Y1aWTyXR7yVYkAwonZI1B7dST19QKj2sTT2TOstGYT+UG86IYIDEfMT79+x/Gq8eqta3bTwOF8ySRGE7fKyDbtG78OvOC5rn2uZ7u3nbTY7m4DdTbyI65IXGdvKjueM4FV4JEsdKErwSpFPG+6eNlcsqnAwp9zwe5I9KPbxD2TOsnvxJ/ZtvFP5cgYEhD98BQSATxj3PYcUkKG7V7iVpJDtzLETyI+cMvfgH8RnvXByNeTz3N2rRpLbWoYeT8rD5gRkjjB2tzjbyOa6CHUTBa28tu7qVAWMkbWU5xtcfdKe49OQKI1ovdidKSPMviDNfaBfK8d26oGz5fJ3DuCfTkfWuRg8XX1hLHf6fdzJMXZnjBITbngfrXonjJX1SxLXtsWjQLCVUYZwPuEN+QJ9BXkGr6feW6QzyoqQ3Ak8tY24G1trDHbnHXrWTd3dMtaLU9V034q3l1D5/2NJpY8KYIwAW9y2CfwFdlB49s2srO61C/eCV/la2tV2eW44YYbJbqDXy+0joNmSFByRnvT4GlYSeXvOF3NtHQd60U5Ii0WfV9n400iWHzIYdQvozxFNMgjLY4zwwBz64Fb2h+LbG7uUh23NnOw3ATA7ZB7Hofwr5k0e58ONZ27XiXZl+7KiS7fxXFdDDZy3DrD4c8SRRgjfDaXU27B7DceATVxqyE4I+po7pZU3qTnp14qG6IlTpya8K8HePdQ0W/l0jxCrxagn3o5CGSQf7LA9fcV7FZajHdWySx5aKRQwIOSOK3jUU0ZuLQrfKckj1P1p6AZzjmoQ4OQT0PBx1FTwnIwxwRUiJUyeByB/KnjJHTB6f/AF6auec5x2p47DoR61aEyRBkAjgYqzGowKrxHJ+tWo/z/CqQiVB3NS49qavFOHvVgFH50pHGRzRjtQB59EfXHqRUrDI9j6UxBwCScVKehJwD0rnRRn3SjAJ/Ssq4HUcY/Kte6B59+lZNxktjPeokNFFxk5zxn8qngxnJPB6+lQuSGyw4x+lTwDhcgZz2Pesyi/b4z246Z7Zq/A3I7D2NUYAcGtCEEgEjGTxVxJZdiByCetW0HPPUmoIR8o6nn61bQZOfStUhE0XtxVpBwPQ96gj4Gc4HHJqGXVLaEnD7yoydtaXUVeTBJyehp5IIGMn+X1py4Rm3sVXAbP3R/niuZOsXc4/0eNYw3OT1p6W1xPLvuZGkBXJLH5c56VzyxkF8OptHDye+hvveWsfDT/N6ZqldaxaplIpGaQg4+TOPc1QuI4oVJIIJ/iIx/n61TnAijMkypDbqh++cY5A57lj0/TBrJ4yb2RqsMurHXutSbdtvBEwBIJkfpj1/GuSlfVIrifzb4XAceYfOjVBGRliRubIXgdhnrxW6LR7yRVKzkEZSGEhHJ/vMx4QdgByOe/FZlzDbnZMXjSIMxVgm7zmBA4B6qDxuOcnpWMq1SW7NI0oroY15cXtyyqHkaVmCq4+WViRklVHA4zyx796l021uR+5i8oKn73a/zBV7ttz9SWJGSevU1fd7fS7WTU9Ud7XesggtmO4uxIAfbjr15IHQnNcfq/irTms5rWR7iS281cISALl+MlyM7xnKhQwUKuBuJJEWb3NNFojXmv7yW8iTTJYkxGWFzdEKNp/iVFUsc88DjHryakks9QRRPHqWwyEEKumpES3BJ3SHLEDnJzg4rm28ZFb0NaK8UjZY7pNsaLtIUlctuwOgAJ44xTI/FGpXEzstzLcISqhDJN5TkjkDa/GSecke4HSnYDptTS4ZYZhcx3m9gEaZY4rjhWJKlCQ+AMHpyTTLLWbiCa3a9W5njicSSQlRGzHcozEcsGIB+6wPJ9RXCWt+0EsUcgQXJzuQGOGTLEhgTk8cLgc4BJrUudQ+1oEHkXB8srJLC0QLtndk8FucMcgcZIxjIqGhHUaPcxobo2yiaxvGMLwRfLLbyhwuAp4G4MwZOpwOAGromgjjuFWNvMsbxpo42CYCSq/AI/hyCeONpyK8y0PV3SWe+G65SaRftcR5doV3YGQcswBVlJyQccgcV6ZeTy3/ANmu4niYXbLHLMi7VlnJzFMR1VmIUN7k5qeW6B7jdXtbaKJYZ0/0cqsAOcbJBKuA2exVjg9j7EVyvj/wrFd6FHBbyeVNFcnbGFAG6ZgOT1xmMfl713+o2I1G1ijY5eckABdpZAoOD6kY/lUN3p8k9lesIXbUGIYHAO3aMKfbgHpzk1pFNNkSSZ8tavoN1a6jcwrGXWKUx7gOCdxHH4g/lUFlpNzcXk0MKqCkUrsXO1cKpY8n6cV9A3GiRq0zWqbU89GRSvzZI53HuN2786yPF/h4W0MrOqqs2GlZgdsiAruRR6/SrTa3IcEfPwJUipBKUPyZGOQa6zxb4RvtO1KRBZvEhYjZkYQ7dxGc9gRXJyW8kbFXXBHvmtNzFpo04tala1+z3mZowQyOT88RHdTXpHw0+IT2t9FYX1wRA52pI4xz2Bx6148Rg4pyZzxn8KNtUHNfRn2zaX0dy5ZAPLcZIznB9QfSr6ZUBwcgdQfSvn/4SeN2k8nSr+X9+rr5TM2C6j+HJ74r6AtHVpMIwZWzjPBx7+4rpg+YzkrFpTuT5emakA7jj+tRqhUMOhHT3qVCGBIP4elarzIHqO2etWk/Kq0fWrMfHX9KaEWEFSVGnzHrmpB16VYAaDkf40etLjjv+dAHn8eRkg4PvUgHAAx61DHjbgnt61Lng8DPoawKRVuQSCO545rInTt3PHtWvccjpWTc4wxORziokNFMgHJ6jn8qfGuABuyPXOKYzHcBzntjpUsQ4z37nNZlGjAvI2k/hV+EBRgcY6CqVuAByOAKu+asMTyzYHZVHf8A+vWkdFdk7l2Fsg5BVR15wKguNRiRytvEXkHQ9qz2e4umGVKxkcJ61agtygCkEMegArmq4u2kDpp4e+siGV7q4AM7nHoOKljj/hER29SenHrV2CFd2FAPXk8lj7e1W7GP7TdO6OAgAIdxkEcjI6frXLeVR3kzqUVFaEdpGw+YQsFHO4jk/h/n6VbnWVJCdknEagKoyxyThfatdITAF2OZXb7qmLOfpgiue1LWle9nTy4yYvlUK27ceBnHplsde59Ca19nZWJ5rsbcTR2ZEs0TTzRjkhxhCfcd+g4Bx255rGmvZLu7Qv8ANcR8RRRAkJknLHtkdMdvrmsnUfEebjZEQSrHfIziLLHrtHLD03dccKBnIfa39vLLIZ54YIlRdlsu5MqM/MXA4UfXt+ND7Iq1tTQngm8maWfCW6q29G4VwBzubGWHTpxzgbic1hS6ldQ3Mtz5ltG6EosjsEjtwv3iARkhCwHHViFAJyKr6zrA1MqgWSNZji2hEhIKq2BI5Y52rk7VPBJGemBzd1r4sNQWQWyXbq3k2atJmGAA8ucD5gCSe33STjJFCQNmd4w1WMMZZ5bu5kic72vAsiySlsrhDwcLjJIIGdoUdTiaatzqjkx26yT7C4DzMgRMffZ+ig9TjHX06Z1rf2c+tCbVc3kbSTXEu/CKWMZOfXBITjsMDOc0yOazt7QNqf2qWFCv7kKo8xsDJkYHhc9FAJPrVNEcx0dno8U8Nw8/2O4QEK13OGaGHbkHbtUFzjnOcD1NcjrN5p0UpFtdCRkxsa1j2rJ1yxBJCk57dOfUVRUvq94QYJZoo1/1ERO5j/dXAPJ5PQnAPJrGkBwWZSCeQcYXHsKaRm59jR/tNjOS0CSRZLCKQkDOD1ZcMT6HNOk1CIqk1sssF4GG7BBQjHYn5h075/WsjJLZPPFKBxnj2p2RHOzqdA8QT2V1E4Z2iWMRyRqxXdFnkHsRySB6+3FeteD9VsrcraXEkiaRewvGlzCokNsCRsMuBwUfHOOjDPrXg1oG84BGCvnADHAbPaux0HWls7Eo8swRlIiRIg7FtuCpHHUAHPoOOazkuxrGXc+ptEnTU7G2kmIN1boBKiqNvmH+IEceuD71Zhj8+7V/MXLMEO08NlAysPTOPfrXi3w48ePatBbXk8RTO1Y5PusflL7XB+8flxn1IPXNes2uqWUl7JtbyoEuXkTgcHDDaRgY+YsB9e1CltcuyH6oGtLeRpfs2zcNuQRuLHgZ9c+oxWVqOmC/V3uYpAB9xJHAIzge4weeODW3b3X229R5mi8mZJDEFYNxtO1c+43H6gYq8LcT2qclmUAFmHJyo+968Gj4g5baHneo+GLe+t44nhxJGcFHAI7j8q891v4Ym5QQaQIYJkAYtnC7vmJTPU9sc9q9nlSQSb4lYxZRgpOWAJCkD16Zxn6elFxYwXUJKp8jgSKvTkH19RzTjK25EqXY+PNW0+4tLphfxNHKFG5QBnOP4vQ1Xsobe5YRvLHBKzBVMmdn1Zv4e3PPvjrX1Vq3g2wuYpxOg/egHAOC2Pf8a8M8a+HL7wvdF1trdokOYpFjUsnf5uMN36g1al3MnCxxEkE1pcH5JIJo8PtbqAeQwPcHI/A19E/B7xoPEGnrp9+wXU7YHZJnll9/WvC01H+244rPUPssU0aCO1uUiSEDn7spUDKn1PQ47ZqjpGp3mk6jFdWcrw3EDZHPp2NWpcruiLJqx9u2028Lv++DgmrAXacjp05rzr4eeObXxJpiu7BLhMCVR1HvXosbeYgYEFSOo6V2wakrowkrEqDkc/lU8Y9+DUMXfNWI+cc1SJJVGDx0qYDOM0xegGKfjnnpVAGB+NHSlo70Aeex/dAA/wAKeMY6HjmoIjxzyT0NWO3GMDj3rnLRVnOBkDkVlXKjAA6fpWtPnHoSeef51mzL3UfhmpkBnSDk8jkVYtzggngfzNQlQX+nHNSROAN+RtHIxUJDNBZI4k3Sg7c4wD94+lJBFJe3PmXBwP4U9BUNpC984c5WLooPU10VnaLgbYwB0JPeuatV5vdjsddGly+8x8Nr5MQyMErwP6n0q5aWm/oRhu3XP/1qnsrECITEiMnn1/Q/1p9wxmxFHIqwld0rsSMJ/Un06etRGFja5HGYJC8YljS2U4kcZJc/3B6n/wDV60mo6qbNoxbQjzW+UCQbmIPdUB5wcckgCmO00iiDTYRAqjasrgbgMdVUcIo68n14rK1G8trG0nbTyiO4JlvpQWllIHGwdh34/wAcVtsBX8TareSQfZXkYzTja0MEpGc8bSygFuTg7cAdNxrClyFis9OjlMibllkSXZDCdpykeOrAFgWHTnB6mo5XWaee4EwhijIEk2/ARQD1Yc7m44XkD3IxY021gutPeeWS/bTxGzG3gi8r7QwxkE4zjJwFyBhRycYqldkvQoWcUlorSJpsOxUwi+YsS8gcFiCTjnpn1zis/VbqWd1tYYYkt/lEvMro4JOGyeTk8AY5+Y8KM1oeItciN3HDZW9pZRodsZBLohAOXfA+cgducE4+vHazqeyAA7zDcLliqfNIoJ5BPzHceM5GeT0xlWG5WMzUL2cKbjyWE0kis0jBdhVATjqAqnHC59T1NcRNrU0txcSzOXeaOSLGfLCITnouBjnG3pyfama1fzarezNPJtaRmKqSxyBwqLnOB9fQ5NLd29rBBYokK7pbHMsxfOJPMYlwO/ygKBTM3LoP8PNBbQXs98zhZIJYVbYDgshw3Xqew4656Csq+mMqCSJkAkZlKIRlcYx8o6Dnv1OaXUJnMSW4zFEvzeUpO0HaOT6sR1P4dABT5opo7WKRmjRYEXywMEszkuOncAgnPTgd8UyG+hoWV7Z6ZpKR26q1/MpE85TPkKeqR/8ATRhxn+EcDkkjC3PPIsQfcOi7+359KQkbQig/LyQSad5apEPNSXe4yOQBii4krFcj5vl5X3oXtgj3yPWrMvltMAcbegEa46dDUM77pMKoVB0UdqExNWHyTEKIFPyAknjqeOf0FbHh+BZYLq6u5GCQqqLlQ4wxxgjOQOchgD8wA4zWLFG3mSEruKjGD6npV6O8TEVtOEMAk3ySIoDt7knjjnA9/pgfYEz0nw7BceU0MscENsF8+COWJTcBGQr5m3HzEo27aOGAI61pQajcQ3umwxxyJNFCGBhc4eNJdw6nn7yA5zjnng1x2m6lby/YofOlihty8oiQrG7qcFUUngYKbskn7357Oi3Kvr8aXUzzm7ESzTXKZaOJf3soXGcdYxkZzg84yahpGikeq+GtdM2no5jjGoGOSaKdXz5yk7iQp5Pysfl/2QeM16dp9/DdwW1xE6PA6YXYdw3ISMc89m4PTFeF6OrahiTT4EKRRLNcGU7URedqDBHmYxlmXk7iAcYz1tpfTJqEM9zOftCksVMfRmcAqm0glzyG3cZJHABNEbxRd77nTXM72kVrJdjZDuIkkJDbNpY8jHIyB/8AqqxdnyJ3lg2spxuXHBfoCPQkd/p9a821zxUy3+oaeZHaJ4uJy+77M4aTCjvtfBHPOceleqafKtzomn3dsp2yQKyq+cBWHzD2xnp7UQjctyKrxrIN3mq6ABuh6n2rlPFOl2Wp6fPFMoeVjuGTtUA9MnrzjgCulm1KPThK0pJVgDtHLM/sDjcT/npWJDci3toL6e1eaSTIhKyqS6/3lHQ555z0x1odh2uj5e8X6RNol61vtZYJG80BhzjoAfasm7nm1AiaRlaWKNUYnALKoCr9SBgevA969s+KUS6hpbSQW5Rgd4kPA2jnqwH5AV4bI48sq8Ue7dnzBkH6en6VUJXRzTjymn4W1670DVor2ykKMp+dOzD0Ir6z8C+IrfX9Jiu7RlXd9+P+63cV8cJJJGjBcFGHJKhuPr2rq/h14wu/CmrrNGS9lIQs0XbHqPQ1tTnyPyMmuZWPsyNgTwOe9WUUE4JzmsTw7qttremW97ZuGSRQw/wrbi5xXatdTC1iwtPFRr16e9SDoe9UAvbFA9qTqvf8KUfQH8aBHnEBJPPb06AVNyR/LNV4BhvbHB71bXG3jPp9a50WV5gMHPQ8VQuE5znHfpWlJjBLH8azrnAB5yN3NDQGWx38lvk5wD3pYojPcASNiJOSq/1qK9nAcJGPmPArY0aBURGb7xO0bu7etclafKuVHRRp31Zs6XbqQqoMkjuK34YI4IJJJ2AUL1/z/Kq1gqxQgQgNKwOM98dz+dWowWZV3Fm7SHue5A7AdM+tZQjY6GyKSaabbGq+TGABjjcgxkknoDj8s+tVY3DMZ58i33gQx9XuGzgOw6kZ+6vQDk89Jp5Y/wDj1RwsPy+ZtGWAOCE93Y8kemPekKSgyStILZMkZjceYF5yS/RQB6c9eeTVpNsTaSK19O5jcXyusMSktAjANIeuCx45PXoOp6Vxeqak0t2GELG6kQFD5ZKiPnovU5OFUcBicnPQWtZvi7OLeNYLSJxHEEQNLK7AbVy2SzHA/DnoKpQWvkxTiWIXFx5Zlm2ScZbIAeTkKMbiW5OMgYJFA15jtNtGneGS/EVwYGiIjVvlMrnCoSBz/GxCAknknpVrxd4iuZLcWVtJHbBx5n2eJQgRM5LlfTAG3zGG487TwKLRWtNPbVr+aKFEDbEiTG9cbc/NnbkBFA9DyCc159dvNqUzRPtto5djbScJHgfvJnJ6ED5QT03e9GvQNL6lWKV78zSSZhilzJ9smffLDEvUjPAZ23HIGS23oBXM+INW3RTzWkbxWZbyItx3FQuAEDfxFVAJY9wMYrZ1J2iu5ltYvLa4aKQqWKhUIzDBubGF2lGYnOfUDOeO8QyrK62oeNorRXUSKu0SuTlmx97nI69uwo20Jbu7ma4kaJr3yhCocGMdVC4wq5PsD161oQKJk05J4Xd0XaCTjahctx+BPX1NT3f2iMi3t4oRCkcdxLHGPvEKGO48njLfrT7+MHQ5bhJJpZ3m8uViu1d20MMc/N/GD6ceuAr3FYwNn2u6Es6/u5pHY7TtH174A4pdUvDcOg8mNETmIRnpySSR3J+Xk9gKbc5tgEXcPMiCn/dI3Y/HipLO2clSc/vSFBHoWA6np170XFylaSIRxpEpMlw7ZYryPYZ7nnnFE0QgYqiyLKMYDHkf/XzmrkcZe83WpkQISxbuBycA/wCfWraR2kFtNsdFYIkYkkjywJ5kk/DhR/vUrjsZ1vp0suny38sgWNDtBJBLHPJxnJ5PXFZZGOO9dJrF5HdultZRzJYWudnmqqnHfgcZ575PNYlvC88xjiXLsQAAPxJ/DGapMmSFljaG2RjgNJ8w9fQfyP51VQ4YckDocelWtRO+52x5MSBVTjqMcH8eTVPt701sZy3NfSpbSBHkdQ0jApsddygNwT14OMkHscVueH0kaxwsiqt7clXWRgxeOMAgEdQu4rz3P0rlLZ3SeMgkMGB/HtXsPwn0ZhqehvIN89xGjtEEBJiaRcKBznIEjEnHXmhouJ6Bp1t/Y+j2ulRxJbSXH76aUMS5G9Qi7jxnKk46AA4xUHjK+i0G21uaGKMizijtbVH5WR45igZ+mRkMSe+Tya2vEJe40vUriJysouZ5oB1LJEnkr9R8z9P73HSuA+ODiOBLW1ZhGzx2SlWCgsrFn3DudxU5+p70SVtjVbHOaZ9u8SQ3EykzxBPJM+4KHfcyg7TyRtL+/PtXu/ge5t38OQRXSiSKM+ZGQGeRo2XeigeoLMM/SvA/hpKIdfCQ+ckNq3mkAcqEuFPIyOditmvafhcWtLbUbNJGDWcz27tk58sMwUAnnAww/ClB2kDWhf1HR4r2KQiKO1ZSdivCpwxGF6cDAzgZ3E5PU1ycFodAv47eZ2QSDCSmVxMCeiqoGME84APU56V6Tq5mMU3lx5txnzZmx+7Xbkldwx2HJz7V5rquoreW80ECR26qTJ5l9MxmkXackggMfXcxVTnHNTOFioybDU7dJo5UuWub4tlwstsSdw6nnBIIz1C8qcV4v4t0CG11FrZ1aC8nIkjjdcAKenTPXsK7bUtRiltpps3V7OqbmeCdE2tgDeccn8DzmvNvEN9JdzlriSXc5LuZF5PuMfqOnGamITRz7wvCWIyAG2kjpn0pW3LuDDbuUNhehHqK07dEutizTiOEyKkhfOE/uscdB/LNXLrSBJ4WfUI54BNZXhtp7cuu8BhlXXn5kOCOOhGf4q2Wpztcp3XwI8cNo+pjRtRkJsbkgQsT/q39Pxr6hibDDnhuhr4S0mFp79YbZiLg/ND7uOQPYnpX1v8ACDxN/wAJL4Sgadj9rhHlSg9cjiujDz+yzKpHqj0FelPyOmKhjY98YxU2c9K6zEBS9uKb+v40h6ccUCPN7cnPTk1cQ/JwR75qnDjAz6dKtpn5cg4/L8KwRYMMDOPesvU2MaAEcscLzWtNhQWBwvqTXOPIdQvw671ii4UkdT61FaahG5cI8zJbHSy1wHk2jcNw+n0rqbCyjG6ZwdkanBbv6mqliojkQKpYuMZxgZ9a6C3gPlnOCBwAOPavPj77uzt+FWJ7RmSMy42lyFRT2HJ/Mdf/ANVVL6f7BaiC2ObucrDHsG5lGDls9OFDH6CpZzAJMeeBGgLPhuvrnH+e1QW0YbUNPjRRPNOJpVWQ4G0bBlsdFyefyFbak6AywaLpVvcTSeTcOyiM43MWOMqi4yzHoW6k47VzWq6lO+nxSXER34JVQwKQliNiY6MQvBPdm6HkUzUtQN7PNqtzJ9qW0GI05G4sSFCgdM8tgcldvvVbRtJOrTub2RFgWMNdTKwA7SGKMjgd9zdskDoDVLayFbqxNI04SzfaZncRFmh88kszA8uFOflLYJZv4UUZJJOLF+0dvAsC/Kjo99PxsBQfKikcEKMcZ5xzwW46XU7i1RXuLmFotItlEcFhEBumVTnAXsrMFAXvgZPavN/FM8k3npfTKr3c+JkDK/mKnzPHkdQo8pcfdyT3zhSVhp8z1KGtatLd3mLcMuxWMAB3MCqnc4xxvweOyDPQ5Nc6XMYu5Q8cNqB5czuT88YIIiQdCSEOT0+YDvWrdXsq/bILUrDPIvk+aMBWj+9IxAHCYC9NvCnrzWTE32OzMiSTMkCDYs4DFckIFCfdLhdwxnAJ45XiSntYguEubq8hmvw/m+U13KDgMo2lmPXIyxjHPTPoK4y3s1u9ThRoJVW5ZZJFzkImN7ZJGfu9CR713HiNJ9Mh1DT7YZKxtBcMZTuEQkZ5csPly7jYDzlQPeuTtIWc3ty8khcB4oghY9Y2LD3xGgA5/iXtRLR2IjrqHkf2hdahJHbj5EkiAjiJ8x2DEKO+Rx07AmqtuDNqP9nRwNO0lzGDjJ34Lrggd2Lge3HFdhoGlxQ60wuxBNDCycRu6pwNzfN2KlxnHo/PSuXuIUfWZvKZIWjLtv2kCABV3P0ycHcB7mpKetzG1WzkXU5Yn4m8z7Om3BU7PkbBHuDW/qGmrb2cJeQKkEW0biB5py2ePXG3kcYyaSxWee4tNVkJfydzRxbQBAsOxlUZ64yR05OepNXG3ywXe43M8kUQDux3CEtjeM9ud3T6cVLZUYnOG4iitWUITdTGPcRyVUglifrkLjsM+tUGyNPaV8+ZPKAAe6gbj17ZK/lVq5JjSU/NDMihmI/iY4KgDtw2aZqdqkcYRZAxht0bYvzhWchmywPGNwH1GKSYpIyYZHL7vvfNwr8jJ/r71YjIitpZcEu5KBsdFxg8+p/pSQCNYoS0ZeRmbCvkIQRgEEehyfwFSajbvbRKucpJCkwx0wVAH8yKq93YixTk+Y7S5JyMgdCcY/QVCV5O0bhkgVfitwIL1ywDxBSpJGSSwHH/ANaqazMu/ZhQy4PuPSqTM2rElnC8ky+VneT8uBjBxXvXwchktmvL1do+y2sQRM7cbVZuVB55Ycnnp0rxzRoA1niWdVRJPMKbfmG5ljyc49ema9l+FLr/AGBqRmhJ8yxmkRNvyNxhckDGSWIBJwOgBJqov3iktDstTla20HVoIpR/osZRWJBzIAJCme7Fsg46AN6ivPvjGcXmnSGNXiDwysCxKkugkbI9hjueMV6f4dsoG8FS3UyiRZriZp7kE/vXl3ZweSQAQv445OTXj3jmT7Xp+ijcJNzRW8iEqCClvtfn3I4P4UqmyNImP4Ckjs/EhVid98jZ/hyGkIAB99wr0ay1BdB8UXiq8ywR3RQySIXVEMkiZzkHbuA54wfUHNcPpenzebHt8qeBoZIhGsp4kREkBAxg7xGQBk5KnocV6U1lJcJ9phMslpeRymJiN6As5kRCW5U71dfUEcjnNQk3sO6O21e+/tWGGCS58mZhlJERnjRsdhkgtwcdenGCa8n8TaTDB5jbGTc5cnUHZFlGeMQx5bJ/2yK76yht9V0q3kliaGcRqzMAcSLuwdyY4xkZ9x83BVqwda0q/t5jG8FrC867d+yI52jJIZhuIxzgEYzkVtN8yvYiKadjzuDT7zU0kQX88SrGs8kNtvCNnjZnfxjj2PauU8T6JdWDxxX+lmzBLbZydh3k8b8/w9ecDg9TXd634V1czoIGuUR4yoeKIOw2c4IBB6HP4HFcXrllP/YkkGoS+bNBMyIwXGwBdwJJ5KkGQY6/u+9ZxVi56nImGW2A3RnEiHIJ6rn+hH6V2nwxhUay4nT/AECaE290rKrGS2kGHVSRkMMblI6FMZrnX8+4st3lkXVmVDMuBgAhc9e42nOOoJ7muj8NME1aN4IPNedQ6Quu/erKdyAHAyRvGTnkj0q1uYtHL+JdJu9B8R3WlXG37XaSBFliPEg6o4PuCCD716X+z1rptPEstq8m1bpclT08wdfzFcz8RUkv9P0jUTHl7SBdNkmUY8xUH7lmHZghVT/uisy1mi0nxFpeqaP58NjNslQSsGZWXAkUke4P4EU78r5kK11ys+2oyCCPXkU9STwcZHBrM0O+W+020uVIIkQE4NaRyGz2r0b31OTYcOhPFJn3/MUev+FB9DQI82iPAHHt2q9HnjP5E1Ri+YjOR2z6VcjIGMjk1jEsp6pMRFINrEDgD1Peq+loZAA3yhm3P7+1Mv2823BJPqzA4xzU9iWE6hSFQcknt71xYmV5JHVQjpc6FYo4lhYlt5OOmTk1uxQmZMynESkED1wD/Ws3SkN0guZEKBxiJT1VfX6mtS9uEtUdAcCCISvjt1IH47enelGPUuT6FOQJ5kqfcRpFQjIG2JOSc9snI/Ks/Xr5LXT5ruc+XLPA8SMRg4cZIA/hVVHX2qvb/Jay+biTygiMBnDSnaCnudx/H8DWb4mnVLnThqOy4vJHmkVGGUYLHxGMdt2MkenXBqou7G0ZWl2ouL/zGaZI4FaWWPdh1jKjYuP4XxsBY9CQoGVNdUnlafYx2k+DJBhpYo+jykgRx5PCqAAcdhyc98y3uYbHSDKVuJZrpmubjIG+WQndtC9ycsR2FUEI+wzz6xuWPynvGQNnzXydwyDnBJVQBnjnNO/YLX3Idb1Ce7ha52SOAogtPOJZI+v709yxUOc9eQB1NYiie5SS0hluF+zRtI08oASFU3ZxkYDuytj9c5Aq1PqHnF5pFijkjQHbsOVUNhImHbPyrxn77HooxW0yIWvhudZ5douLeKdjvIBbOFjU9BycbRznk9RlLVg9DnJvljWSQtb2QMVnaxiQZ2sWLFR1YsySMSeTtXnFN04C+uW1W4Co0KtPDAzLsyCohUDHzDJJIA5L4z1psFmNRu59RVZZLSyiCLEnynzmRUUKcckKcse2Rwc1vaRpoXTh5qW9sszJIiMzKvDEIuDn5VJzjIO09yKUdXcc9FY4/wAUKTDfQyuJQluQCx+bdCoj2/7QDu7dOuaz9KsXMMMlvFKs80qvANhLh1Xe7c/7BUADrkA9Kv3tusnh21leCSWW9b7SsnVhGGG8MfZTnGP+WnPbN+0JsZJri6ZnkF4sSICXYKDuQqCOQ2MY44cdcYqHuUl7pYsLR4PEc+mqjZZJLU+TJv4yTjIwGPJ5xkgH1rlZQlzqesyQh4VuLnymSRMBVkmUhSATjC5PPTn2ruNAfyNcJvUka7tYrm58wMfnmCRFQ3GeNgbuCWrAs9Lil03VImimVTeiDDDqqsqjgckjeDnGDn6CptdaDbs9TL8OWPnmWO0gd3nsQFB6FmlI349FwCMY+5k1XureXyJgIiHviCoJ3n5S3U46Fjk8YJHpXbW2j/aWjhtpwjy2RtttyRmSfLxfKincM7w4HAwMnNY1xBEy3lzFayeUsQjhAkGRGUAGR0zxwR3cYFU4WJU7nD31s7ancW00StPMIUdtv+qb5CwXBx3A5qjqCs7XrJuwp3MAR83zbc+/UcV0+oWfkeInhVfMRJnmwi8ttC4Oc85K/QZrE1O3f7TclnWQo6hsL8mWCgAD6Dt3FYXs7GrWhTe3LaRbyhZiPPlt1LHhfkRiAvX+JifqKsanbvcWbNId00CRxIoABC4DEY74B5/OuifSnlsrdreR/Le5cRlF2hQ0aHdu7EqH7du1YmoJP9hknU7gsg3yDPytg5OcehA+oNJt3QcqszBYAI5TIVI0wCe/yk5/EmqiMEk3ovy5+UMM8V1N1pb2IZ1XdEXMIdlIRuuGbHTscVQtdNWWK7kmLGK2ki82SMjAXDbsA85JAA+v0rWMrbmMo7C6OsUhlWaOSQm2lkZY8g5BDD9ATx2Ne2+AdVnk8Lam1r5kbjTzKzJ8qqiqxWOLrgZOTjktnpivIbeJ40tbgAIbj92pZtiDO1WGDyRgj2A55r0DwheXFn4DeC3Ct5haEOzZBxtJVfoSSTnAwueBirhK2oOJ6lq9/Fb+E7PQNLkWMRw28CNwFVnSNDIcfV2HToT6CvD9bkF9e3xIdUjuWW3jQqVVP3xxx3GEyfrXpWteTZ6KLWNgklxcwWeBncyofMnkGenSJBnGMnvXketQT262UatKbgs5fCkBS8hYYPTkOMn6CicrhFGz4blkifT44ZFCbOo6eWWdTnsTtkAx1Ga9QsLS9srPT2hnItp5BNbgozqXkDB4354wxfA6/M2DkFT5x4OiDeKbMzmO4iDuGVQWQlpCpBHU4Gzp3Fe1aGkj2uo6dMf9Ika4eBgANjrJ5igL2wc8+x+tXSV0wnpsP0CW1vNLkZgxVJA8m195ywIGP7rfKecbWwOu41tSWxuZY4Lg2stveoyOHyEmfI2lT/Axz2yDWJpfnSo+p6arzxSQvHPb4+/sf5goP++DjsVYjrg78MEM+hr9lYsjKrxBxuDpjcv44IGfYelWnpYl7nNXNpNZ63DbXZWadJWWCWQld6NEcqxxgMNoPr1IHXMHiOws5tw1C0d4Z1Xe0nlBMo+cblHXDSLggZLe9afiVfMGmXFwSpeeJTIcschvusAfvKeVPdTircsqPpcDuv79ijJgHBbcBsIPqeOeOmacWndA1sz501vwbd6F4hksZFjmtpo3it53GVaMnauSvdTj8CKl0C3WPWJbG0uUg2XKNBIMsIjjzU468SBkycgbznpXrXjCy+36Bc2k0cm63YvaToDuUxngMB2KqAccg1w09pAl7JPCcJcjZGpVixnZEmiGQeCWDfNwDz0yalKz0B6o5/xpE81petCDDYMsdwoJ2q0UpAyF5KuGb5lPrkcV51pgnlMunhWdwzSxLnG2RRyfxAx+VerPcm/0eOC4Scz3Ok3dhkBtjywOrISSOW2bc4H8IFcN4mgii1CLW7F2R5p0mCPg7VdQysCOvIcH0xRIlH0Z8E9W/tTwZANw8yIYPtXpQwVz1Br5/wDgVrBg8QT2BAW2uf3sQUcLuGcf+hD8K9+hPBXqRXXQleCOaqrSY8dPf3oxQDnqP1oNbGR5pCfu9N3f3qxIzeWwU/Mw2jmqtud2MD/9dThsyKSBtFYLYtFLVYzb28MZOXm7DrtHHPpS2oMkZjUEFvkxUeuLs1KBy37sxE+4x60mlylRb7idwLPt7tXDX1md1FWidxYXIjtw0iPiNQvqCfrVHUrlpNE1C5QMVmbl+m44CgDPYAH86gWfzbiNTJmOOMTTovKr6K3vwSfYe9ReLpWh0hYmWNR5AkVd2GXe+ACegyOv+9Va2GlqS3Lmxt7GIMPNt1Eyb/uiRxgO3qR87c+g96wZEN1q8ESM0UOBZxKQd4hYqWd8jbuOUbA65UVf8xr+/eOcYVQrNhQCWONo56kqCAO3mCs3wuHudZsVOZ0ivcNIsgKksTkZGRjPTHJ2/jVLQTNvXoVgeGHfJH9puo900gyyxhG56cnl2+uOOlUtXtx5dr58UcaPE13cCTHliNRlIiTjuIlPIzvb0q5fSiTV57q5dhiXf0K42xyYweflBjOPXJNYeuXVzc3TiQB3iso5miaMA7ss+3njA2Ac8fOM1TsSrmE8TX880M7SeYm9p4t2Su1FeQ7sY5wBnoN6gc03X7gywX9xdKXkjmVuCFRnUyIqnGSQAGPb7kfXJNWLiOWCzkSR5JZmjmLorBVkBfqT1+d0PAI3bcfXElkhkAKxF44yGEbKFhmcYXdwctuHlgYB788ms29Gi1uiPRLaQ2dqkSG5nlfeQshhJZuQNwPy5kMa5HPyEHGOLshudYsbyOJmjtbOFI7JYPlLO7rFudgMYwDjPP77gHdxYvIxbXsOlwJczLbAJMVU73IIIULjgu5j4HAAY571q+GbdWe0ndxHaWkZmkLEjzJUkJRQfUyENyM4XAz3cF9kmTu7nNa3pTrrsOlxxLcC1EFvE/3VIDKrsQcHDSbjnJ+6oqBiUk1S2vPP+zXyrDHKuAU8jLRyhepIA7k8SA8kV1N9ZeXZxoFukuby6UglPnEcYUqPqz7ec8YfismSyhmvZWgMVx9lUoiImQHEjCRQOclg3B6YA65IGclrdGsXdWNC5sZTrlokccii/itgZC4DbXUKWO47WwV289eexGMnS/LthrU8Ey5a9gv4kkXbvCBmmjCqTgblRST3UetbGn3Qn0yylWV5jp96S20K8hxKqk7gecMwxjH3frWH4vuJbW2M9qkxjczZK5YBcS4Yn+7kJt5zkfStLWVzJu7sXiVS68PSyebLkz3Hlk4EiyQ/IQOu/KDnvkVb1HTpLZYtPgZnSEw7Qq4y6qm3GSMgEDHtnqTiq1hcwabcwR28txIlnYuVnKDeUgZAnBOVJkDMwPUE9jVl72QM+o3crloVhu/3mWYSrGzyZAxgqSuAQfm5xitNLEHH39okV/O9iYxcKs6xs0apmHEQQ8kKuNrcA8Z9a5+6tY0eFFjgjAjSIyFvNIfawYAAEt1/Dn617Pf+HBFqtolxELtZFiQBhjaN0YdseudvIx3/AB599AP2LR7aBG8ppY7h3VSpVwXViobocc4474zmspUGmaKqtjJstAE0dlaXxeGykuRGf7qAqgYkckt8x/4CKytV8ItbaEjLJI7XF1Ivk+UwMyq+1CByCctjHT5Wr1GTSY4LeVkuJIzhEiMucx7SuRjqATjv/OugudGFtJvRJZWhe2cbmC+W4YEnJBwQAxJ6Yz3xWscNdehm6zTPErfSZprKdpInmvnc3YxGz7RviVcnHDENuwOg/EVVsvDwlFxYASS/aLxZ7mR+o2tIQpGcLlRub65HAr29NIRtKt0tJcGWCEyOrkgpkElQMZJPGfQk1yOpaGthFewRRlLm4kKLLGdsnMeDGyj7qghiTnowFKeH5dQjUu7HC+I9GF/LZ/ZLaOW0LwRRTRMPliZkBK5PGTkcjpt966DwzAtn4Lvb1olWOy80xuAAXkkLo6juAV2nt8oAHJzWzp/h+J4WVoozcOyDa7kBQfLYLtHYGPIBxwT61Frdj/Z2hxWVpPM0bF5nUocysV+Ytnt93ntnPHQZyi0nI1g7uxTt7GXVrq6aWSHyY2BmWb5f3RGML/tGaQhuMDjk4OMXxJY/amnkX5IVgaSBkyVVotqGPI/2Bvzx09K661hmi1C+tmGXcx2qMcLxCC7sM4AVpnDAHAISksHFprRju4o2ie+jmc5B3LLFGhQAH5VxISGx0HfHMwitExzb1ZzPgTTBZ65ZKwIcX08ccgO3zVPksFCdVwGJ3HnJHpXqRkjs5mjErYjkX/SB1HyqZNzdeBnHIyWNZ9tpsj3OnSpHtkEsE7TKXbf+42vlWGANu3rzkCp7ecnxRrREzPHFcIhUryikhT17gr9Pmrbl5FYzvzamz4XuD9veJHRJUm3KQSckx+55PyAZ6nNT+F5THus+TbmUywEKCBuUu0WfoMgexHpWPDPPb3KXsZHnFGyGU7g3z7QQOjEsAfcjtWxpSqn2u0hY/wCh3qpbucHIBDxHPsGA+nB6VNymkQ6vbrP4fa1iLNPFNFJE24jkswxx2yrD8qzEunj0md40LtCUnVSvRT8xQn0yHI9q07u4Bkh8k4DXbqg9dr78fT7xrLuHU3zxW+G+12iQbdwwXSYgZ+ilv8ipvZ3KtpY0rmEuLqF2AR53Eci5BUMSQcexyPTivMfEWnznU4oTOfJjMSBIFysrLGpPH8OAJueRxxjmvSdSm8u2tkdmMKvLA5AJxtfvnJzsLEe/5VxPjARxXNpqMjubhRvYb8BpImVsdhjl+nYmrckyEmecot8ZbD7NGVt1uZJQSPm877OokUd8EbTzWjpml6HPaa/br50glswWUbWWF8biozgqyy9xwQ1U9WjltYZvs8jSRu0VxgOd0RBwQM98befQVl3MlxZWWtCBoopHlw7BT8ybQcrj1OKhTsypQujW+GDtZa3abIZY9oGwycN1z+PSvpy1mE6iRDwwzmvm3TJFfU7C5WPcZUIYFsbX3jn9a+gtAnD2du+SRImc+h7iunD6KxyVtXc1h1brinj16VGvU/lT/wCddSMDy+3xuxgnA5qxb5cqOeVJxVaM4+8OBweelSwMY1fp8uRzXPEtGD4guQdQk+bGxQOvbHNSabM0I+0v80jqFiT0rNumWa/ZjjDNzj0zWpJtF3PGg+W3hVVPozE/0rgm7ybPRp6RRurJ9msI4Aw3SnMpGQXY/M3Pbj+lUvEOozPCywRpPcTh5cSMAHOcRADpgvg/SM9BUUsyvfeS77YLYAtJjK5bjnue/wCVU9UuEe2m1DDG3haO2gQAEs3PzdPu9BjGQGNUrg0bOkOrFxBMzyGR5pZlODkhckemBgZ7YYD1rM8ITJZIjOXjECbyHXneHKscD0D/AK1p+EysGh30bfvZEiLM5B4WQs3H8TM2QMf7P0rA8NeYLNhJECIWMTx7+TvBy4IPzdOoPY09dAS0kbetXUkZcohM9xPJaQRtkgMVwoI6ZAl5PXgAVmaz5M+ozbkS4iBaOMB9xlbcGO3j5m3uDjpwR0p5neW4tQWjRku3usocBnZXJbOSBwoIyeTyemKq65c200umJZeZ5cQkM53bQEYAoTnuMe4zjOKTlfUSVtDPjRYtSO+IujT+SrRkqs0mRGmTnhR87g85JH1ppQ3mvW8NqjQWlixlAQMAyRnPDckEZ9ec8dBU7RmW5uJGgZIIpUVSvO1iVMhIAOSq7cEkd6taZGz/ANoPbsyOiC5D7stbmYDar85ISNBjGfmOT1p2voJy6mXB5lze6lcKky3F0RH8uSNzEYRecg5L7iD3I6Zrs47Ro7q208wun2kRSlWfYoMSBGAC/wDAed3O446VV03R421PRYXuGLzxmeUyM399j856Eqo78jNaGpTsbhrqJY50gRhEVACmTaY1LlR1LA4A9sHFaRVk2yG+Z2RV1G+cajc30IV5Ycx26owGbqQExhRyRjcDjsZD1NZhtY9Lgt1TDW6RSQMwwPli4LZ6k5LkEdOPQ1u6EIru9s1t3ZrAyedmRQHkJD7ScYAOUc/Qr6Vj3ofUND1OTLFY44o4UVd23IZuBjgfxE/7Sg1jLVm0VZGVopltJL1bgAG6jvZJN0RY+bHbQyjLA4A3oxA79qyLW0kkSVtXIaVbAT/NI3yq3mO44XA+6TgcDcDxiuh02+d4LK+mEaKushZZQCdkcqsqjcTjGXCt3HasjxraW9p4ZiW3uftct5ZtEzqWLSSBJX5wwAwN3J7g8Vsl7tzB/FYpXtzYPoA+0M8k16sc11NEoYgxmAncc5I2lxnP8R9eJ9Auri61OGWdImS/hE0lvjgRrLg5J+bcVjYY5JDDtXI+Ioxp+laWlsxmaU3C3bZAV5NwbaMcdduV7ZFbPhu/ivfGVi8D7rWKZoCpQ79i2/loDkkElncdzuBqeb3kiuXS57Bot1JrunrPI7pMJFVmywCRlo8AZGemcnrnJHUVneJTYRSKXl/f73MJV+QsgIKjr97a3JH86xfDmqwQeNSrX0xihDrcPcKQd6OqEHaQMhFjyQCB+eea1TxDLLc6rMIJftHmmKNjhfLaPBYlew2j0HX1NdUqi5fMxUW3oeoS3EB0a1sYY03rPl9kRKI5dmwf9jcFzngDFSaN4iin8QafbQLgySMquVOxlKbgfRcSYBJ5x7V5u2tpqnhWS+uZAyw3piDKwQbYwjOAvTcXbgnGdxHOOeVsNalW4h1MtFPAlz5awxSCORRGWIIXqQVXkjPYml7e1hch7x4avYpLl9PhjATz5oHO/Jx5pA3ZPQ7QAeuQwxVWeGC88P3s8lzCEkIeGNeSZS7bgMnDDJUAc/dNef6x42ih8aXTxmcW7zrcq0iZOQUcruGMIE5J55bmtzw5qSzpqGm3VypktdTCiOM7mhTcw3Nng9e2MEetU6qasEYu9zce0k02xUWETwyTI25EUAyeVEzAFs8BihXdg/KT7GrevaUk1rCYy322a3kbEbbDgBsxrkDAxwT64PpS3uqmbUzyDJiQQRFQNyEHBySexY4B5zSw6y097OmfLKxh4nVtwwfkwQeQv7rPHHJFT7rjY01uVIoLW40We9uCFH2tknYrzjYISNvruxndxheoBrONp9tkYyEBLtEDFOGDwyqgRNvJJUgY9xngU/UFMPiDUdHZ8BHS5A8zhkIQyDpgku2TnjHfmniJTcBFdGuAgg2KCCkzJu3luqggOMk4O0Vity2tCR7yNNKEtqwuRaxTbZIgI2ysaL5bKPlUZ7ejelR2SyR6nqayDzEl8h9kigHA3b8/UMp/HHaud1iWOXUbnSCoRVmuXcqVIyC20kY7rtwOnY8gZ6fULm1X7Feu8Km/00AFePnxE+MjpyScc8ClUdwpqxetZ3gBe43l4UiJkkYFnIlKnOTnBwmRz1pPDsixeIVilmY+dd7wQpwfJVgcn3WIHPfPvQqeZY3C2zFHnu5BFgcNvkVY+e3BBqqN1t4ha4g3LEkd0V4BUE7o0JPuAePespOzNYpNGhFk6npiMSGE6ySbV6EqQT9PX6VmXjSvr1pLA6farVn3lOhVGVAx+pYGtQW+dStUQkB7uZzz0WJNpJ78s361h6bE96819DEyXU9sJo8ZGfNuXb/0FCT+FRdlW1Nmd2mFzEh3F5/tagZB+UDIyD1/xrl/E0AuY0ikxkXCzq+RjDo6PxznBH5Vt6XMr6xcOdvkThvJC8EAh9uB1wdmR9cdqw9fma2WKQqGaBROwVtm4ISWAx6qTQpA4nANcfbhMhjX944GS7bclVICDpuPzdegrnNavDDaxKiALdWvlSFxu+YMNxHbv2rf1KJbQ6gY/NSWPUElUA4/dkAqdvXOHGD9fWuZ8XW32O7ggjSTy40yPxyePy6+1KTaQJJmj4X1Ga9MsWCGtsyq2doYb8AH8MV9I+FnU6aiDJ8t8dex5r5b8ITqmt3pQjyWQIA59ZEHHqc5r6b8JMn2aSOKTfhRzjAyBgj8xXXhWzixG51UZyzA8mnk49qjQ5jU557U8kZ5z+VdpynlkWAB2PSm6xIYNKkuE+9sbjGO1CnJzgDvmo9SKyaZcLIW2mFwMH7vHauZ7GsdzC8MiS40aCd1zIxJ5AOCTwCK2pxuYuSFilHl4A6kcj8eKTwdahPB9m3O5SGLfjyat6zm3sQgVSom3x5PAJ4P6Z/OvM5rPU9GCOeW5TYWmkKRXFwUdlGTtGR09vSpNXWSS2tLdEMQe6G1c8KCCQR9cDk1Qumdp7wKxVYnaTcx5925+tSWZlu7gJI8mI4hsYgnyhnkn6bcfiBWyehfLqbwvZnuoktQS8sKbI07KnHXvtw2OwCjtzXPeHblLTR40jBcAq0iquWOAq9+hBdsn1NR2OqSFmnWMSTPAsDY6rGEBYADozjIPYU3TY4otavIWuEMi3JeAKn+vVl8wDoeNwkHPcAcZpOV3cOWyszZu4XS4FpHsma0YbmTO0IkQG0DpkKZCOozgEc1Q1OCOO4nt9g+zymGPzFdcyyIitvI5xuMn3TgDA963LV47aMeeyFZp/OaRU/1ZDgEhRkDABHB6A46isO7tJIb2zlui0clzkOi/OzHzoy248Z+QsAQTx+NTK/QSLMttb3Vi7kIGa5MhbaF4JykW0jJzhu+PkPXIrT0SOOaMTmRRJPP5jpgb9kbMACedwZsD228DFc9PfGDS3tmuTJJC6m3dh/q83ON+X+7kD8N3HU1tS6nDHoaXMJFzhiV8tAfnBY5wc/dGCT6k8dDXRGxhJPY3/D9xaN/aGpPFtZYGES9NmFEcsY5G7LMx7n5SM96j8ReXBp1tGU3TrEsoWNvLCkDCAIfRs8npg4rO8PwTJaRxSowLYdWGHGUbc7nAALF8EHuFYY6VNr17FqFzO1y5AieSSVkG4C3hHl7Qo/jd5JgOeuMe1VJe6FONpCy5tNDuLYZElyqPEy8ty4j2L65TAB9GYirmusj+assW63Z5N0kbbd7ZVsZHVcsPlPXBGRVq0tmuriO9lKI0cStHFGCVRxv2gH0yeo/uVjaxtOl3u4M0BhYxezDbuRcdcAuR/8AWrnTsjotc5C61Qaa2mSvGJbWKe01CRYImPl/OUYsQNoI4z+hz0rePLue71Kx06S5lgVZ/satHKrGW3kYFOv8ODIMknoM4zWVf+I5YvD0tuzQvbSPLaSwlchN8ayoSSeAkykjPUMfocHW9XbVXlu7aEoqINRBMYDL+82kDGRtGBgDjr0rRztGy8jn5ffKGoanNFIZwywymW5kVIz8pLOAEYdMY3c9+PSr3guafQbRtSyWjbKJGku1zLyoI7jDMx4B+6KoXNxFC1xY3uZYpVtbgnHzCUbd6Z7ZDP8AkKZr1v8AZ5JbZJPs5hEcoXdhF/dpuIOTzmQ9PTpWbbTLWx0dxroTxlY6gsgkguzFdxrI+Y9rrtk3DsCyAt/k1kXOpeZDrDR3LTXJudgd2+R45MDkdOxGc9Kzg8eoWOkq3kwy212kTP38qXBXOOwKt/31isuG5IDW6ICHIgYKv+s/e7sn34ArRtmcUdHo2tTQaSyyvCunm8kmMboG371jDhQemF5H0rE1jzrW8+z7o8WjND5qqMNnd8xI9ck/SkurZIrWQxMZbaC6MPOec8oPTkDp/smqWp3DXFwJ5VBbYIicbSSq4yR69PxqPIrzOkj1mzl8VaczyMdNIigmZxtbY8SpJnjnGCenauu8AX09zrOoed897PA07ONo3y78llHX7rnj/ZryS1jWRnSQtuVG2hRk7tpI/DI/Wu8+H91NDe3U0Bjl8mUAvyCwlDp+W4r+FNydx00rnqHiW4itDpF1aRmb7TcQRREAhCQjYGOuN0hwvsaZotwLHxBKt0slxHuv0jeViFdhIjg4PYKJPxrA8fXT23huwNrJcLcR3cVzHt4wJIzIGxnGfmx26Y604uE1xmhhEskd3IoQHhlnt33Jj3cnGD3FHPqacmh1/iG3uH12zvJtspvw0DsQf3jNgOw6Htn6A4qDw7raTnWpID5ckscF8pcfMFDxKoyT0ByM+jenFP1K8Q6JY3LTozaZPDIzqpYyxuEldxxxwGwD/crN0FYdP1JdPmj8uSW1/s8HaWUHbIRzg54gBz6ntT5rSDlvEwdQ1Ar8TUtoyUR3KCIkbsMjErkdRlVPfkg13EtwJfh/4OiTzkWNbLfMgyQChib8lOc+oFeWROY/iFpDTrIGDmFXChfMdGK8jv6575Fd/wCEWln+G9xIZQzW1j5sZ25UtgSAk+21+Paknf5icUn6HolpbGHxRbgqVtVmdECkhAyCNgeOCQWUcj+E1Qnnh2QXbgurXayn5MjyY1kGOf7xAH41LDli8loEjkkF5sywyr/u4yc9ztPJ9Qaqa6qpE0C4B+1W8EfO4bfMLcfQsR9GFOWwQV3YW9MsMEzQMWvWgXTYAW6yTSF3Ptjn8FFS6FvkZjagNFLH5NufRBhQBg9eXP41n6jM8yoFidZJHkeLyyeWkAjTac8kRqfxauk0G1P2dHVAIrdVSBB90quM/X5twz071kk3IqTsjH8RrFZ6zutGwI0aABRwqxsrg+ndv++a5bxbdM8Vm2PKDQEPjBw5LYGfYDr712ni62BW1iRkWRJyjE8LtKspz6dRz71wGu4bwnbibdOzxKARkHL7kDKR1wSv1xTaaegRasc61stw7RGYhpoYB8qkvuAiVgwPqQx9hXM+NI5WvL25Enmxx4XeSBtyMAH68/nXqVxYQAwPbqbi2Vt0RChNrFYW55znHJz+HWuK8T2oFpqElwvzyGLMYwGZCxYHjoRgVpUhoZxmcZ4bBW21Eo5EkMBkJx/dkQ19J+A4zFNcKJPMWUb0OO3f9a8B8I2ZuBr6F8GHTZWfLdAJI92B+Ne2/Dm9kub9ZCQ0RtVQcAYKkjIHpxWuG7nPX7HpsfAIqQfjUMRyePxqYe9d6OQ8nU98Hk9Pb1qrrLhNKu8ZBMTAA9uKtBUzwxGR1NZ+omOWKaGYMQwwMDpXM9jSO4/4TXhutBS0kOSqkFD9a6jUbRpbcKzYdW+9jPQgZ/HNcB4EWTTNZLK2EkkYbf7ue1ep3kSzhFVc716E9815M00ektDzPWrRWNuwLCO5iMThRyTnP8xVCzuYyzF2VFitdrEDB3b2yPchSBj3rrPEcP8AoV4EIimVRNEf7pXlj/IV5tCHe4mtzFI0t4pZBFhhuEhPHsQDzn09KqE7GqVzW0WZL3ThLGxNzG7xTIilVUhwyg+uR8pPoAKNftFgtNOlSVRHcxhmCAeYpV/kIJ4H8eQSO9VvAcg8yAcrHOrJMyHaN6u2Hz65P6Cres2dzfGWGfzIrWyhDRkLnDtkKPfG8EjuCfaobui7WZ1FlLFOiSkiFN5Bds7cglCnccFXbr3rF8QaiLiTRWYJLH5/niPoTFgK/I6BgrN2I496fo+oO1hcSxyOF2FbmNgQgZVI27R1KnIPPPUcZp0cU1zDcXeP31paQbSBne+1mJ9ssuD/ACrSUndWM+XuUL+4s2v4YZ3R3Ma27eaRsjVXI4GQMBAuDnnP40yLU7a90FoY1yTqIiRw3mNgkAnkdNmccjccE5xWPfKs1zZvARCvmSKd7bSQwYxtyMAkKFI7GI/3qq2MyQTQRQZCywwT+W2drTeSQ5IPy4LtIcZ7/hWrm0rmagm7Hew6sq6nfusUkSJauUXKbWQMzEqfqzAk/wB3txT/AAsi3dzZQTsskfnQvMw4DLlWCA/7WCPq2ehriNI1FtmoNh987T22wHKFQ0QYjgkDZwPfPrivQvDEKyajcSTERQK0ty+D9yD5lU/TCfkp+lZznzNWNIxsmdZIS9uIw4WG4iDKMcsrk9PTCb8H/aziuf1xB9itY5XjjMVpMJNy/KkjBI2+Xr2kI9l/Cuqli2XmkBldUFwE2bcsqFwiKff5SMZ4GPeuN8cLLdPri27Bfs1ml4rrkgFYnVx7/M5A9waqUrahE+e9dlklvLhLWdmgm/fEKcAsuRkg9gAfpms2C5Md4TE7qFtmjO7nGUIZfpknj/8AXV7xCEig066gxEzqSIVziMHOBn9fx9qy9M3SapbrHGC8sqxBD90luMH2OaI6q5lPSRsWiNqN1bFZ7eJJ5XfyGZnMPlIG5zkkEAY555pvjNoFmso4HYkWqmQMRkSk5OMexWotNjlfxDHFbkAO0mxAchSFZVGTjt37Aio/EFybnV9saxoJFjRUzkJlfU+5Jz6Ec8VS3E9IlbSyilDI21w2xQeME/NGx9twwfY1Pp0ci+XesjFEvF8xXHB+bP1P3WzWfPG9vPfW86kOmUKsSCGRgPxPBFPvLgyW8Lh/vj50yT8y/wARz3Oc8VRknZl6xu4Ql/AC0cfl+ZHhsZmRwQ598bgB71DrCKsFk6vuLQI0nPKuck59yAD+PvS6JJGslyLogRyQyOjhfuybSFORyOpHpmp/EMRQ28CgbVt45DjOT8mOfpjFK+pSWhiQNsnXPTPIzjIrtvCE5trXURGV3XGn7sOQCHinV1AI652Djqc1w/AUfL34b+lb3hS6EWvafvI2mVVYHgfeB+b245ontdDpb2Z6j46lin0GwIQvFs8hJAcq5Dq8ZGeeI5Tn6YrDlvJ1vNHcRRJcW1zbiZifmLxgKST3UrsOeO/euxs9Okvfhxb+X8zWkpQ4PR08yJcnqNx6j0Kjvz50sZuNtsGcukUkTZJAV0Qlfx4b61jNtO52RtJHsqgWU9xbrGTaTPDeRIqja9rIiExr0B2kSj6P71wltcXWi6rHY3kjS3ulX8BYAHMsKBiWHoAsjcnqGPpXqV/A6aZok8MQmmto4gpbjesjDA5I4DNIhPYEccV5Z8QyLa90zVfJMywqttcoPl80gME5HcKVHvtxWk9DOGph/EgSaT4vtWifzIYZ0uISB8xBC49+VVfxr0/4ZSRy+DRYy9JUFi4dcFQWdFJ9flYAH1PNea/F1YnisNStfLJuQm1w3zAKqleOcfeI+q123w6vI5dPtpBkLdS3ClSdpQKI3B/N368/lQnZ3E1zaHaeHLvztL0+KICOVmePy35bdMUJY4HXnPp8tT+IZIZ5fFAhjJ8qKMKS33jGASw78fJ+BrE8ISkanpzX6sxt5pmuC64AEMuN3tw+K0NVZxZ20P3JriCeGZQDw2ELAHPPC5+gNUneImrSDwhItxrVxfSPuEMKpEGxgMQ43YyeoAXnBwF9a7TwvEsV2sB4jS2XcM8b9q/0z+lcb4WlaG3iEjxMJ587lxgKswRDkdsds12mgFhA88oA3CRjhugZlx+mBRDTQmps2Y2vSEQtMQTuG1h6gLhs/mteY3d1KPDFlZkgyO8Cqyn7mJFYHJ6YAA5r0TxNdgWeoKobcryFepB3bcZ/74I47VwWp2iJdRoWMIgkVsqwLAqd3Az33qPpQ97IF8Opo37zQ3OlvcSxPbLPNHcRHO4Kg+V2B4OURTjtnNYetodQljWYFQ8UVureWQCwVQR6nmX86ztT1UQ6+klzFLD5d1ITEznCxlOGHOchSwPUcYFdNYWrard2PmSYSO0hV1k4ByoYSKx45CDP0xXT8ehzP3dThdHLaJqGuhZ9sD6XeQBiBmY5TIOB1P8ASu5+Gmo3D6/aQyqoWKDYHC43AsSB71yXiCaK18N6gI5IjcX07kkxjIG4AgHtjA6etdd4NkSLWLJVjbzPK6t0IBABH60QXK7IzqO6ue0RfeGBU45PrVa3IOD14qwOmc12o5jyRj7e/BrMvZChO9Ay9xnr7VosRt4HTjis3UIhMvJK4zjaelcrNImbo16rarPF9x+Dg+v0r1fSJ1uxHKvD7cEE8D1rxCWEWWqxXklz8oyrAnqK9V8KXyNbK2c5U4YGuOrC7udtOV42L+rWjPbSyxqBKhDKpHJBGDkfQn2rxnV7KW1vNStkTBglEkXHJjbJIH1yRX0BcL52kyIwDkoGA9MYrzH4g6dJFrWn30S7g58srtzuIyRke4zXJNW1OmlLoYngW3RjdQhmQctGknJx/GuQPc8f4VftLVnn1O5DRl52CFU3BNwdEXcPTp7DIrL8L3Q068vY5Nw/dgrjnaCSCQfUqSB3OPrXV6Ogmhcw7AWt/MxngKCQQfbhc+/NJSvY0ktzB1y1XSG1Ex7ljubS4/dDKt5uAFOOmTlQTxxz2q74VuhHYzwSKrPNJHbwsSCpyo4OCOfmJz6A0eI7VpdEWYsYLiBp5S+wsQEbbkbfm6MO3OM5FUtFXNsjxQFIom3o20FiwjBJOD8uMngfL0IrROzQmroyPGtotjPKHtYGtba7kKzyx4coZSDxnnmXI7jdj0rj1vsLcbIYgbBZFyDkuseAC3PJwR+tekfEWQO895CxhngnabiMcuwiJjXI6hVJx2z615QJlkvvEs9uY44JY5pUjkKsMPkbR2JG7gj0rWTurGS0dzb8DMz36wXBzELhEYbOmZIS3P0XB9iT0r1LwyzOkoPyPqHk25UfdaHDyEcZx+7dev8AtGvM9AbyUSJN0Et3qUsSuBkxgxR/LtHdv0r0XwPMG1B7qZPLhYS3Ei/88yVwxA7bOmOvPFZR0sbPqekahdufD9lfxgrdy3MUsGByDuXHB6YUA+249zXGa+r2VtqcaZMtzELcszYASMRzHA7/ACFh+dd1Zaf/AGlYXU08YjSbdDapnmOErgn2OCWz7fSuC8QTNc3ZmkVow93IMMTwyoYpSo9jtHvirn3M49kfP/jKHytO0rcsa77dJl2cgq4LAZ/2d23HbFc1YzNDdwyRhi6uCNpwc+oPY+ldz4zti/hvTyICrwoCXb+IMqtjHruEpx6Z9K4lFgiggcS77iRzlBlREoIwd3vz9AB61dN3iY1laSNfQyTfpJbQ5uIeEfr5jDcSDk4GULdP7oGOag14h729LhCEMaRkY+4FO3GOxXH6UaHcC21i0jklAtXlTzSSdq5BBbA6lQxINW9WSL7RrcspiWZp22BFJQIzcFT06Y98fjinoFtzHvpvtlwlyzu003Exd9xL5xnPXkY69809bMpYM9yrRlHAIJ+bBUEFV74yCeejCorkeWoggO5mClwOQzAdvxJqaXUWHmrApFs06zCGT5xkKRjPXGCQR3GPSnuZPQiiVRbskmBnOJOcHvj6cGunOnzXtvqt2jKYrGGGMyFuBnarKBnOPmP0rI0jLRRMVVbUNKrfvANziNmXIOceg456V6BY28Uul+OGspFNpIpRM/MDEirI5477hEB67j1qWrtmsHseTFP3KE984qe1cJhjkEODuHOB3pbKKF7kxXLeUucB92Ah/wBrAJI6jjvSw+W9220NHCZPuryVTJ9ucVTehENGfR/g7yrnT/EXh2eENJcMk3ByrJMmA4PqHSM+x/MeOhwmoxRNjfdBGlbp8w3glfQcryP7tel+ELu1OmeGNQGbie3jn0u9BBU+WG3qp7ElZAR7oelcT8S7aGzura7gLpcAOmUQop2SMp4PT/7E1lNXSOuDs2e26HLFqHguyN1JvhEEMPnA8hZgoOSfSRVbOPWuG8UWTzC7gvInaCefbNtG3y5QgWQ8D5ctkng8P7V1Xw9WO78DLHhmhlsIRJ8oJXO8KcAerKPy96pazAdZ8My36xssty8kgO7lJmLgL6cvC0Z+q+lVNNxRMWlJnhXiW5uH0eytpyyzWjNDJEf4X3Enjt82T+Nd/wDDmV5vCUauYjLDLNLHu53j7Ocggde4z2rgfHgMWvXhR2eCdVuI2YENggDnOOQRtPutbXwwu2tbaaQk4V2MaA4yRG+W+gBIP1qbe7cd/ft5Hqtk4TxdrtuLhWDM8VuZOeJ5kwPoSGyO+K1tQvgmozHam6O2+2RsTkozJH8wB6YKsMDrmuba4GnePbmR8qyyRIyt/F5RZycfjn/gPvV3X5Ujv5I2kKM1nYKu0fOhcbuv1XBP1pRdkDs2a2hqtv4fsoVA2RQwnPYorncR/wACQn8a7i1uF+x30I+UIipluCGA7/kK426jFv4fsUkRvMFnDtGOmN2/6N+8Qn6Zq1HqZOmfxF7iUwnnOXLNGB+e0/Sqi9bEzV1cpavKZzJvUsJwpLKcbS0qY59MN/OuV8bGX+0HRgEV5QZAV4ORjqRn+EHj0Fa2sXYWa3WMgK14m4hvlMYZio5zx2/4DXN+OLuLExWUvLsdC0pOUyCqZ/DmtbaGXNqef6retNOjDEa3AAUkZKq5cFhnoMkkAHHevVo9fXRYrO4nuGaygt/IVkXG5gpGzPQZAOM9xXg7TNJPbJI+PuqNxPyDcCPoOTXR6rqNw9pbafE7rbTRm58on5FkLMN4JOeV/nVU5uOpnOPMbXjGN57bTtu0tIXlIP3k3Mh5PQ5yTXoGlXEUeqaK8eWWKIqwXp95Tz+decaxeQT3Igs7YW0cNxHbpGxLMuxeTnrycH8a7fCvqunxRsv+rJGFAJPynn2q4v3mYzWiR7lYEmPJ6ZyKvdfesrR332yZH8AP6VqL93Fd0Xocp5HIMduapXJJyDjH1q1KeRjP41n3JODk857d65mWjkvGL+XaERoWnfhQDjvUnwv1u+tm/szUUKKMmB+2P7tdHp+jnVLsM3KgVoR+H1F28axgFRkHHvXLKV58p20opR5jvtKuC9sFbLcAH3qn4n0xtQ0CchcyQgmNh1DK2f6Cl0JXEaxsCD0yeD+VdOluq2RRgSrfe5zXPKPNdGilZ3R856myQaurIg8tjvUg5BfPU+oIOPbNdV4amCqruP3RQAhj0U5+Un0JH4dar6zoMh1K9gKhLdWIjwv3SeB/+qrOlqI7/Tba5jTdJxOueM8gY/AfzrjV07nfo4nSapZpNod4YQqbSMOWIYq7EnkdDk/+OVheAAz3RM5SUM2+aJwCNrLsOO/3ifyH0rqfEn+i6GFhPzzsEdMZyqgsT7jAI/GqOh2v2W+keLaI5jJGm4fw7Fwfb+I4rqS95GP2Wcv4k0eaLw3cTWPm7rSUM2WwS4Z9rH1YqUPqcd68q1ux060OoMSYoZXmWFG+9HkB41YDIxlSOP7496+idXsZV07UzZ72W5SPYr87mHIz685weorw34h2xfUJbfTlRyfkiBALMm4yKfYgsyn/AHh+Fr3ZWM5aow/Cty39qR2oLMBOz9cZ3RhPzxkYr17SI2abWrHbJGkZeSPAPEjoC8RPZTlgD0yfpXlPh6z83xZblSrNdKJFcsCh3YK89iTwc9DXuvhsgXbRzW/mG4WE3JK4yqZ8w5H3iwbcB6Lms1q7G70VzvNG1QpHbTyHzHuHQQNuwPmTKPgfw8SZHboa4nW4FtxdnlBHqUF6NwIHlSrub6gvC+frWlPb3EEO2GYjBaKKTO0ls7g4B4AyvA9d3XIp3jBUk0u2vlAe2vLYRFQo/dkFJIlI6YGGXHB+Y+prdu6aZjyWenU8B8U2psdEks8hvJuntmJB48t2KOPU4Z16H0rza9EeVeNdpACyKOxAHT68+1er+KkX7DeqwLs8cYRgpGJV6g+5w3I7V59rtpbaZ4lu7e3uI7izjlyjEb1eJgCAcEEnH6jqKmnoxYiOhVvYGVkWQHzYwpYqAfkC4BA74AGT9a1440fQrq0vQ0ctu5G5htMY3rwV6lSZB6kcnpwaFzBCtvbXenGZJY8B4pTkqc/KyHGGXO7jrxzVq/uNn9uQ3tuUvLpIsHOBGwKsT9CAent2q7LqZX7FDUhcwzRQXG4zw3DEMrAtyFIIxzzjIPTmsolWQbflcKd5J4Y57Cul1afytWcAusIKXVnMECMqN83THTBPHr7Vzd0qx3EqJnarEDJzxnFXEynuXrS4hYGF1ZVlkjcMeiuMg59vmJr2L4KQ282j+KzPuEF1HPbspGdo8ktwOmQAx9flrxSAKY0aQnaG25UcqMgk/lmvXvghcJEmsRyyKILwGEHdkI7RyKNw4yG3YGfQ470RspFq9jyjUbcwXwifKzBMOpH3XGcD37c+9JthCTPE0oliYNlSMYJIJ9uq/ka2dfKv4gtJAn71BGtxG68Bw5X8RjbzWNbQbr/7IXIEjGNmPADZOCanoDV3Y9P+FUj30Uttw0d3JFBtd+EkdHiViOwJG3P+4O4qDxrbyXehaRfSM8ontpWmBJ+e5R23n6sjoxOPvfjXPeCbxoLC/hjDpcRfM4TO5kZ4xxjujqjj3HvXWzTi91m0sZyqRSm6kGzBAZlf5lA45ZVOBjoKidrWRtTbevQ7/wCB+pwzeGNJikVvs4sri2uGKg7tkoJYe22UY91NRWryWsl3p0kCCGV8bgAPLlbL5I9N+4+nzV558IdUaLTzp5ldE+1fvMf8s43Xaz/7oyMj3r0fVphc6g1yIijNEHdEIyGjjMZOP+/RGO4q27ijdHl3xnskjv7PUrcKLe5SSBwOf3ke3PPuHU/nXPeB50cywSoxjWFixHOMnHT1+YCvQPjTBs8M2LxyRPGLt5RgYIWTfsx65TaPbYK8z8DMg1ZFd3XzMx/Iu44Ksc/gQKUoqwKT50eleLb0y+MI7gGUvPBG6yD72HjViRkYPyg1taxdpeT+dKSovLWGJc4IGLZCOD3+d/8Avmud1lw/ivSWEibIbSCAui4BAjkQgZ7jOPwp9vfuNRso2AcC3tzsboWVwo46ZxvFZdXc16JnqetvFLprIr5EK+THg/xGN3H5KqVyMer7Cywt5aLdxXCk/LhnB6HPYsT+taMlwDo1nA7opYRFyg5JwMnP0z+oNeZavfqDOjLuU5c4ODjcwXjt94EZ9at6NMhaqxteJNTaC6skeXBggiZl2gqpVlAPT0c1H41LXcuralHITbNdqisV28KjF1x0xkgj1BrkdU1F5bqa48xfsiolu2QOXCF8EdxvTGe+K0LWVdU0eG0FyMuJpzG3VpWAQe3ITPbrW8eqOaRxFvKrSvJM+3yUZ14zltuFHtzitCWC7i1a3trmYPIsac+aGVU2hwM9Bx29awhlk29SxGKssHllkIAOBkjGO4HSoYJ3O7tM32pRXUvMtwWusB92NxAx+AFegyzY1+zhXhk6kj2FcB4Hty9zcEDdHHGuT1wyngj8yPxr0GEGbxEkmc5YrnrjGKqm7q5jU3sewaMcwRf7uOa116f/AFqxtKAVIBgYxxWwh4r0IbHKeQSNkEknHTFZ122AR17HNX5u/YDmsu8OVJ71z9C0dT4NizbhwBk10UVti5R8dRjiuf8AhzdxPE8LsNyHbXX+Ur3DMDjHANciTU2ztb/dpEVpGVvCQOAeldBHJhFBGcjiqIjxszxu7+lWFHdWOaVrDWpiXWnLNqbykKSudqn3rMufDaxXNteQ582FwSM9Vz/9euq2kTK56gYNPZNxIPQjJrF00dMZtGDNZyTvfqoBlXaIm7cgZ/z7VFdWBhubNEBPl7zg9DwBz7V0ltCU8x3I3MOT6VFPb5hd5FLuBwB3yapLsHMUdkc0LxrJm1Zdp55HBGR9K8G+M2ltDYWOoR8SxubeReoIQEDPrkY6+uK+jBZhQicBRjAXjpXnPxk0JLzRpioUMHjlycnGAQxHv938qKl0rhTabseQeA7SGfxALrSZV8poJNsEoO6GT5SpGcgndyD7Z9QPoDS9CEloky/NeLswG+dlkXO85PTqw6dMV4H8IbAK95fQsxnsyjrGPmMkY4lXGRztcke4r16y8W6/pGo3Ty+F5ru1t38tp7a6UycgZO0ryThc8jO2olG7NEpNabnpKeGLeSzQ2DPFGVACsS6smcgEE9sDkEYIrlPE9hNbadLpV87pa3jyCOTqY5CpaNt3cBs56YBHXFdH8OfGmka691Z2s7JLD+/+y3CmOeJWPzKyH0Y8EEjDCux1PR4dRt2E8avG42+WQCAP8fX6VolpoYOo4StI+U/EsDXOiW1xNvSe2tiLyFDtdDGdpYccsrFj/wABxxmvGfEUOy8EsQjWPAVtjEqCBkYOTkYxj8jzX0v8Q9NufD2qS5TdbTF3iuGJIYhQZImUYHKjPfd8w7mvDvHWhNYj9zhtOkkVoyCfkJU4XJ4x2BPXA7g4cXZmtSPPDQ56Xzn077PMpdo4vkjLEsh3jJOe3Uj/AHjjvUmi3cq39vFMy72aNFeUBigBIIIbOMZx7Vo2rzQxXNxCVlmYoscsB3gqY2yMDlWB2NzyGFYtpfGe8si8Blnjbazx8tKuQRx/fHTPfj8bcbnNF2szovGlqklh4ZvLeMKlzZRxMpPCSp8jD2B27vT5j71yWsiMahLIg+SV3kAUYXBY425HT/Cu+1mF7jwtdQEyh7LU4TbxupWRoZUldTj2LH164ya8+1BQ8m9VILKGI9+9NPUU43Q61WWW1njtyzFVLlR/dGN2fwA/I123w41Y2yyMjxRywjODGf3gEyOqggHkMc9vriuGhlXzMojLEI/KYE5PIwT+eTWn4Vu2sb2GdCHlhuEcRMMq2DnkdwSACPQ0paCp6tGt4zeJNRkgTezC2yWyQwfcGYN3OMAj0zj6c5dTefqPnINjyTH7p4GcYPtzk1r675Fz4ikdJHnSZ97MFAYliSxI6Z6H6msO4ZhapExB8sk5AB5zg89cYxx9fWlHsVJPf+tDo7ydLHVIdQg2FZk2zw9NrhFBJ+hJYf7vetfVZBb6PoN/AxlnsvMimCNjYVkwMAdjkn6MPWsdlTUfDd8MA3kXlToduDKi5U/iAwPvn2qla3P2q3Fr5iiO4RQ+77qsCAWP4KpP0qPM1WjaOy+FcHleINStRg+dZNEqsuWMjN5aqOf75TPsK7wQGGexROXltYNpdslQ0xBB75PljPsD615/8LZxb/EfQ1nizFdS/Z2c/MC6nG7jsDt/LNeiatZhtMS5BZbq2t4XULz9xxu5/wB5yOnYdKfS7C+tkcn8UI/9Bms0DeTbX626OzDC5GQPyAH4V5v4Ok8jXbORiVTeAxHYYau48U3D32j2V40agXV/LqDoj9MxoxGfQAkfWvPNIBbU1KY35yn5/wCFNPRhL4kdlc6hLPqmj+ZKokdmD/Nwv7xufycVu3F5ax6lFdxK+bZIbmUyclibh2Ube3DAY964e8mZtRgl+848tlUfNyRGenrk9K6oBLKHV2ugrNbyWMLlTnlSXYDtwBWaRbZ1jXLCxht5BmQW4Qj/AG2kGfpgDH515zrd4YrGOaeJme4uXlDNxuTqg47ZwQP9mtrW9W8pmt1y4tYPs6Ek/Nklh+pFcJqd202I5BlAAF56YGMj9Tj3q1K7M5KyB5mk0qWQ7R5l0v8ACAchG/8AivSp4NXuLCyVbdyiu4kHAzlQVzn0wSMVliZ3tktlP7tZGk6c5IUfyUVDMwViE4AGOta9dDne2o6xu5rG8gubZgs0LB0YqGwR0ODxT7curPMMnaMsT6k1XVWbkKeBnI9KsRMHi8o7sdV245ORjPtRLYInp3w/jeHSZmJI8zaP1ya7LSmL6vHCvT77eucg1zvh1Vg06KHptQD8cD/Gut8M2b3Gr3MqnCR7WDdj7fpSo3aMaj1bPVLA4WAZz15rXQ9umO9YunZIQjHHetccjr+ma9GDOY8huMEEenOKyL1sDIBOfyFa1woI4rHvuh/l0rnbNEZVrq0+k6kk8RbacKyg+9e2abcK8UUmfmYA8968DugGvYQ3eRRx35Fe46OFMESAEbFByayetzaL2R1MeGYdsjH0qaJco2PrVRGIKbT2ySauQYJwDzikbLuQtwTmhG+Zh6in3Cdc8ioVG04PSs2jaOxZC7wwZuBgD2qRY1bhmx2/ColccH+dTpgjB52mpY7ig8kA7vWsbxbZDULE25QFnKquP4SWAz/Ot5MBlKYzTMCWQq64YEHOOmOlO11ZiTs7nz14I0WfQLq9LLIMzuCgUncNn+P8/Y17jLpYuPD++3L+dEgZnjGSG6nI6kbufoakk0a3S6kOwFZZFY+xKlSfxqWxS78PytLao9xZE5ePq0Y9v7w/UVFP3dxyqNu6OX8WaTZ+INFtfEOnOtrq1qnn297bMA6sByCf4hwQQfSvT/A2s/274ZsL5womkjAlUfwyDhx7cg/hiuE8UNZnTXl0pFit7zf5kSjaBIRksO3PP41N8O5F0jUHgZiINShWVP7vnoMN+LIVPvsNXdXIqLnh6HVeMNBh1fSZI5VDsW8xCRna2cgj6V4B4j8PXN7pVlZXEQMkiiCOXbkDaH3xSY4wSFweDwCDkE19OysGi2e2PpXnOvaTDc3mpWUhVBcIs8LAEFWDfN+uG475p21KoTsrM+KZvtFlNcQNGtvcpLwrKd2R8pT6dDz3HrS3+nrNi5crbXF2vnpB5exD1yAegBwSoHpivYvi54LuHWbVJo2M8E4V5VAHmRtxvOMcqxGfbPrXletW13JarNuZ49xcofmCsuSw9sFmOB1zmo57OzN5UbpuJc0/XA1vJeXEAVpo4bWeSPGUeJlZJQD/ALoDDvk9KyUsWsdXNlc2+4xsEZSQNyPxkE/UEHp0NT3JgFsY4jG0E0SKyoCGinHQP68FgG7jGea1b23ieOzuUuZUMnm2oSaQu0TqcqrMOmVbjHHyk/RtmSicJbgRXah8bVbnIBH5HqK0NL22+txK7r5MjKrO3ACkjJPp/wDWpNbWJ9clkRPs8E0pfY2f3YJ6epA5H4U67Xy/J+Xf5LcyKciRSSRg4+o/Kqbv8zKMeW/kb1vblPFN1buG84747cZwWfeoQHsM/wCfSoPEVhFFEs1oriMo6knaWc5GGx6HjI7YNdtrNkb3xVJd27xXLNZQvvjODJmTaJP94qitn1+tZ/jzT1u45DAxkkFtDcAFdudwxI3sdwBwccFuvFZ2szZ6o4G0kf7I4lBMSjbkD7wGMrn6HNS6FAXa6jJUGBfOB6nCn5gATzn068VBZzD+0LWR2wkior+hIwOfxAzWzpJ8qK7tXytzI7sm2MBtwVs4brkMoIHTg03pcla2ZrWiNYeKrO9mjEZzJcbA3XCjcUPvksPbivdde091iuII9my8W7iPyjc8jh5VA+uwDA/DrXhBYStprsjKWAj4HQvmOXP/AAIZH4V7vA80vhOUuRHdPLFOikcxMGkgK89Nsm0ce/XiqhrdDlo7ngtzfH7LYRwuZPIt7mT5xjBLliCPTCgfj7VyujM/2kuMFthGT78VvXWRNqk8e6JoLdmXPRS3DKc9Sc/qaytDgWSHAOyWWWKBD9W5P5VC+EcviRZsw0FzC+MBZIWAXOc+ZjGe33K0Z7hbyTVGjciJ5mn+Y/NgkYznqQD+tRyD7Pr8sJlkZVlQ7AOJAgY5Pv8A4mqM7/Z7HylcZd5A2DngYx/I1D7FLuR6tfSXVxcTuTulO/B7ZHFR6Xp41G8leaQQWFrH5s8w/gQdhn+JjhQPU+xqvcyAn1+UAHvx/wDqqxeajDHpcVjaLOYy/nXBkKhZJMYU4HJ2gnGT3PAya1prqzGq9NDJyHmIRSAThVHJ9uaSRl2PlcuWGCTyAKdZyeRewylQ4R1cqe+DnFR3DBp5GA2qWOB6DPFa2OdvQapIY/TvVuw+aZIxj53UZ/Gqa9T9K0dHj3XdqSDjzV5/WpnsOB7BpKAFx12IGx79BXWeEpZXv77a2I1OSO3cVy+kjdHIf7zfyrpfBymIXcrj5piuQKKDskYS1uem6YuI48g9M1ro3GePrWTYNuC4bOBj6Vpp93gEV6EXoYM8iueUJ4x6Vj3ozxz/AErZnUZOe/bFZV4v1/KudmiOZuz5dzG3911J/MV7jpWxrWB25JjB+teH6mDtcDOR3969j8HXqXWg2UxGcoAfWoW7NY9DqFlDIqrVuBiByc9h9ayomCPgHOKv2z84xxUPc6ImgwBUep9Kg4JIPaposYGefTFQSA7iAaGWgRuWDflU0b4GR9MioDzzjJpeQOOV71BRdt5gep6mpoyS5PX6VQhYtkn7x61ct9xbCnBHrUu4FqRFC7mABH5mtXTRH9md5BhQMnNZl9n7Kzfd45PXFWUu4V0Y4I27ck+tJK0jNq+hxWo6RqGvXGpSabFax2TfIYX3K8pH8YYfcYHGDj61B4fjutW0Q2VxGbXWLGYCQHrFNHyrD2bg8dQxFegeH4/sulGSQAM3OAK5S4/4l3jaz1EsRb6mDZTjsJBlom+p+ZfxFVKKVmaKV7pLY6nS777bp8FwAULL8yf3T3H4HI/CsXXgI9UsZcfe3wZPuuQffkfrV/TR9m1K+tRjYz/aIxnoG+9/49k/jWb4uOyxEyg5hlSTj2YU5PQIr3tBt1aW97bSpdRrLbXK7SrDIyUwQfY/zrxy78Gw6FrskUmWsJnO4SHcoTAwcdwMOD14/Mew2twXtJYzhgWYjB9eah1Cyj1G2Md5gOuNkq/e+oPYmpsprzNoScT508XeCbnSNStbiBLu50y4TyA8JG5Y1HK5HVsEFWP3toFctr2nSadYi31EM8DmN4ruOIhJ41ztlU5wcq0gI4I2DOOcfTv9mj7HCBGha2bzCirgseh4HcgnkV5r8QfCcMFrcT2rOIA/2rgLt8tjn5ccbSCchh1BIPzGh2SJvdnhGtWcb6JZ3Uf7x4GeOd1/iXedje3BxSaRMI8iSCKZwcBXG5XIK/KR05AOD3yR6V0dzok0dhdiZfNsrZSZPIVWaJWb5S4XoAScPjByPQCubjwsUKRhYnh/czZc5YFtwY+mMge2M1Leg0le56J4Rv4hqlkkqSRy2unyRGZOsm1vNhIHQnClef8AGt/X/D5Xw9pUrbiUtPIkI7qZ3iA9Ogz+A9K5R4JC/ntHKgtpI5MPGFwrdCO23L9xgggivUtU1OOa3urdrVkaKKNpFDLxGoLkqM56yqcdQQacXdNSCSs00fMksOIHidgHhlcFWGDkj5gPpgHtWu9z5kMF5EDC0bNIzLkncw459DtI9txqvqcMkmqMz5H2x3kZ26btzA/r+NLotvLNDdQbHKLG0hVQAflIc9e21GI9waG77EqNro9D03Tf7ZS1uYozGrGOMKowBIIg0jcfw7x244b0rvbnV/Nsr2bYA8fnMABgHfOk6HHY4JOe52/WsDw2Y4fAU9xbYS5sLCaJccESq/mCQgdQY3wfXB9K09IiWWx1q/kj+SPThP5Z5IOQijHb/ln+VCfbqNq+/Q8P8VPMkl4GJ2zSY65ywYk/zq1HAlhe6cS2wQlpdxHG5Qv+HJ96g1mZdS1exggRvJhTcQ5HzFVG4jHQHbx9a1vGVyLHVlayy3kDajsuQjsSxwD1xuUZPpUPoh9W/wCu5kKxuLgOWxITu3MQMfezn/voCs+QM6hyOxJAHqSa0IlmFvPHGeGXym3dgATj65H6VNLbKtrayoufMjGQxx2K/wAyKjmsXY5+dsCMbRgjIPfrUbBGhyr/AL3fjZj+HHWrF3CwWTOMQjkj1zjFUmHU9sYrpjsctQltUBZ3k5AU7R71WODgk1dhjAiLegJHuaq5Kq8YwQxBzinF3ZlJWRGo4Nb+iooFmFz5rXAIx6CsSBgjqWUN2wa6bQYg2sWIAOxMk7qiq+g4aJs9N0tRFbSF1YgIRkHoT3rpfCWf7PHHRstz26VzMTgaedpwZJAuD1P+c12fhy38qxK4G3GcHvWlFaI5ZHd6ZnywT168mtWNht5ArJ00gog9u9aiNx7V3QMWeVTYPzZ5IPOKybvBU9K1Zz8uWHPTmsu8HynjjFYs0RzuqDliSPWu0+Fl7v0ua3brE+PeuL1LjOOasfDy/wDs2uzW27aJlGOay2kaLY9tiI9OTjPNXoH5AOax7FtigOcselakeGTr0pOJ0pmnE5DZJFPlTjIAz6VSgJxnNWlbgD86zehduwi5Vj70btq4wMd6Ujd0H50hjZmOemehrO76FCo2RxV+0bO0CqKAsCMfKP1q1aEnBxwKpCZpT5ktHUDqpFQadoySxo2+QrgEoTwKmRwVI9RzTtOvTatJF2wSKHa6ZHM47GhfSrHCkAIHtWLr+lNqOiXUcRxMFEsRHUOh3KR75Aq5FA95mVnKFuQQOg/Gmapa3dtYzyRX4ChCcSJnHHtVuSlq0VF8qstyra3HnatZT9BPbt+hU/1NR+LUB0m5BxkrmqeiyK9xpahjuWB8g/RR/Or3iNgdNuO52ED8ql7FxVpIxbCZXXKHKnvWipyVYflWXbDECEYBKj+VWIZFPCkZ71mnZlS1JbmNjkwfLI3y7vT1z6ip5bWAwMDGCAmGDdMYxg+2OKSEEYapZQxtpQhwSuM1tG25jJngfjXwtJoV9p93ZLKIJYntpURvmWNgCVx/EueQvPAI+nlfijRpNJurW78qOazdPlmh/wBXOo4OO4ZSdrKckfKeQQT9Y+L7KLUreFnODAUKuOCD7fQH+deC654eF7fXMFnxFb7QqHogyV3fmQMd8H0rCdoOx0U3zK7MbQQ66Ze24uPMBtgbOV84aMjG0Dt1PfqOPSu6vrldSh1R4wxF0sVugbhfKI4P1AVSPw964XWBdaJcxaNqwhexgnJQ7QpToWUEdiQCR6g+tdj4fYWfh/yb8bryVY7pjJgEuowBzxgKRwPSo5uhbXU898a206aJpwjcFVkluvL4A+dtuT78KOfQ0S6cdMvmlicSxxNA2Il3LsyDtJzg4+YZB/Oug1rT4rmO0s2UsJCFcd/LVf5k7z+A9aoaTbTf2drlpdKzvawmJWydqseQSO3zHIPTGRS5x8vU19OZv7Ae00928trJhdBvvYUvsT13YwM+hNdZ4kuP7I8P+LHt2OZraCC3G3PmKzK7Y+hUj8azri1bTbXQ/IiOb8Qs6KA3LjYQT/usef8AZqL4nXKaLpemuFMu66csM7gRESwXB7Elc/Wri2iJWZ59omlC68V61IciHSrYiQj+8m1G7d23fnVDWPNv9R0/5G88xtcvux/E5Kj8Biuo8LRGz+HGp3s7+ZNqMmZGHG47uAScZwQT6VzWn77nV3uUztX90kh5wQgAbHrjJx61Emk/QcFdf16iWtv5ySShR5czELnqR7+9b7aez6b5zrlIcR/MP4vXHscfrV/+zlsLCI4O+IK4GMnA9R9f5Gtu2tNngu9aaTzH3lg/97kc/rWRo2eS6jZukk6ueB+8POA30/E1kCPEwyyrzuOfauu8WwtHdiMYABIQdCRgYrkrghYyhX947dT2A7fn/KumlK5jVS3HXEpmVnChN7cKOg+lUpeGC/nWnJbOBBgfIRkVnTgeY3rmtYNHNNaCKucMexwR/I10vh/d/bESpkt5WOO2a521AMqgnCt8p+ldz4SshHrroB86oAT/AIVNTexK0i2dxZW7GW0RgG2AsRXfaOv7sLnIwMkCuV0iHdL5h9CBzXa6agEagcYPXOK6KSsjkk7nQWa4RCBt+taaHKD+grNs84AYEexNaCnA+QAg9s11x2MmeXSgBST2/nWVekkNxkHrzWpNnOPzyKzrpSc5J4HasWWjmtSH3sdOeormlvHsNThuIzjY3OD2711WpL1x0PpXJapbli3HFc9XTU2ie56NqMd1awSq2dwya6azugQOwNeNfDLUw8Emn3B/ex8oSeo7V6Zp1zhgDnimpXXMbQfQ6qCbGT1B9Kuq47ViW0gOOeB1rQhf8jUyNEaMeRjpg1KCM+xqsknG3gnOKsZLdDj61CVhjwFUE54NLGdpOAME9DTAWIPfFOUO3DNweOlJ6gWI2DLkHj1zUd4BGyXAGcHH4GpIUCgDHHrmku1SSB1bhccmlFtMhmvoc8UsOwN93jn0qzq+l/aLCaNXwrrjB6Vxmiag1vMI5jhhwrdmFdTf6kTpzAEAkVq5O12g5WmmjkNFSaDV7szOCsYESY/Mn+X5VZ8QXiR6fK0hKqoyxHp6VVjuUiZmZgDySc4Hvk1g294nizV4I7BjNo9jJ5k1wPuXEo+6qH+JV6k9CcelZKWnmzfrdnQwxOYI1YYYgZH4ULbMrkY68/WtmOIAgkA5pXgUYA+92xVuKepHOUIwVA3c053wh4JPQc1I0JZ8NlRjPFQ3aBEQlzs3c4PQVLdkTuZPiCeGz0iYz5dvujB5Ge/1wDXBeG4fLe1adUafUJ/PZMcqqDcq89sMB+Brd8RK2pX43ti3gjySTgZJxj3OKi0KO3sZPt12TgEKARkqpyAfqeK53K80bxVonCfFzRifKIjXe0YjXvjOcZ/IZPtWZFOX0l9JZUkleZVlEqfPbtkfMpBzjaAARkHIBHWuq+IF7KdXtJLhMzyShVg9MDgH6Yrl9ZzZeZNF819IqogU43SMMsCPzPsOazlO0nY2grxSYtlv1LxOj24/cwfKqc7kO4E57HIXPHrVpdP/ALPvtSm2k22orLAGPKl85GPwbj3Wug8DaWbO0aeRma55EznpuP3vyGBVu6tvtlzY2so8pJLhplVj91QQSfqeB9OKV+om9bGO8j3cfhgeUqyhhMoL7tmCMAY/3T1rzb4qahJrviqHS7YM0VmrZOfvFjljj3wBXoialY6LDr+rmJpRGGitB2IPXB6AFyfwrivDGm6gbeW+v2ds3BnII3BGZQCwHcnAA+lUp21Dku7dCTxbE8OkWuhQufKsbZZZii4G9toVR7kmrvhzQkNtJvXazuuzbyff9Aea249Ea3Fml2jPeXFx9sdGJJYgHaCf94p+Arq20xdOmgkYAJCvltt6cCs27lN20OS1O2a6cxry6YZtvQY5xVS5u47bwy1tIxUAB3B53KTnFdJGohnvZ3C75ImdVHXHp+lcBd2r3s0FsCRHGPMl9h2qttQWuhxutXD6hNJPKhX5wEHou2sK4+ctwTtUsM8nj3rqNUUS3E8MUZLtINnsoB4rBv4ltR2a4UncM5C/X3rak7k1FodDpv2RtJe5uAp+z2+R2JY9K4eUZdgOSW61sWiidPLllZY1BYgdT6VlSgPJhO5wK3gzmnCxaS3KG1Kg7nbGT0P0r0HwfbSf2hfSuCWXainHbFczNcLOdLiEYUxEKD68f/Wr3b4SaFbalf36KqnawZzjOc9KqEPaSVjCtLlVitpKFevBPeup05QVUleev0P9K373wkibjGpVvUVmpYTWbASc7T19q6+Vx3OO6ZqQHAGM4q4gyMA475qhB6YwPWrsL59sVtHUhnmL/OMDBI71RuFJJyPfp61f8tmyOnf8aJLfIOT3zWFzSxzN1b7s5HFZF3ZZ3ZHOK7aWzLMeOP5VQnsupxxWcldFRdji7aCawvYrq3JV0OcA43CvUNL1CO7tY7iMndj5gBzXKyWQLDj+lXtDV7W52g/Ix5FYQ92XL0ZfNbVHeWV2u3BPHatm3nPr3rj4t0Ug2kFD0IrZt7nYy5P3vU1q49zeM0zpopjgYzj0zV5HG0HJxXPW84PUj8+taEE2RknioaLuaavubI71MpGOpGKoRS5I68mrAc9R/OkDLqMMcZx0pWxtwcEHgg+lUxJjAHWlEgAxnI+tQ0I5nU73+w7xlv0cafJys4QssZ/2sdPrSXXizSzZmO2vlvpCdixWj72c+gx0+prpm2SLiQKyHqCMjFU7bTdPtJTLbWcEUh5LKgBNHNK3KWppHFjwVea/OLnxFcNFak5j063O2NR6Oern1zXfabYW2mWqW9pAkUSDConAH5UefzyPwqYSe46dKUEkxSnKW5chHI4UH161Z2jvyfyqpDJgD19jVpWyuPxrW5BBKuXIA69KxNStSzN5kmABuGegPtXRBAG561Wu1BGAoLAHr0I71nJFR0OBlt4p90WNqtIG3Dg7R3GPw4qOW3QwzIGcGMkk5ztPY49farV9MkWp75MwwgbANp/Oq8t+WZ4LBJmRgfPmK7VHHHPWuS6OlXOKv5Gv/EtvKUBt7RGIyM8sOT9eKx9Csvt+tPeSqJLS2I2ADgDGOvrx+VdDqOmSRTyIJMq8edx6DjnArZ0HSvJ050aNUGQvl92JIrJ3ZtdJF7Srby45wZAQp87p7Z4/HNYeu3UgnTylCzSxOPlPRcgE/wBB+Naer30dgW2Pk52bU5L5qlaxx/bxc320SEKoTqEAGQMDvScugox6lW/8Nx3Fvp8MqHyof3oXqqkdMjue9bGg6EJdQtp3i8uzjOY4ycbiowGb1zzXT6fpkmtRCeeF7fT1OdhGHlx0+gq/qsEkNkkFlaskm0jceAq+1aqH2uhDm3ocfDENS8Ty3siqlpbSeWnfIAOT+dO1uM3qKCQkAl8x2PHArXtdOmttOjgYjfIcsMcgVn640SxSRzSFAkZyPX2+tCV9yb9jidbnDahAtv8A6sIVY9iO1cVG0kY1JlfLSOF3DHHtXYX8D/Zo3CEZbJY44H0/CqOl2CXQlMYJSNy2T0z7029NDWJxd9bfZ3EUeFkKbCe5J75rOg8ONfv9mXCyM+M16DpelC8vr2RkB8iQKhxkHjrWPrc5029dlOxj8wwO/anT0d5Dm7q0Tzi/tf7PlvYQwOxvKLfSqmh2gmu2Z1BjTrn1q/qpZmuTIf3jSFySfWtDwdYrcQSGTOdwGMda2UtHYylHVXE1HS3OlrOikOjbge9ex/s8619l1WWK+Ow3KqFJ4BIFY66Qs2n+Uw4YYrQ0bSVtowuMY5BHUfSnSm6ck0Y1YKcWmfTclusse9RlT1FYmoacjA/Lj2Nc74B8XsJE03VH+fGI5T0f2z616JcxJPFvQg98ivUp1VLXoeXOm4uzPOrmyaJiUHygdDUKbSDnn3rq7uFJXIHDjjFYl1YlX4wCa1cbaozTuebxwdCOp5qylqSMfiantwOeB/kmrsYB7CuQ2MtrTvt59PQ1WktBgZ61vSAYk4HANU5gMdO9AHOzWiqCQpIzjp+tRJGI5M7Rg1qy/wAR71ny9R+P9K5qis9BXLsEq7VyctyAetTLMSMDkj1qgDiM49asWn+tP41vCXOlccXYv294U6/TJrWtb5AB+tc3c8MSODkf0qzbk1lezsdMZXOqjuhtGG/OrAujxz1rnYGO/qeD61cUnnk9KlyNEbS3XGM8GgXIB46c1jozeZjccc9/anxk7TzUvuM1Rc4Jwc037UScZ/KszOBxSp94VmOxrLNuqxC5IHQD9azIfu/gKvQ/cH1/rTEaULNkZIx71eiJ4HXiqMHWr0X3R+FaEkynIwSQacIw2Ce3rQev41LbgbBxSLKd5ZQzoRNGjA8cjpWVJYxQqYlhUuRxxwa6OYAKeKoxDdIxbkjpntWbjqUnocJdaM0t2kkocIG2v6YHNZ9/ei0D7PMeYggDHftmu6veIePU/wA6zbeNHmJdFY7h1Ga5pq2xtCV9zitC8PX+obLibA3n53Yc5PXHoK7jQfCtpZ3KtjzZA27e/NaqgLaS7RjDDGK1LP8AgqoU0twlUbJZIiwEcY2r/ERVe9QLFjqxG3PtWinRarXXU1szFPWxzt7JHCzPJ97GP/rV5/rcMl5vuXwke/jJHIBrsdWJMzgnIArG1VV+xIMDGPSsJvdG0Ecffxt5CSgbt42Rx/1qKJ10uxNrsDTyjJA7ZrXmA86H23Y/OsjUeSWP3iBz36VCk7GvkSaHZS26tngTHLHPTNcl46sYZNQwjEkkLjr716dbIn2OMbVxgdvavPvEYH9oLx6/yrRb2Enrc43WdLis7GSRl3lgERTyWNbXhLRZbOxgMsfzNz0qTWUVtTiBUEAKQCOhyea7u1VTFECBjYO3vWtZWdkZxk2tQhs1ESkDjHNWBCBytW7YDYvA+8RT2A3dB1NSmJlOSNZEx34IPpXc+B/FjwMlhqkm4HhZW649642H+I9+lMl+457g5B9K0hUdN3RlUpqasz2++slk/fwHqMnFYV7yQJAQfUVr+DmZ9Cti5LHYOpzVfVAPtB4HWvaoSu+VnkyVtT//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Widespread patchy hair loss is present in this patient with extensive alopecia areata involving the scalp.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fleisher GR, Ludwig S, Baskin MN. Atlas of Pediatric Emergency Medicine, Lippincott Williams &amp; Wilkins, Philadelphia 2004. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_63_30712=[""].join("\n");
var outline_f29_63_30712=null;
var title_f29_63_30713="Lymphocutaneous sporotrichosis arm";
var content_f29_63_30713=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F50115%7EID%2F74515&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F50115%7EID%2F74515&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Lymphocutaneous sporotrichosis on upper limb with ulcerative fungating lesions typically spreading upward",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 334px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: da Rosa AC, Scroferneker ML, Vettorato R, et al. Epidemiology of sporotrichosis: a study of 304 cases in Brazil. J Am Acad Dermatol 2005; 52:451. Copyright &copy; 2005 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Fixed cutaneous sporotrichosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 328px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Fungating lesion on upper limb (hand).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: da Rosa, AC, Scroferneker, ML, Vettorato, R, et al. Epidemiology of sporotrichosis: a study of 304 cases in Brazil. J Am Acad Dermatol 2005; 52:451. Copyright &copy; 2005 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_63_30713=[""].join("\n");
var outline_f29_63_30713=null;
var title_f29_63_30714="Overview of diabetic nephropathy";
var content_f29_63_30714=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of diabetic nephropathy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?29/63/30714/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?29/63/30714/contributors\">",
"     George L Bakris, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?29/63/30714/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?29/63/30714/contributors\">",
"     Richard J Glassock, MD, MACP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?29/63/30714/contributors\">",
"     David M Nathan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?29/63/30714/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?29/63/30714/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?29/63/30714/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 15, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diabetic nephropathy occurs in type 1 (formerly called insulin-dependent or juvenile onset) and type 2 (formerly called non-insulin-dependent or adult onset) diabetes mellitus, and in other secondary forms of diabetes mellitus, for example after pancreatitis or pancreatectomy, in which duration of diabetes is long-enough and level of glycemia high enough to result in complications. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/33/14874?source=see_link\">",
"     \"Classification of diabetes mellitus and genetic diabetic syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following data concerning the epidemiology of renal disease may not represent the current clinical course of the disease. Some of the evidence was obtained before the availability of data supporting the efficacy of tight glycemic control, aggressive blood pressure and lipid control, and the specific benefit of angiotensin converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs).",
"   </p>",
"   <p>",
"    This topic provides an overview of the major nontreatment issues in diabetic nephropathy. The treatment of diabetic nephropathy is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/48/40714?source=see_link\">",
"     \"Treatment of diabetic nephropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6319416\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diabetic kidney disease is a glomerulopathy defined by characteristic structural and functional changes. The predominant structural changes include mesangial expansion, glomerular basement membrane thickening, and glomerular sclerosis. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Pathology'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The major clinical manifestations of diabetic nephropathy are albuminuria, less often hematuria, and, in many patients, progressive chronic kidney disease, which can be slowed or prevented with optimal therapy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/48/40714?source=see_link\">",
"     \"Treatment of diabetic nephropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H95228671\">",
"    <span class=\"h2\">",
"     Albuminuria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Functional characteristics include hyperfiltration in very early disease (primarily in type 1 diabetes), microalbuminuria, called high albuminuria in the new nomenclature (defined as urinary albumin excretion between 30 and 300",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    or between 30 and 300",
"    <span class=\"nowrap\">",
"     mg/g",
"    </span>",
"    creatinine on a random urine sample), and macroalbuminuria, called very high albuminuria in the new nomenclature (defined as urinary albumin excretion above 300",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    or above 300",
"    <span class=\"nowrap\">",
"     mg/g",
"    </span>",
"    creatinine on a random urine sample). Microalbuminuria precedes the development of macroalbuminuria and is considered to be a finding that predicts high risk for future nephropathy. The onset of macroalbuminuria (very high albuminuria) is, in the absence of effective therapy, usually followed by a slowly progressive decline in glomerular filtration rate (GFR) and, given enough time, end-stage renal disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/1\">",
"     1",
"    </a>",
"    ]. Issues related to microalbuminuria (high albuminuria) in patients with diabetes are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/49/42777?source=see_link\">",
"     \"Microalbuminuria in type 1 diabetes mellitus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/33/39449?source=see_link\">",
"     \"Microalbuminuria in type 2 diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H119609355\">",
"    <span class=\"h3\">",
"     Progressive disease with little or no albuminuria",
"    </span>",
"    &nbsp;&mdash;&nbsp;For reasons that are not understood, the degree of albuminuria is not necessarily linked to disease progression in patients with diabetic nephropathy associated with either type 1 or type 2 diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. This was illustrated in a report of 79 patients with type 1 diabetes from the Joslin Kidney Study who were followed for a mean of 12 years after the onset of microalbuminuria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/2\">",
"     2",
"    </a>",
"    ]. Twenty-three of the patients progressed to advanced disease (GFR less than 60",
"    <span class=\"nowrap\">",
"     mL/min).",
"    </span>",
"    Among these patients, 11 had either stable microalbuminuria or regression to normal albuminuria. The other 12 patients developed proteinuria that usually accompanied but did",
"    <strong>",
"     not",
"    </strong>",
"    precede the decline in GFR. The rate of loss of GFR was lower in patients with regression to normal albuminuria compared with patients with stable microalbuminuria or progression to macroalbuminuria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/5\">",
"     5",
"    </a>",
"    ]. Patients who progressed to macroalbuminuria had the highest rate of loss of GFR [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/5\">",
"     5",
"    </a>",
"    ] and all six patients who developed end-stage renal disease had progressed to macroalbuminuria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The factor(s) responsible for progressive GFR decline in nonproteinuric diabetic nephropathy are not known. One possibility is intrarenal vascular disease. However, in a study of patients with type 2 diabetes and a GFR below 60",
"    <span class=\"nowrap\">",
"     mL/min,",
"    </span>",
"    intrarenal vascular resistance on renal duplex scan was elevated to a similar degree in patients with and without proteinuria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/4\">",
"     4",
"    </a>",
"    ]. In addition, nonproteinuric progression occurs in type 1 diabetes, a population that is generally much younger than those with type 2 diabetes and less likely to have intrarenal vascular disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H95228685\">",
"    <span class=\"h2\">",
"     Hematuria",
"    </span>",
"    &nbsp;&mdash;&nbsp;The urine sediment in diabetic nephropathy is usually bland, but microscopic hematuria can occur as it can in any form of glomerular disease, including disorders such as membranous nephropathy that are not associated with glomerulonephritis. This is an important issue in diabetic nephropathy since nondiabetic renal disease, either alone or with diabetic nephropathy, is not uncommon in patients with diabetes. (See",
"    <a class=\"local\" href=\"#H26\">",
"     'Nondiabetic renal disease'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The prevalence of hematuria in patients with diabetic nephropathy and whether it is due to diabetic nephropathy or a concurrent renal disease has been evaluated in a few studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. In a report from Japan of 154 patients with diabetes mellitus, glomerular hematuria was observed in 26 (17 percent), 10 of whom had IgA nephropathy and one of whom had membranous nephropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/6\">",
"     6",
"    </a>",
"    ]. The remaining 15 patients with hematuria, compared with the 128 patients without hematuria, had more severe diabetic nephropathy on renal biopsy, as manifested by advanced diffuse glomerular lesions and by interstitial lesions, and by a significantly higher serum creatinine concentration.",
"   </p>",
"   <p>",
"    Red blood cell casts have also been described in patients with diabetic nephropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. The clinical significance of this finding was evaluated in a study of eight patients with hematuria, red blood cell casts, and known diabetes for 6 to 18 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/7\">",
"     7",
"    </a>",
"    ]. Renal biopsy, including immunofluorescence and electron microscopy, revealed glomerulonephritis in three (postinfectious in two and IgA nephropathy in one). The other five patients had only diabetic nephropathy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Type 1 diabetes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The epidemiology of diabetic nephropathy has been best studied in patients with type 1 disease, since the time of clinical onset is usually known. Approximately 20 to 30 percent will have microalbuminuria after a mean duration of diabetes of 15 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. Less than half of these patients will progress to overt nephropathy; microalbuminuria may regress or remain stable in a substantial proportion, probably related to glycemic and blood pressure control. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/49/42777?source=see_link&amp;anchor=H9#H9\">",
"     \"Microalbuminuria in type 1 diabetes mellitus\", section on 'Prevalence'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/49/42777?source=see_link&amp;anchor=H11#H11\">",
"     \"Microalbuminuria in type 1 diabetes mellitus\", section on 'Regression to normoalbuminuria'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Prior to the current period of intensive control of glycemic levels and of blood pressure with ACE-inhibitors and angiotensin receptor blockade, it was suggested that 25 to 45 percent of diabetic patients will develop clinically evident disease (the minimal criterion for which is a persistently positive urine dipstick for protein) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/9,11-13\">",
"     9,11-13",
"    </a>",
"    ]. After so-called macroalbuminuria or clinical grade proteinuria (&gt;300 mg albuminuria per day) develops, the majority of patients will progress to end-stage renal failure.",
"   </p>",
"   <p>",
"    The overall incidence of end-stage renal disease (ESRD) was also substantial, with reported rates of 4 to 17 percent at 20 years from time of initial diagnosis and approximately 16 percent at 30 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. In comparison to these findings, subsequent studies have found that the renal prognosis of type 1 diabetes, including the rate of progression to ESRD, has dramatically improved over the last several decades [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A study from Sweden noted a dramatic reduction in clinically evident diabetic nephropathy to 8.9 percent at 25 years, a presumed reflection of better glycemic control [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/17\">",
"       17",
"      </a>",
"      ]. The average hemoglobin A1c concentration in the later part of this follow-up period was 7.0 percent; patients without overt proteinuria had a lower hemoglobin A1c concentration than those with proteinuria (7.1 versus 8.1 percent). A similar decline in incidence was not noted in another report in which this degree of glycemic control was not achieved [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      One study from Finland evaluated the long-term outcomes of 20,005 patients over the period 1965 to 1999 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/18\">",
"       18",
"      </a>",
"      ]. During the median follow-up period of 17 years (maximum of 37 years), progression to ESRD occurred in only 632 patients, with the cumulative incidence being 2.2 and 7.8 percent at 20 and 30 years, respectively. In addition, the rate of ESRD was relatively lower among patient cohorts diagnosed at later time points, and the incidence of ESRD was lowest among those diagnosed prior to the age of 5 years.",
"     </li>",
"     <li>",
"      33 of 480 patients (7 percent) with type 1 diabetes and normal GFR developed ESRD after 16 years of follow-up in a prospective cohort study [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In the",
"      <span class=\"nowrap\">",
"       DCCT/EDIC",
"      </span>",
"      type 1 diabetes cohort, less than 2 percent (10 of 711) of the intensively treated subjects developed renal insufficiency (serum creatinine &gt; 2.0",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      or renal replacement therapy) over an average thirty years of diabetes duration [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition to the importance of glycemic control, more aggressive blood pressure reduction and the use of angiotensin converting enzyme inhibitors have been shown to reduce the rate of progression of, though not prevent, diabetic nephropathy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/45/21210?source=see_link\">",
"     \"Treatment of hypertension in patients with diabetes mellitus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/49/42777?source=see_link\">",
"     \"Microalbuminuria in type 1 diabetes mellitus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/49/42777?source=see_link&amp;anchor=H23#H23\">",
"     \"Microalbuminuria in type 1 diabetes mellitus\", section on 'ACE inhibitors or ARBs'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The onset of overt nephropathy in type 1 diabetes is typically between 10 and 15 years after the onset of the disease. Those patients who have no proteinuria after 20 to 25 years have a risk of developing overt renal disease of only about 1 percent per year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/11,20\">",
"     11,20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Type 2 diabetes",
"    </span>",
"    &nbsp;&mdash;&nbsp;In Caucasians, the prevalence of progressive renal disease has generally been lower in type 2 diabetes than in type 1 disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/21\">",
"     21",
"    </a>",
"    ]. However, this observation may be a function of the usually later-onset disease and shorter-duration \"exposure\" in type 2 than type 1 diabetes, and may not apply to all groups with type 2 diabetes, some of whom have had a more ominous renal prognosis. In a 1990s study, for example, nephropathy developed in up to 50 percent of diabetic Pima Indians at 20 years, with 15 percent having progressed to ESRD by this time [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/22\">",
"     22",
"    </a>",
"    ]. As previously described, however, the use of modern therapies lowers the incidence of ESRD, even in groups at extremely high risk such as the Pima Indians. In a subsequent study, for example, the incidence of diabetic ESRD was noted to have declined significantly from the period 1991-1994 to the period 1999-2002 (32 to 15 cases per 1000 patient-years, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Data suggest that the renal risk is currently equivalent in the two types of diabetes. Evidence in support of this hypothesis includes the observations in one report that the time to proteinuria from the onset of diabetes and the time to ESRD from the onset of proteinuria were similar in type 1 and type 2 disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/24,25\">",
"     24,25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some of the most robust data relating to the development of diabetic nephropathy in a population of predominantly white patients with type 2 was reported from the United Kingdom Prospective Diabetes Study (UKPDS) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/26\">",
"     26",
"    </a>",
"    ]. The UKPDS was designed to compare the efficacy of different treatment regimens (diet, oral hypoglycemics, insulin, antihypertensive agents, varying blood pressure goals, and other interventions) on glycemic control and the complications of diabetes (including renal failure) in newly diagnosed patients with type 2 diabetes. The details of this study are described separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/25/7578?source=see_link\">",
"     \"Glycemic control and vascular complications in type 2 diabetes mellitus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/48/40714?source=see_link\">",
"     \"Treatment of diabetic nephropathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/45/21210?source=see_link\">",
"     \"Treatment of hypertension in patients with diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    With respect to the development and progression of nephropathy among almost 5100 type 2 diabetic patients enrolled in UKPDS, the following results were reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/26\">",
"     26",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      At ten years following diagnosis, the prevalence of microalbuminuria, macroalbuminuria, and either an elevated plasma creatinine concentration (defined as &ge;175",
"      <span class=\"nowrap\">",
"       &micro;mol/L",
"      </span>",
"      [2.0",
"      <span class=\"nowrap\">",
"       mg/dL])",
"      </span>",
"      or requirement for renal replacement therapy was 25, 5, and 0.8 percent, respectively.",
"     </li>",
"     <li>",
"      The yearly rate of progression from diagnosis to microalbuminuria, from microalbuminuria to macroalbuminuria, and from macroalbuminuria to an elevated plasma creatinine concentration or renal replacement therapy was 2.0, 2.8, and 2.3 percent.",
"     </li>",
"     <li>",
"      Based upon a statistical model, an estimation of the median time spent in each stage without progression to another nephropathy stage was 19, 11, and 10 years for those with no nephropathy, microalbuminuria, and macroalbuminuria, respectively. Among those with an elevated plasma creatinine concentration (&ge;2.0",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [175",
"      <span class=\"nowrap\">",
"       &micro;mol/L]),",
"      </span>",
"      renal replacement therapy was required after a median period of only 2.5 years. This rate of progression is higher than seen in other studies probably because of two factors: appropriate therapy (eg, angiotensin inhibition and rigorous blood pressure control) was not taken into account; and most of the patients had more advanced renal insufficiency as defined by serum creatinine concentration &ge;2.0",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [175",
"      <span class=\"nowrap\">",
"       &micro;mol/L].",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As with type 1 diabetes, some patients with microalbuminuria due to type 2 diabetes, particularly those with good glycemic control, experience regression of microalbuminuria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pathologic abnormalities are noted in patients with long-standing diabetes mellitus before the onset of microalbuminuria. There are three major histologic changes in the glomeruli in diabetic nephropathy: mesangial expansion; glomerular basement membrane thickening; and glomerular sclerosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/28,29\">",
"     28,29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The last abnormality, which may have a nodular appearance (the Kimmelstiel-Wilson lesion), is often associated with hyaline deposits in the glomerular arterioles (reflecting the insinuation of plasma proteins such as fibrin, albumin, immunoglobulins, and complement into the vascular wall) (",
"    <a class=\"graphic graphic_picture graphicRef56156 graphicRef63754 graphicRef77108 \" href=\"mobipreview.htm?43/15/44282\">",
"     picture 1A-C",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/28,30\">",
"     28,30",
"    </a>",
"    ]. These different histologic patterns appear to have similar prognostic significance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The mesangial expansion and glomerulosclerosis do not always develop in parallel, suggesting that they may have somewhat different underlying pathogenesis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Renal Pathology Society classification",
"    </span>",
"    &nbsp;&mdash;&nbsp;A classification of type 1 and type 2 diabetic nephropathy was developed by the research committee of the Renal Pathology Society [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/30\">",
"     30",
"    </a>",
"    ]. Four classes of glomerular lesions were defined:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Class I: Isolated glomerular basement membrane thickening. Basement membranes are greater than 430 nm in males older than age 9 and 395 nm in females. There is no evidence of mesangial expansion, increased mesangial matrix, or global glomerulosclerosis involving &gt;50 percent of glomeruli.",
"     </li>",
"     <li>",
"      Class II: Mild (class IIa) or severe (class IIb) mesangial expansion. A lesion is considered severe if areas of expansion larger than the mean area of a capillary lumen are present in &gt;25 percent of the total mesangium.",
"     </li>",
"     <li>",
"      Class III: At least one Kimmelstiel-Wilson lesion (nodular intercapillary glomerulosclerosis) is observed on biopsy and there is &lt;50 percent global glomerulosclerosis.",
"     </li>",
"     <li>",
"      Class IV: Advanced diabetic sclerosis. There is &gt;50 percent global glomerulosclerosis that attributable to diabetic nephropathy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The severities of interstitial and vascular lesions were also assigned scores:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A score of 0 was assigned if the interstitium had no areas of interstitial fibrosis and tubular atrophy (IFTA); scores of 1, 2 or 3 were assigned if areas of IFTA &lt;25, 25-50 or &gt;50 percent, respectively.",
"     </li>",
"     <li>",
"      A score of 0 was assigned if no T lymphocytes or macrophage infiltrate was present. Scores of 1 or 2 were assigned if infiltrate was limited to the area surrounding atrophic tubules, or if infiltrate was not limited, respectively.",
"     </li>",
"     <li>",
"      Scores of 0, 1 or 2 were assigned if no arteriolar hyalinosis, one arteriole, or more than one arteriole with hyalinosis was present. In addition, the most severely affected arteriole was assigned a score of 0, 1 or 2 if there was no intimal thickening, intimal thickening &lt; thickness of media or intimal thickening &gt; thickness of the media.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A pilot study in which five pathologists independently classified 25 biopsies demonstrated good interobserver reproducibility (intraclass correlation coefficient [kappa statistic] of 0.84). Although this classification scheme is helpful to pathologists, its clinical utility is unknown.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Other causes of nodular glomerulosclerosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Causes of nodular glomerulosclerosis other than diabetic nephropathy include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/31\">",
"     31",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Dysproteinemias such as amyloidosis and monoclonal immunoglobulin deposition diseases (MIDD), mostly kappa light chain deposition disease. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/29/13784?source=see_link\">",
"       \"Renal amyloidosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Organized glomerular deposition diseases, fibrillary and immunotactoid glomerulonephritis, fibronectin glomerulopathy, and collagen III glomerulopathy. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/18/33064?source=see_link\">",
"       \"Glomerular diseases due to nonamyloid fibrillar deposits\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/31/31221?source=see_link\">",
"       \"Fibronectin glomerulopathy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Chronic hypoxic or ischemic conditions, such as cyanotic congenital heart disease, Takayasu's arteritis with renal artery stenosis, or cystic fibrosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Chronic membranoproliferative glomerulonephritis (Type I). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/51/43833?source=see_link\">",
"       \"Clinical presentation, classification, and causes of membranoproliferative glomerulonephritis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Idiopathic nodular glomerulosclerosis, which is frequently associated with smoking, hypertension and metabolic syndrome, but without overt diabetes mellitus [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/31,33,34\">",
"       31,33,34",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Many of these conditions will be identified by characteristic findings observed by immunofluorescence or electron microscopy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There appear to be different pathogenetic processes leading to the pathologic mechanisms in diabetic nephropathy. Glomerulosclerosis, for example, may result from intraglomerular hypertension induced by renal vasodilatation, or from ischemic injury induced by hyaline narrowing of the vessels supplying the glomeruli [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Glomerular hyperfiltration",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of glomerular hypertension and hyperfiltration in diabetic nephropathy is reinforced by the apparent benefits of blockade of the renin-angiotensin system. Antagonizing the profibrotic effects of angiotensin II may also be a significant factor in benefits observed with these agents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/36\">",
"     36",
"    </a>",
"    ]. Support for such profibrotic elements underlying diabetic nephropathy is provided by findings in an animal model of diabetic nephropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/37\">",
"     37",
"    </a>",
"    ]. Transient renin-angiotensin system blockade (for seven weeks) in prediabetic rats reduced proteinuria and improved glomerular structure. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Glomerular filtration rate'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/61/22484?source=see_link\">",
"     \"Mechanisms of glomerular hyperfiltration in diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Hyperglycemia and AGEs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperglycemia may directly induce mesangial expansion and injury, perhaps in part via increased matrix production or glycation of matrix proteins. In vitro studies have demonstrated that hyperglycemia stimulates mesangial cell matrix production [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/38,39\">",
"     38,39",
"    </a>",
"    ], and mesangial cell apoptosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/40-42\">",
"     40-42",
"    </a>",
"    ]. Mesangial cell expansion appears to be mediated in part by an increase in the mesangial cell glucose concentration, since similar changes in mesangial function can be induced in a normal glucose milieu by overexpression of glucose transporters, thereby enhancing glucose entry into the cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Glycation of tissue proteins also may contribute to the development of diabetic nephropathy and other microvascular complications. In chronic hyperglycemia, some of the excess glucose combines with free amino acids on circulating or tissue proteins. This nonenzymatic process initially forms reversible early glycation products and later irreversible advanced glycation end products (AGEs) (",
"    <a class=\"graphic graphic_figure graphicRef80716 \" href=\"mobipreview.htm?22/4/22606\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Circulating AGE levels are increased in diabetics, particularly those with renal insufficiency, since AGEs are normally excreted in the urine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/43\">",
"     43",
"    </a>",
"    ]. The net effect is tissue accumulation of AGEs, in part by crosslinking with collagen, which can contribute to the associated renal and microvascular complications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/44\">",
"     44",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/34/11817?source=see_link&amp;anchor=H2#H2\">",
"     \"Glycemic control and vascular complications in type 1 diabetes mellitus\", section on 'Pathogenesis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/45/11993?source=see_link\">",
"     \"Estimation of blood glucose control in diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other proposed mechanisms by which hyperglycemia might promote the development of diabetic nephropathy include activation of protein kinase C [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/45\">",
"     45",
"    </a>",
"    ], and upregulation of heparanase expression, as a decrease in cell surface heparan sulfate may contribute to increased glomerular basement membrane permeability to albumin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/46,47\">",
"     46,47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Prorenin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial clinical studies in children and adolescents suggested that increased plasma prorenin activity was a risk factor for the development of diabetic nephropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. Prorenin binds to a specific tissue receptor that promotes activation of the mitogen-activated protein kinases (MAPK)",
"    <span class=\"nowrap\">",
"     p44/p42A",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A possible pathogenic role for prorenin in the development of diabetic nephropathy was suggested by an experimental model (streptozotocin diabetes in mice) in which prolonged prorenin receptor blockade abolished MAPK activation and prevented the development of nephropathy despite an unaltered increase in angiotensin II activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Cytokines",
"    </span>",
"    &nbsp;&mdash;&nbsp;Activation of cytokines, profibrotic elements, inflammation, and vascular growth factors (vascular endothelial growth factor, VEGF) may be involved in the matrix accumulation in diabetic nephropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/52-67\">",
"     52-67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hyperglycemia stimulates increased VEGF expression (a mediator of endothelial injury in human diabetes) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. A potentially pathogenic role for VEGF in diabetic nephropathy is supported by the observation that VEGF blockade improves albuminuria in an experimental model of diabetic nephropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/54,68\">",
"     54,68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A hyperglycemia-induced decrease in activated protein C contributes to the structural lesion of diabetic nephropathy and worsens proteinuria in the streptozotocin model of diabetes in mice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/69\">",
"     69",
"    </a>",
"    ]. The role of activated protein C in diabetic nephropathy in humans is not yet known.",
"   </p>",
"   <p>",
"    Hyperglycemia also increases the expression of transforming growth factor-beta (TGF-beta) in the glomeruli and of matrix proteins specifically stimulated by this cytokine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/52,63\">",
"     52,63",
"    </a>",
"    ]. In addition, diabetes is associated with decreased expression of renal bone morphogenic protein-7 (BMP-7), which appears to counter the profibrogenic actions of TGF-beta [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/70\">",
"     70",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The effect of some genetic factors may also be in part mediated by TGF-beta [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/71\">",
"     71",
"    </a>",
"    ]. TGF-beta may contribute to both the cellular hypertrophy and enhanced collagen synthesis that are seen in diabetic nephropathy, illustrated by the examples below [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/71-75\">",
"     71-75",
"    </a>",
"    ]&nbsp;(see",
"    <a class=\"local\" href=\"#H15\">",
"     'Genetic susceptibility'",
"    </a>",
"    below):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The administration of an angiotensin converting enzyme inhibitor to patients who have type 1 diabetes and nephropathy lowers serum concentrations of TGF-beta [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/73\">",
"       73",
"      </a>",
"      ]. A correlation has been found between decreased TGF-beta levels and renoprotection, as determined by changes in the glomerular filtration rate over time.",
"     </li>",
"     <li>",
"      The combination of an anti-TGF-beta antibody plus an ACE inhibitor completely normalized proteinuria in rats with diabetic nephropathy; proteinuria was only partially lessened with an ACE inhibitor alone [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/74\">",
"       74",
"      </a>",
"      ]. Glomerulosclerosis and tubulointerstitial injury were also improved.",
"     </li>",
"     <li>",
"      The administration of hepatocyte growth factor, which specifically blocks the profibrotic actions of TGF-beta, ameliorates diabetic nephropathy in mice [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/75\">",
"       75",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Nephrin expression",
"    </span>",
"    &nbsp;&mdash;&nbsp;The renal expression of nephrin may be impaired in diabetic nephropathy. Congenital mutations in nephrin, a transmembrane protein expressed by podocytes, result in severe congenital nephrotic syndrome of the Finnish type. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/36/7753?source=see_link\">",
"     \"Congenital and infantile nephrotic syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When compared with nondiabetic patients with minimal change nephropathy and controls, patients with diabetic nephropathy had markedly lower renal nephrin expression and fewer electron dense slit diaphragms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/76\">",
"     76",
"    </a>",
"    ]. By comparison, the expression of two other important",
"    <span class=\"nowrap\">",
"     podocyte/slit",
"    </span>",
"    diaphragm proteins, podocin and CD2AP, was similar among the three groups. Similar decreases in renal nephrin expression have been reported in other studies of diabetic nephropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/77,78\">",
"     77,78",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24966693\">",
"    <span class=\"h2\">",
"     Impaired podocyte-specific insulin signaling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Defects in podocyte-specific insulin signaling may contribute to diabetic nephropathy. Mouse models have been generated in which the gene encoding the insulin receptor is deleted in a podocyte-specific manner [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/79\">",
"     79",
"    </a>",
"    ]. In the absence of hyperglycemia, affected mice develop albuminuria, effacement of foot processes, apoptosis, glomerular basement membrane thickening, accumulation of mesangial matrix and glomerulosclerosis. Activation of the insulin receptor appears to trigger remodeling of the actin cytoskeleton through the mitogen-activated protein kinase",
"    <span class=\"nowrap\">",
"     42/44",
"    </span>",
"    (MAPK) and phosphatidylinositol 3 (PI3) kinase signaling pathways, suggesting a possible mechanism of proteinuria. The podocyte insulin receptor may provide a target for agents that prevent proteinuria",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    development and progression of diabetic nephropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/80,81\">",
"     80,81",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies in patients who have or do not have clinically evident diabetic nephropathy have identified a number of factors as being associated with increased risk of renal involvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/28,82,83\">",
"     28,82,83",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Genetic susceptibility",
"    </span>",
"    &nbsp;&mdash;&nbsp;Genetic susceptibility may be an important determinant of both the incidence and severity of diabetic nephropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/29,45,84\">",
"     29,45,84",
"    </a>",
"    ]. The likelihood of developing diabetic nephropathy is markedly increased in patients with a diabetic sibling or parent who has diabetic nephropathy; these observations have been made in both type 1 and type 2 diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/85-87\">",
"     85-87",
"    </a>",
"    ]. One report, for example, evaluated Pima Indian families in which two successive generations had type 2 diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/86\">",
"     86",
"    </a>",
"    ]. The likelihood of the offspring developing overt proteinuria was 14 percent if neither parent had proteinuria, 23 percent if one parent had proteinuria, and 46 percent if both parents had proteinuria.",
"   </p>",
"   <p>",
"    The familial increase in risk cannot be explained by the duration of diabetes, hypertension, or the degree of glycemic control, although a genetic predisposition to abnormal sodium handling and hypertension may be important [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/85\">",
"     85",
"    </a>",
"    ]. Genetics also may contribute to the influence of race on diabetic nephropathy (see",
"    <a class=\"local\" href=\"#H20\">",
"     'Race'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    Many studies have examined the role of the angiotensin converting enzyme (ACE) gene genotype as a potential genetic risk factor with conflicting data:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients with type 2 diabetes, the DD polymorphism has been associated with an increased risk for the development of diabetic nephropathy, more severe proteinuria, greater likelihood of progressive renal failure, and mortality on dialysis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/88-90\">",
"       88-90",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A critical review of nineteen studies examining a possible link between the ACE gene genotype and diabetic nephropathy failed to confirm an association among Caucasians with either type 1 or type 2 diabetes, but could not exclude a possible association in Asians [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/91\">",
"       91",
"      </a>",
"      ]. Unfortunately, due to poor methodology, no definitive conclusions could be drawn.",
"     </li>",
"     <li>",
"      An analysis of over 1,000 Caucasian patients with type 1 diabetes found a strong correlation between genetic variation in the ACE gene and the development of nephropathy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/92\">",
"       92",
"      </a>",
"      ]. However, a family-based European study found no correlation between diabetic nephropathy in type 1 diabetics and certain ACE polymorphisms [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/93\">",
"       93",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Another implicated genetic factor is the angiotensin-II type 2 receptor gene (AT2) on the X-chromosome. Male patients with type 1 diabetes and the AA haplotype of the AT2 gene had a lower glomerular filtration rate than those with the GT haplotype [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/94\">",
"     94",
"    </a>",
"    ]. A similar association was not observed among females.",
"   </p>",
"   <p>",
"    An enhanced risk may also be due to inheritance of one allele of the aldose reductase gene, the rate-limiting enzyme for the polyol pathway. In a controlled study of patients with type 1 diabetes, homozygosity for the Z-2 allele was significantly associated with an odds ratio of 5.25 for the presence of nephropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/95\">",
"     95",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/44/13000?source=see_link\">",
"     \"Aldose reductase inhibitors in the prevention of diabetic complications\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Variants of the PKCb1 gene have been associated with kidney disease in Chinese patients with type 2 diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/96\">",
"     96",
"    </a>",
"    ]. Four common single-nucleotide polymorphisms were independently associated with end-stage renal disease in two large cohorts of Chinese patients.",
"   </p>",
"   <p>",
"    The Genetics of Kidneys in Diabetes Study (GoKinD) has assembled a cohort of individuals and families with type 1 diabetes with and without kidney disease to facilitate examination of potential genetic factors predisposing to diabetic nephropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/97\">",
"     97",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Age",
"    </span>",
"    &nbsp;&mdash;&nbsp;The impact of age at onset of diabetes on the risk of developing nephropathy and end-stage renal disease is unclear. As an example, among patients with type 2 diabetes, increasing age, along with increasing duration of diabetes, has been associated with an increased risk for developing albuminuria in Australia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/83\">",
"     83",
"    </a>",
"    ]. In contrast, in a population-based study of 1856 Pima Indians with type 2 diabetes, patients who developed diabetes prior to age 20 had a higher risk of progressing to end-stage renal disease (25 versus 5 per 1000 patient years at risk) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/98\">",
"     98",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For type 1 diabetes, the risk of developing ESRD is very low for patients diagnosed prior to age 5; at older ages, the relationship of age to progression to ESRD is uncertain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/18,99\">",
"     18,99",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Blood pressure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prospective studies have noted an association between the subsequent development of diabetic nephropathy and higher systemic pressures. The pathogenesis of hypertension, the goal blood pressure, and the choice of antihypertensive drugs in patients with diabetes are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/45/21210?source=see_link\">",
"     \"Treatment of hypertension in patients with diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Glomerular filtration rate",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately one-half of patients with type 1 diabetes of less than five years duration have an elevated glomerular filtration rate (GFR) that is 25 to 50 percent above normal. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/61/22484?source=see_link\">",
"     \"Mechanisms of glomerular hyperfiltration in diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Those patients with glomerular hyperfiltration appear to be at increased risk for diabetic renal disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/82,100\">",
"     82,100",
"    </a>",
"    ]. This is particularly true for overt nephropathy if the initial GFR is above 150",
"    <span class=\"nowrap\">",
"     mL/min;",
"    </span>",
"    in comparison, lesser degrees of hyperfiltration may have a slower course, with a lesser risk for microalbuminuria. In one prospective study, for example, patients with type 1 diabetes and a GFR above 125",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    had a risk of developing microalbuminuria within 8 years of approximately 50 percent versus only 5 percent in patients with a lower GFR that was similar to that seen in nondiabetics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/100\">",
"     100",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The glomerular hyperfiltration in type 1 diabetics is typically associated with glomerular hypertrophy and increased renal size [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/101\">",
"     101",
"    </a>",
"    ]. The association between these hemodynamic and structural changes and the development of diabetic nephropathy may be related both to intraglomerular hypertension (which drives the hyperfiltration) and to glomerular hypertrophy (which also increases wall stress). Therapy aimed at reversing these changes &mdash; with aggressive control of the plasma glucose concentration early in the course of the disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/101\">",
"     101",
"    </a>",
"    ], dietary protein restriction, and antihypertensive therapy &mdash; may slow the rate of progression of the renal disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/48/40714?source=see_link\">",
"     \"Treatment of diabetic nephropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The findings in type 2 diabetes are somewhat different. Up to 45 percent of affected patients initially have a GFR that is more than 2 standard deviations above age-matched nondiabetic and obese controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/102,103\">",
"     102,103",
"    </a>",
"    ]. However, the degree of hyperfiltration (averaging 117 to 133",
"    <span class=\"nowrap\">",
"     mL/min)",
"    </span>",
"    is less than that seen in type 1 diabetics. Type 2 diabetics are also older and more likely to have arteriosclerotic vascular disease, which will limit increases in both glomerular filtration and glomerular size [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/104\">",
"     104",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The potential importance of intraglomerular hypertension in the pathogenesis of diabetic nephropathy may explain why systemic hypertension is an important risk factor for the development of diabetic nephropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/105\">",
"     105",
"    </a>",
"    ]. Studies in experimental animals suggest that the diabetic state is associated with impaired renal autoregulation. As a result, raising the systemic pressure does not produce the expected afferent arteriolar vasoconstriction that would minimize transmission of the elevated pressure to the glomerulus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/106\">",
"     106",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Glycemic control",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diabetic nephropathy is more likely to develop in patients with worse glycemic control (higher HbA1c levels). This has been well established in controlled clinical trials and is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/34/11817?source=see_link\">",
"     \"Glycemic control and vascular complications in type 1 diabetes mellitus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/25/7578?source=see_link\">",
"     \"Glycemic control and vascular complications in type 2 diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Race",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence and severity of diabetic nephropathy are increased in blacks (3- to 6-fold compared to Caucasians), Mexican-Americans, and Pima Indians with type 2 diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/22,107,108\">",
"     22,107,108",
"    </a>",
"    ]. This observation in such genetically disparate populations suggests a primary role for socioeconomic factors, such as diet, poor control of hyperglycemia, hypertension, and obesity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/109\">",
"     109",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As an example, there appears to be an important association between hypertension and disease progression in black patients with type 2 diabetes. A cross-sectional study found that the GFR was normal in patients who were normotensive; in comparison, hypertension was associated with a decline in renal function, particularly if it developed after the onset of diabetes and the patient had been diabetic for more than 10 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/110\">",
"     110",
"    </a>",
"    ]. It is not clear, however, if the hypertension worsened the renal disease or was simply a marker for more severe renal involvement. (Blacks are also at increased risk for some other renal diseases, particularly hypertensive nephrosclerosis, (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/58/11174?source=see_link\">",
"     \"Hypertensive complications in blacks\"",
"    </a>",
"    )).",
"   </p>",
"   <p>",
"    However, the importance of genetic influences in the racial propensity to diabetic nephropathy cannot be excluded. Even when adjustments are made for the increased incidence of hypertension and lower socioeconomic status in blacks, there still appears to be as much as a 4.8-fold increase in the risk of end-stage renal disease due to diabetic nephropathy in blacks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/107\">",
"     107",
"    </a>",
"    ]. This appears to occur only in type 2 diabetes, with no increase in risk seen with type 1 diabetes.",
"   </p>",
"   <p>",
"    Pima Indians, on the other hand, have larger glomeruli than Caucasians, a finding that may represent a specific genetic trait [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/111\">",
"     111",
"    </a>",
"    ]. This increase in glomerular size, via the mechanism described above, could lead to enhanced susceptibility to diabetes-induced glomerular injury. One manifestation of this increased risk is the observation that diabetic Pima Indians with a known duration of disease of less than 3 years already have evidence of glomerular dysfunction (increased albumin excretion due to impaired glomerular size-selectivity) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/22,112\">",
"     22,112",
"    </a>",
"    ]. These patients also have a higher GFR (140 versus 122",
"    <span class=\"nowrap\">",
"     mL/min)",
"    </span>",
"    when compared to matched patients without diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/112\">",
"     112",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Obesity",
"    </span>",
"    &nbsp;&mdash;&nbsp;A high body mass index (BMI) has been associated with an increased risk of chronic kidney disease among patients with diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/83,113-115\">",
"     83,113-115",
"    </a>",
"    ]. In addition, diet and weight loss may reduce proteinuria and improve kidney function among patients with diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/116,117\">",
"     116,117",
"    </a>",
"    ]. However, the contribution of obesity (or weight loss) to the risk of nephropathy (independent of diabetes and glycemic control) has not been convincingly demonstrated in these studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Smoking",
"    </span>",
"    &nbsp;&mdash;&nbsp;Smoking is associated with a variety of adverse effects in patients with diabetes. This includes evidence of increases in albuminuria and the risk of end-stage renal disease and of decreased survival once dialysis is begun. Some of these effects may be related to worse glycemic control. The supporting data are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/4/5189?source=see_link&amp;anchor=H2#H2\">",
"     \"Smoking and cardiovascular risk in diabetes mellitus\", section on 'Health hazards of smoking'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Oral contraceptives",
"    </span>",
"    &nbsp;&mdash;&nbsp;An initial report suggested a link between oral contraceptive use and the risk of diabetic nephropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/118\">",
"     118",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Predictive capability",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although each of the above factors increases the risk of developing diabetic nephropathy, none is as yet sufficiently predictive in the individual patient. The earliest detectable sign of diabetic nephropathy is microalbuminuria, which is associated with a substantial risk of progressive renal damage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/82\">",
"     82",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/49/42777?source=see_link\">",
"     \"Microalbuminuria in type 1 diabetes mellitus\"",
"    </a>",
"    .) Macroalbuminuria is far more predictive of the future development of severe nephropathy with decreased GFR.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     RELATION BETWEEN DIABETIC NEPHROPATHY AND RETINOPATHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with nephropathy and type 1 diabetes almost always have other signs of diabetic microvascular disease, such as retinopathy and neuropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/9,11\">",
"     9,11",
"    </a>",
"    ]. The retinopathy is easy to detect clinically, and typically precedes the onset of overt nephropathy in these patients. The converse is not true. Only a minority of patients with advanced retinopathy have histologic changes in the glomeruli and increased protein excretion that is at least in the microalbuminuric range, and most have little or no renal disease as assessed by renal biopsy and protein excretion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/119,120\">",
"     119,120",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The relationship between diabetic nephropathy and retinopathy is less predictable in type 2 diabetes. In one study of 35 patients with diabetes and significant proteinuria (&gt;300",
"    <span class=\"nowrap\">",
"     mg/day),",
"    </span>",
"    27 (77 percent) were found to have diabetic nephropathy by biopsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/121\">",
"     121",
"    </a>",
"    ]. Diabetic retinopathy was present in 15 of the 27 (56 percent), and in none of the eight individuals without diabetic nephropathy, thereby resulting in a positive and negative predictive value of 100 and 40 percent, respectively. Further analysis of some of these patients plus additional type 2 diabetics with proteinuria found that, among those without retinopathy, approximately 30 percent did not have diabetic nephropathy upon renal biopsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/122\">",
"     122",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thus, type 2 diabetics with marked proteinuria and retinopathy most likely have diabetic nephropathy, while those without retinopathy have a high frequency of non-diabetic glomerular disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/123\">",
"     123",
"    </a>",
"    ]. Data from the third National Health and Nutrition Examination Survey suggest that 30 percent of type 2 diabetics with renal insufficiency have non-diabetic renal disease, as inferred by the absence of albuminuria and retinopathy in this population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/124\">",
"     124",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some insight into the correlation between nephropathy and retinopathy was provided by a study in which 36 patients with type 2 diabetes and renal involvement underwent renal biopsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/125\">",
"     125",
"    </a>",
"    ]. Seventeen biopsies displayed diabetic glomerulosclerosis with Kimmelstiel-Wilson nodules, while 15 revealed changes characteristic of diabetes (mesangial sclerosis) but without classic nodules. Patients with and without nodules did not differ with respect to duration of diabetes or degree of glycemic control. A close correlation was observed between the presence of severe retinopathy and nodules on biopsy: six of seven patients with proliferative retinopathy had such nodules, while seven of eight without retinopathy had mesangial sclerosis. Overall, severe retinopathy was more closely associated with nodules than with mesangial sclerosis. The reason for this association is unknown.",
"   </p>",
"   <p>",
"    Blockade of the renin-angiotensin system slows the rate of progression of diabetic nephropathy and may have a similar benefit in diabetic retinopathy. In a randomized trial of 285 patients with type 1 diabetes, normal blood pressure, and normoalbuminuria, therapy with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/35/26168?source=see_link\">",
"     losartan",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/19/8505?source=see_link\">",
"     enalapril",
"    </a>",
"    reduced the odds of retinopathy progression by 65 to 70 percent, compared with placebo [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/126\">",
"     126",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/48/40714?source=see_link\">",
"     \"Treatment of diabetic nephropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Based upon the correlation between retinopathy and nephropathy, the 2007",
"    <span class=\"nowrap\">",
"     K/DOQI",
"    </span>",
"    Guidelines for diabetes and chronic kidney disease suggest that chronic kidney disease should be attributed to diabetes in most patients with diabetes if microalbuminuria or proteinuria and diabetic retinopathy are both present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/127\">",
"     127",
"    </a>",
"    ]. By comparison, other causes of CKD should be entertained if diabetic retinopathy is absent. (See",
"    <a class=\"local\" href=\"#H26\">",
"     'Nondiabetic renal disease'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     NONDIABETIC RENAL DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Proteinuria",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hematuria in diabetes mellitus is occasionally due to a glomerular disease other than diabetic nephropathy. As examples, membranous nephropathy, minimal change disease, IgA nephropathy, focal segmental glomerulosclerosis, Henoch-Sch&ouml;nlein purpura (IgA vasculitis), thin basement membrane disease, proliferative glomerulonephritis, and pauci-immune crescentic glomerulonephritis have all been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/6,7,104,121,122,128-139\">",
"     6,7,104,121,122,128-139",
"    </a>",
"    ]. Since renal disease in the setting of diabetes is often ascribed to the diabetes, without further diagnostic efforts, the coincidence of nondiabetic renal disease in persons with diabetes may be underestimated.",
"   </p>",
"   <p>",
"    With respect to membranous nephropathy, porcine insulin may be the inciting antigen in some patients. This was suggested in a report of seven patients with diabetes who developed membranous nephropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/129\">",
"     129",
"    </a>",
"    ]. Three of the patients had granular deposits of insulin along the glomerular capillary wall, as detected by anti-porcine insulin antibodies, along with IgG and complement. The nephrotic syndrome developed after the initiation of porcine insulin in all three patients and, in two of these patients, the use of human insulin rather than porcine insulin led to amelioration of the proteinuria. The other four patients had idiopathic membranous nephropathy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/54/19306?source=see_link\">",
"     \"Causes and diagnosis of membranous nephropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The major clinical clues suggesting the presence of nondiabetic glomerular disease are [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/121,127,131,140\">",
"     121,127,131,140",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The onset of proteinuria less than five years from the documented onset of type 1 diabetes, since the latent period for overt diabetic nephropathy is usually at least 10 to 15 years [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/9,11\">",
"       9,11",
"      </a>",
"      ]. The latent period is probably similar in patients with type 2 diabetes, but the time of onset is often difficult to ascertain.",
"     </li>",
"     <li>",
"      The acute onset of renal disease. Diabetic nephropathy is a slowly progressive disorder characterized by increases in protein excretion and the serum creatinine concentration over a period of years.",
"     </li>",
"     <li>",
"      The presence of an active urine sediment containing red cells (particularly acanthocytes) and cellular casts. However, hematuria and red cell casts can also be seen with diabetic nephropathy alone [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/6-8\">",
"       6-8",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H95228685\">",
"       'Hematuria'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In type 1 diabetes, the absence of diabetic retinopathy or neuropathy. In contrast, lack of retinopathy in type 2 diabetes does not preclude diabetic nephropathy, which was absent in 12 of 27 patients with biopsy confirmed diabetic nephropathy in one study [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/121\">",
"       121",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Signs",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      symptoms of another systemic disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/127\">",
"       127",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Significant reduction in the glomerular filtration rate (&gt;30 percent) within two to three months of the administration of ACE inhibitors or angiotensin II receptor blockers [",
"      <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/127\">",
"       127",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The reported frequency of other renal diseases among patients with diabetes depends upon multiple factors, including ethnicity, geographic location, and a given institution's biopsy policy. The importance of biopsy policy was evaluated in a multicenter study in Italy of biopsy results in 393 patients with type 2 diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/135\">",
"     135",
"    </a>",
"    ]. The biopsy policy was either restricted (in which the procedure was performed for the indications just mentioned and some less stringent criteria) or unrestricted (in which the procedure was performed for much less stringent criteria). The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      With the restricted biopsy policy, 29 percent had diabetic nephropathy alone, 38 percent had another glomerular disease superimposed on diabetic nephropathy, and the remaining patients had either nephrosclerosis or nondiabetic glomerular disease.",
"     </li>",
"     <li>",
"      With the unrestricted policy, the rate of diabetic nephropathy alone was much higher (51 percent), 22 percent had another glomerular disease superimposed on diabetic nephropathy, and the remaining patients had either nephrosclerosis or nondiabetic glomerular disease.",
"     </li>",
"     <li>",
"      The most common nondiabetic glomerular diseases were membranous nephropathy, IgA nephropathy, postinfectious glomerulonephritis, and minimal change disease or focal glomerulosclerosis. These disorders typically have a relatively rapid onset in contrast to the slow progression over years from microalbuminuria to macroalbuminuria in diabetic nephropathy. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Nephrosclerosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to nondiabetic glomerular diseases, renal insufficiency and proteinuria may also be induced by other diseases, particularly arteriosclerotic vascular disease (nephrosclerosis) in older type 2 diabetics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/63/30714/abstract/25,104,135,141\">",
"     25,104,135,141",
"    </a>",
"    ]. This disorder cannot usually be distinguished from diabetic nephropathy without performing a renal biopsy; this is rarely necessary since making this distinction is of no clinical value. One potential clue favoring the presence of nephrosclerosis is a rise in the plasma creatinine concentration, due to interference with renal autoregulation, after institution of an angiotensin converting enzyme inhibitor to treat hypertension or to slow the rate of progression of the renal disease. However, this is also consistent with renal artery stenosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/60/19398?source=see_link\">",
"     \"Renal effects of ACE inhibitors in hypertension\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/48/40714?source=see_link\">",
"     \"Treatment of diabetic nephropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?24/4/24644?source=see_link\">",
"       \"Patient information: Diabetic kidney disease (diabetic nephropathy) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19609597\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diabetic nephropathy occurs in both type 1 and type 2 diabetes mellitus. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The risk of progression of diabetic nephropathy has improved over the last several decades, largely due to rigorous glycemic control, more aggressive blood pressure reduction and the use of angiotensin converting enzyme inhibitors. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The three major histologic changes in the glomeruli in diabetic nephropathy include mesangial expansion; glomerular basement membrane thickening; and glomerular sclerosis. Different histologic patterns have similar prognostic significance. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Pathology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pathogenetic processes that contribute to diabetic nephropathy in susceptible individuals include glomerular hyperfiltration; hyperglycemia and the increased production of advanced glycation end products, increased plasma prorenin activity; hypoxia-inflammation and the activation of cytokines. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Risk factors associated with diabetic nephropathy include family history of diabetes, black race, Mexican-American or Pima Indian ancestry; higher systemic blood pressures, evidence of hyperfiltration early in course of disease; poor glycemic control; smoking; and possibly the use of oral contraceptives. Obesity and older age may also be risk factors. No one factor is predictive in the individual patient. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with nephropathy and type 1 diabetes almost always have other signs of diabetic microvascular disease, such as retinopathy and neuropathy. The relationship between diabetic nephropathy and retinopathy is less predictable in type 2 diabetes. The 2007",
"      <span class=\"nowrap\">",
"       K/DOQI",
"      </span>",
"      Guidelines for diabetes and chronic kidney disease suggest that chronic kidney disease should be attributed to diabetic nephropathies in most patients with diabetes if albuminuria and diabetic retinopathy are both present; other causes of CKD should be entertained if diabetic retinopathy is absent. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Relation between diabetic nephropathy and retinopathy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Proteinuria in diabetes mellitus is occasionally due to a glomerular disease other than diabetic nephropathy, or to nephrosclerosis. The major clinical clues suggesting nondiabetic glomerular disease include the onset of proteinuria less than five years from the documented onset of type 1 diabetes; the acute onset of renal disease; the presence of an active urine sediment containing red cells (particularly acanthocytes) and cellular casts; signs",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      symptoms of another systemic disease; or significant reduction in the glomerular filtration rate (&gt;30 percent) within two to three months of the administration of ACE inhibitors or angiotensin II receptor blockers. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Nondiabetic renal disease'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H27\">",
"       'Nephrosclerosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/1\">",
"      de Boer IH, Rue TC, Cleary PA, et al. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. Arch Intern Med 2011; 171:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/2\">",
"      Perkins BA, Ficociello LH, Roshan B, et al. In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria. Kidney Int 2010; 77:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/3\">",
"      Caramori ML, Fioretto P, Mauer M. Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions. Diabetes 2003; 52:1036.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/4\">",
"      MacIsaac RJ, Panagiotopoulos S, McNeil KJ, et al. Is nonalbuminuric renal insufficiency in type 2 diabetes related to an increase in intrarenal vascular disease? Diabetes Care 2006; 29:1560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/5\">",
"      Perkins BA, Ficociello LH, Ostrander BE, et al. Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. J Am Soc Nephrol 2007; 18:1353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/6\">",
"      Matsumura N, Hanatani M, Nishino T, et al. [The clinico-pathological significance of hematuria in diabetics]. Nihon Jinzo Gakkai Shi 1994; 36:1036.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/7\">",
"      O'Neill WM Jr, Wallin JD, Walker PD. Hematuria and red cell casts in typical diabetic nephropathy. Am J Med 1983; 74:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/8\">",
"      Lopes de Faria JB, Moura LA, Lopes de Faria SR, et al. Glomerular hematuria in diabetics. Clin Nephrol 1988; 30:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/9\">",
"      Orchard TJ, Dorman JS, Maser RE, et al. Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 1990; 39:1116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/10\">",
"      Newman DJ, Mattock MB, Dawnay AB, et al. Systematic review on urine albumin testing for early detection of diabetic complications. Health Technol Assess 2005; 9:iii.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/11\">",
"      Parving HH, Hommel E, Mathiesen E, et al. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br Med J (Clin Res Ed) 1988; 296:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/12\">",
"      Ismail N, Becker B, Strzelczyk P, Ritz E. Renal disease and hypertension in non-insulin-dependent diabetes mellitus. Kidney Int 1999; 55:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/13\">",
"      Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group, Nathan DM, Zinman B, et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005). Arch Intern Med 2009; 169:1307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/14\">",
"      Krolewski AS, Warram JH, Christlieb AR, et al. The changing natural history of nephropathy in type I diabetes. Am J Med 1985; 78:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/15\">",
"      Matsushima M, Tajima N, LaPorte RE, et al. Markedly increased renal disease mortality and incidence of renal replacement therapy among IDDM patients in Japan in contrast to Allegheny County, Pennsylvania, USA. Diabetes Epidemiology Research International (DERI) U.S.-Japan Mortality Study Group. Diabetologia 1995; 38:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/16\">",
"      Krolewski M, Eggers PW, Warram JH. Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study. Kidney Int 1996; 50:2041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/17\">",
"      Bojestig M, Arnqvist HJ, Hermansson G, et al. Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 1994; 330:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/18\">",
"      Finne P, Reunanen A, Stenman S, et al. Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA 2005; 294:1782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/19\">",
"      Rossing P, Rossing K, Jacobsen P, Parving HH. Unchanged incidence of diabetic nephropathy in IDDM patients. Diabetes 1995; 44:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/20\">",
"      Costacou T, Ellis D, Fried L, Orchard TJ. Sequence of progression of albuminuria and decreased GFR in persons with type 1 diabetes: a cohort study. Am J Kidney Dis 2007; 50:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/21\">",
"      Cowie CC, Port FK, Wolfe RA, et al. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med 1989; 321:1074.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/22\">",
"      Nelson RG, Knowler WC, Pettitt DJ, et al. Diabetic kidney disease in Pima Indians. Diabetes Care 1993; 16:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/23\">",
"      Pavkov ME, Knowler WC, Bennett PH, et al. Increasing incidence of proteinuria and declining incidence of end-stage renal disease in diabetic Pima Indians. Kidney Int 2006; 70:1840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/24\">",
"      Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 1999; 341:1127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/25\">",
"      Ritz E, Stefanski A. Diabetic nephropathy in type II diabetes. Am J Kidney Dis 1996; 27:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/26\">",
"      Adler AI, Stevens RJ, Manley SE, et al. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003; 63:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/27\">",
"      Araki S, Haneda M, Sugimoto T, et al. Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. Diabetes 2005; 54:2983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/28\">",
"      Fioretto P, Steffes MW, Brown DM, Mauer SM. An overview of renal pathology in insulin-dependent diabetes mellitus in relationship to altered glomerular hemodynamics. Am J Kidney Dis 1992; 20:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/29\">",
"      Adler S. Diabetic nephropathy: Linking histology, cell biology, and genetics. Kidney Int 2004; 66:2095.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/30\">",
"      Tervaert TW, Mooyaart AL, Amann K, et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol 2010; 21:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/31\">",
"      Nasr SH, D'Agati VD. Nodular glomerulosclerosis in the nondiabetic smoker. J Am Soc Nephrol 2007; 18:2032.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/32\">",
"      Westall GP, Binder J, Kotsimbos T, et al. Nodular glomerulosclerosis in cystic fibrosis mimics diabetic nephropathy. Nephron Clin Pract 2004; 96:c70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/33\">",
"      Souraty P, Nast CC, Mehrotra R, et al. Nodular glomerulosclerosis in a patient with metabolic syndrome without diabetes. Nat Clin Pract Nephrol 2008; 4:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/34\">",
"      Suneja M, Khan A, Katz DA, et al. Nodular glomerulosclerosis in a kidney transplant recipient who smokes. Am J Kidney Dis 2007; 50:830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/35\">",
"      Fliser D, Wagner KK, Loos A, et al. Chronic angiotensin II receptor blockade reduces (intra)renal vascular resistance in patients with type 2 diabetes. J Am Soc Nephrol 2005; 16:1135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/36\">",
"      Hilgers KF, Veelken R. Type 2 diabetic nephropathy: never too early to treat? J Am Soc Nephrol 2005; 16:574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/37\">",
"      Nagai Y, Yao L, Kobori H, et al. Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats. J Am Soc Nephrol 2005; 16:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/38\">",
"      Harris RD, Steffes MW, Bilous RW, et al. Global glomerular sclerosis and glomerular arteriolar hyalinosis in insulin dependent diabetes. Kidney Int 1991; 40:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/39\">",
"      Heilig CW, Concepcion LA, Riser BL, et al. Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J Clin Invest 1995; 96:1802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/40\">",
"      Mishra R, Emancipator SN, Kern T, Simonson MS. High glucose evokes an intrinsic proapoptotic signaling pathway in mesangial cells. Kidney Int 2005; 67:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/41\">",
"      Vasylyeva TL, Chen X, Ferry RJ Jr. Insulin-like growth factor binding protein-3 mediates cytokine-induced mesangial cell apoptosis. Growth Horm IGF Res 2005; 15:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/42\">",
"      Lin CL, Wang JY, Huang YT, et al. Wnt/beta-catenin signaling modulates survival of high glucose-stressed mesangial cells. J Am Soc Nephrol 2006; 17:2812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/43\">",
"      Makita Z, Radoff S, Rayfield EJ, et al. Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 1991; 325:836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/44\">",
"      Singh AK, Mo W, Dunea G, Arruda JA. Effect of glycated proteins on the matrix of glomerular epithelial cells. J Am Soc Nephrol 1998; 9:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/45\">",
"      Cooper ME. Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 1998; 352:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/46\">",
"      Maxhimer JB, Somenek M, Rao G, et al. Heparanase-1 gene expression and regulation by high glucose in renal epithelial cells: a potential role in the pathogenesis of proteinuria in diabetic patients. Diabetes 2005; 54:2172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/47\">",
"      van den Hoven MJ, Rops AL, Bakker MA, et al. Increased expression of heparanase in overt diabetic nephropathy. Kidney Int 2006; 70:2100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/48\">",
"      Wilson DM, Luetscher JA. Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus. N Engl J Med 1990; 323:1101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/49\">",
"      Daneman D, Crompton CH, Balfe JW, et al. Plasma prorenin as an early marker of nephropathy in diabetic (IDDM) adolescents. Kidney Int 1994; 46:1154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/50\">",
"      Nguyen G. Renin/prorenin receptors. Kidney Int 2006; 69:1503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/51\">",
"      Ichihara A, Suzuki F, Nakagawa T, et al. Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol 2006; 17:1950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/52\">",
"      Wolf G, Ziyadeh FN. Molecular mechanisms of diabetic renal hypertrophy. Kidney Int 1999; 56:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/53\">",
"      Hohenstein B, Hausknecht B, Boehmer K, et al. Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man. Kidney Int 2006; 69:1654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/54\">",
"      de Vriese AS, Tilton RG, Elger M, et al. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 2001; 12:993.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/55\">",
"      Utimura R, Fujihara CK, Mattar AL, et al. Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes. Kidney Int 2003; 63:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/56\">",
"      Hayashida T, Schnaper HW. High ambient glucose enhances sensitivity to TGF-beta1 via extracellular signal--regulated kinase and protein kinase Cdelta activities in human mesangial cells. J Am Soc Nephrol 2004; 15:2032.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/57\">",
"      Mezzano S, Aros C, Droguett A, et al. NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrol Dial Transplant 2004; 19:2505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/58\">",
"      Lassila M, Jandeleit-Dahm K, Seah KK, et al. Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice. J Am Soc Nephrol 2005; 16:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/59\">",
"      Gruden G, Setti G, Hayward A, et al. Mechanical stretch induces monocyte chemoattractant activity via an NF-kappaB-dependent monocyte chemoattractant protein-1-mediated pathway in human mesangial cells: inhibition by rosiglitazone. J Am Soc Nephrol 2005; 16:688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/60\">",
"      Chow FY, Nikolic-Paterson DJ, Ozols E, et al. Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. J Am Soc Nephrol 2005; 16:1711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/61\">",
"      Zhang SX, Wang JJ, Lu K, et al. Therapeutic potential of angiostatin in diabetic nephropathy. J Am Soc Nephrol 2006; 17:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/62\">",
"      Pfab T, Th&ouml;ne-Reineke C, Theilig F, et al. Diabetic endothelin B receptor-deficient rats develop severe hypertension and progressive renal failure. J Am Soc Nephrol 2006; 17:1082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/63\">",
"      Sharma K, Ziyadeh FN. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes 1995; 44:1139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/64\">",
"      Burns WC, Twigg SM, Forbes JM, et al. Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. J Am Soc Nephrol 2006; 17:2484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/65\">",
"      Navarro-Gonz&aacute;lez JF, Mora-Fern&aacute;ndez C. The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 2008; 19:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/66\">",
"      Kelly KJ, Burford JL, Dominguez JH. Postischemic inflammatory syndrome: a critical mechanism of progression in diabetic nephropathy. Am J Physiol Renal Physiol 2009; 297:F923.",
"     </a>",
"    </li>",
"    <li>",
"     Kelly KJ, Dominguez JH. Treatment of the post-ischaemic inflammatory syndrome of diabetic nephropathy. Nephrol Dial Transplant; April 20 2010 [Epub ahead of print].",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/68\">",
"      Sung SH, Ziyadeh FN, Wang A, et al. Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice. J Am Soc Nephrol 2006; 17:3093.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/69\">",
"      Isermann B, Vinnikov IA, Madhusudhan T, et al. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Nat Med 2007; 13:1349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/70\">",
"      Wang S, de Caestecker M, Kopp J, et al. Renal bone morphogenetic protein-7 protects against diabetic nephropathy. J Am Soc Nephrol 2006; 17:2504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/71\">",
"      Janssen B, Hohenadel D, Brinkkoetter P, et al. Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1. Diabetes 2005; 54:2320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/72\">",
"      Isaka, Y, Akagi, Y, Kaneda, Y, et al. Gene therapy by transforming growth factor beta receptor-IgG Fc chimera blocked glomerular hypertrophy in diabetic nephropathy (abstract). J Am Soc Nephrol 1997; 8:639A.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/73\">",
"      Sharma K, Eltayeb BO, McGowan TA, et al. Captopril-induced reduction of serum levels of transforming growth factor-beta1 correlates with long-term renoprotection in insulin-dependent diabetic patients. Am J Kidney Dis 1999; 34:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/74\">",
"      Benigni A, Zoja C, Corna D, et al. Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat. J Am Soc Nephrol 2003; 14:1816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/75\">",
"      Dai C, Yang J, Bastacky S, et al. Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice. J Am Soc Nephrol 2004; 15:2637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/76\">",
"      Benigni A, Gagliardini E, Tomasoni S, et al. Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy. Kidney Int 2004; 65:2193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/77\">",
"      Langham RG, Kelly DJ, Cox AJ, et al. Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition. Diabetologia 2002; 45:1572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/78\">",
"      Doublier S, Salvidio G, Lupia E, et al. Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II. Diabetes 2003; 52:1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/79\">",
"      Welsh GI, Hale LJ, Eremina V, et al. Insulin signaling to the glomerular podocyte is critical for normal kidney function. Cell Metab 2010; 12:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/80\">",
"      Fornoni A. Proteinuria, the podocyte, and insulin resistance. N Engl J Med 2010; 363:2068.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/81\">",
"      Gurley SB, Coffman TM. An IRKO in the Podo: impaired insulin signaling in podocytes and the pathogenesis of diabetic nephropathy. Cell Metab 2010; 12:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/82\">",
"      Mogensen CE. Prediction of clinical diabetic nephropathy in IDDM patients. Alternatives to microalbuminuria? Diabetes 1990; 39:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/83\">",
"      Tapp RJ, Shaw JE, Zimmet PZ, et al. Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Am J Kidney Dis 2004; 44:792.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/84\">",
"      Krolewski AS. Genetics of diabetic nephropathy: evidence for major and minor gene effects. Kidney Int 1999; 55:1582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/85\">",
"      Trevisan R, Viberti G. Genetic factors in the development of diabetic nephropathy. J Lab Clin Med 1995; 126:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/86\">",
"      Pettitt DJ, Saad MF, Bennett PH, et al. Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1990; 33:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/87\">",
"      Satko SG, Langefeld CD, Daeihagh P, et al. Nephropathy in siblings of African Americans with overt type 2 diabetic nephropathy. Am J Kidney Dis 2002; 40:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/88\">",
"      Jeffers BW, Estacio RO, Raynolds MV, Schrier RW. Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy. Kidney Int 1997; 52:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/89\">",
"      Yoshida H, Kuriyama S, Atsumi Y, et al. Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 1996; 50:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/90\">",
"      Kuramoto N, Iizuka T, Ito H, et al. Effect of ACE gene on diabetic nephropathy in NIDDM patients with insulin resistance. Am J Kidney Dis 1999; 33:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/91\">",
"      Kunz R, Bork JP, Fritsche L, et al. Association between the angiotensin-converting enzyme-insertion/deletion polymorphism and diabetic nephropathy: a methodologic appraisal and systematic review. J Am Soc Nephrol 1998; 9:1653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/92\">",
"      Boright AP, Paterson AD, Mirea L, et al. Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes: the DCCT/EDIC Genetics Study. Diabetes 2005; 54:1238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/93\">",
"      Hadjadj S, Tarnow L, Forsblom C, et al. Association between angiotensin-converting enzyme gene polymorphisms and diabetic nephropathy: case-control, haplotype, and family-based study in three European populations. J Am Soc Nephrol 2007; 18:1284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/94\">",
"      Pettersson-Fernholm K, Fr&ouml;jd&ouml; S, Fagerudd J, et al. The AT2 gene may have a gender-specific effect on kidney function and pulse pressure in type I diabetic patients. Kidney Int 2006; 69:1880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/95\">",
"      Shah VO, Scavini M, Nikolic J, et al. Z-2 microsatellite allele is linked to increased expression of the aldose reductase gene in diabetic nephropathy. J Clin Endocrinol Metab 1998; 83:2886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/96\">",
"      Ma RC, Tam CH, Wang Y, et al. Genetic variants of the protein kinase C-beta 1 gene and development of end-stage renal disease in patients with type 2 diabetes. JAMA 2010; 304:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/97\">",
"      Mueller PW, Rogus JJ, Cleary PA, et al. Genetics of Kidneys in Diabetes (GoKinD) study: a genetics collection available for identifying genetic susceptibility factors for diabetic nephropathy in type 1 diabetes. J Am Soc Nephrol 2006; 17:1782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/98\">",
"      Pavkov ME, Bennett PH, Knowler WC, et al. Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians. JAMA 2006; 296:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/99\">",
"      Svensson M, Nystr&ouml;m L, Sch&ouml;n S, Dahlquist G. Age at onset of childhood-onset type 1 diabetes and the development of end-stage renal disease: a nationwide population-based study. Diabetes Care 2006; 29:538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/100\">",
"      Rudberg S, Persson B, Dahlquist G. Increased glomerular filtration rate as a predictor of diabetic nephropathy--an 8-year prospective study. Kidney Int 1992; 41:822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/101\">",
"      Tuttle KR, Bruton JL, Perusek MC, et al. Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus. N Engl J Med 1991; 324:1626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/102\">",
"      Vora JP, Dolben J, Dean JD, et al. Renal hemodynamics in newly presenting non-insulin dependent diabetes mellitus. Kidney Int 1992; 41:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/103\">",
"      Nowack R, Raum E, Blum W, Ritz E. Renal hemodynamics in recent-onset type II diabetes. Am J Kidney Dis 1992; 20:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/104\">",
"      Gambara V, Mecca G, Remuzzi G, Bertani T. Heterogeneous nature of renal lesions in type II diabetes. J Am Soc Nephrol 1993; 3:1458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/105\">",
"      Earle K, Viberti GC. Familial, hemodynamic and metabolic factors in the predisposition to diabetic kidney disease. Kidney Int 1994; 45:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/106\">",
"      Hayashi K, Epstein M, Loutzenhiser R, Forster H. Impaired myogenic responsiveness of the afferent arteriole in streptozotocin-induced diabetic rats: role of eicosanoid derangements. J Am Soc Nephrol 1992; 2:1578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/107\">",
"      Brancati FL, Whittle JC, Whelton PK, et al. The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. JAMA 1992; 268:3079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/108\">",
"      Smith SR, Svetkey LP, Dennis VW. Racial differences in the incidence and progression of renal diseases. Kidney Int 1991; 40:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/109\">",
"      Kohler KA, McClellan WM, Ziemer DC, et al. Risk factors for microalbuminuria in black americans with newly diagnosed type 2 diabetes. Am J Kidney Dis 2000; 36:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/110\">",
"      Chaiken RL, Palmisano J, Norton ME, et al. Interaction of hypertension and diabetes on renal function in black NIDDM subjects. Kidney Int 1995; 47:1697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/111\">",
"      Schmidt K, Pesce C, Liu Q, et al. Large glomerular size in Pima Indians: lack of change with diabetic nephropathy. J Am Soc Nephrol 1992; 3:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/112\">",
"      Myers BD, Nelson RG, Williams GW, et al. Glomerular function in Pima Indians with noninsulin-dependent diabetes mellitus of recent onset. J Clin Invest 1991; 88:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/113\">",
"      Gelber RP, Kurth T, Kausz AT, et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis 2005; 46:871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/114\">",
"      Ejerblad E, Fored CM, Lindblad P, et al. Obesity and risk for chronic renal failure. J Am Soc Nephrol 2006; 17:1695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/115\">",
"      de Boer IH, Sibley SD, Kestenbaum B, et al. Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study. J Am Soc Nephrol 2007; 18:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/116\">",
"      Morales E, Valero MA, Le&oacute;n M, et al. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis 2003; 41:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/117\">",
"      Saiki A, Nagayama D, Ohhira M, et al. Effect of weight loss using formula diet on renal function in obese patients with diabetic nephropathy. Int J Obes (Lond) 2005; 29:1115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/118\">",
"      Ahmed SB, Hovind P, Parving HH, et al. Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathy. Diabetes Care 2005; 28:1988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/119\">",
"      Ng LL, Davies JE, Siczkowski M, et al. Abnormal Na+/H+ antiporter phenotype and turnover of immortalized lymphoblasts from type 1 diabetic patients with nephropathy. J Clin Invest 1994; 93:2750.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/120\">",
"      Chavers BM, Mauer SM, Ramsay RC, Steffes MW. Relationship between retinal and glomerular lesions in IDDM patients. Diabetes 1994; 43:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/121\">",
"      Parving HH, Gall MA, Sk&oslash;tt P, et al. Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int 1992; 41:758.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/122\">",
"      Christensen PK, Larsen S, Horn T, et al. Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy. Kidney Int 2000; 58:1719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/123\">",
"      Huang F, Yang Q, Chen L, et al. Renal pathological change in patients with type 2 diabetes is not always diabetic nephropathy: a report of 52 cases. Clin Nephrol 2007; 67:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/124\">",
"      Kramer HJ, Nguyen QD, Curhan G, Hsu CY. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA 2003; 289:3273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/125\">",
"      Schwartz MM, Lewis EJ, Leonard-Martin T, et al. Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy. The Collaborative Study Group. Nephrol Dial Transplant 1998; 13:2547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/126\">",
"      Mauer M, Zinman B, Gardiner R, et al. Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med 2009; 361:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/127\">",
"      KDOQI. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007; 49:S12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/128\">",
"      Kasinath BS, Mujais SK, Spargo BH, Katz AI. Nondiabetic renal disease in patients with diabetes mellitus. Am J Med 1983; 75:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/129\">",
"      Furuta T, Seino J, Saito T, et al. Insulin deposits in membranous nephropathy associated with diabetes mellitus. Clin Nephrol 1992; 37:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/130\">",
"      Gans RO, Ueda Y, Ito S, et al. The occurrence of IgA-nephropathy in patients with diabetes mellitus may not be coincidental: a report of five cases. Am J Kidney Dis 1992; 20:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/131\">",
"      Padilla B, Weiss M, Kant KS. Henoch-Sch&ouml;nlein purpura in a patient with diabetic nephropathy: case report and a review of the literature. Am J Kidney Dis 1992; 20:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/132\">",
"      Matsumae T, Fukusaki M, Sakata N, et al. Thin glomerular basement membrane in diabetic patients with urinary abnormalities. Clin Nephrol 1994; 42:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/133\">",
"      Mak SK, Gwi E, Chan KW, et al. Clinical predictors of non-diabetic renal disease in patients with non-insulin dependent diabetes mellitus. Nephrol Dial Transplant 1997; 12:2588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/134\">",
"      Olsen S. Identification of non-diabetic glomerular disease in renal biopsies from diabetics--a dilemma. Nephrol Dial Transplant 1999; 14:1846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/135\">",
"      Mazzucco G, Bertani T, Fortunato M, et al. Different patterns of renal damage in type 2 diabetes mellitus: a multicentric study on 393 biopsies. Am J Kidney Dis 2002; 39:713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/136\">",
"      Hill PA, Barit D, Toussaint N. ARF in 2 patients with long-standing type 2 diabetes mellitus. Am J Kidney Dis 2005; 45:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/137\">",
"      Pham TT, Sim JJ, Kujubu DA, et al. Prevalence of nondiabetic renal disease in diabetic patients. Am J Nephrol 2007; 27:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/138\">",
"      Nasr SH, D'Agati VD, Said SM, et al. Pauci-immune crescentic glomerulonephritis superimposed on diabetic glomerulosclerosis. Clin J Am Soc Nephrol 2008; 3:1282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/139\">",
"      Heine GH, Sester U, Girndt M, K&ouml;hler H. Acanthocytes in the urine: useful tool to differentiate diabetic nephropathy from glomerulonephritis? Diabetes Care 2004; 27:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/140\">",
"      Wolf G, Ritz E. Diabetic nephropathy in type 2 diabetes prevention and patient management. J Am Soc Nephrol 2003; 14:1396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/63/30714/abstract/141\">",
"      Myers DI, Poole LJ, Imam K, et al. Renal artery stenosis by three-dimensional magnetic resonance angiography in type 2 diabetics with uncontrolled hypertension and chronic renal insufficiency: prevalence and effect on renal function. Am J Kidney Dis 2003; 41:351.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3103 Version 16.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-61.234.146.186-A7177AF1CA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_63_30714=[""].join("\n");
var outline_f29_63_30714=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19609597\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6319416\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H95228671\">",
"      Albuminuria",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H119609355\">",
"      - Progressive disease with little or no albuminuria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H95228685\">",
"      Hematuria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Type 1 diabetes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Type 2 diabetes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Renal Pathology Society classification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Other causes of nodular glomerulosclerosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Glomerular hyperfiltration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Hyperglycemia and AGEs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Prorenin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Cytokines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Nephrin expression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24966693\">",
"      Impaired podocyte-specific insulin signaling",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Genetic susceptibility",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Blood pressure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Glomerular filtration rate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Glycemic control",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Race",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Obesity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Smoking",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Oral contraceptives",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Predictive capability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      RELATION BETWEEN DIABETIC NEPHROPATHY AND RETINOPATHY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      NONDIABETIC RENAL DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Nephrosclerosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19609597\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/3103\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/3103|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?22/4/22606\" title=\"figure 1\">",
"      Glycosylation of proteins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/3103|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?29/30/30185\" title=\"picture 1A\">",
"      Diabetic nephropathy Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?42/49/43800\" title=\"picture 1B\">",
"      Diabetic nephropathy Light II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?42/45/43736\" title=\"picture 1C\">",
"      Diabetic nephropathy EM",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/44/13000?source=related_link\">",
"      Aldose reductase inhibitors in the prevention of diabetic complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/54/19306?source=related_link\">",
"      Causes and diagnosis of membranous nephropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/33/14874?source=related_link\">",
"      Classification of diabetes mellitus and genetic diabetic syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/51/43833?source=related_link\">",
"      Clinical presentation, classification, and causes of membranoproliferative glomerulonephritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/36/7753?source=related_link\">",
"      Congenital and infantile nephrotic syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/45/11993?source=related_link\">",
"      Estimation of blood glucose control in diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/31/31221?source=related_link\">",
"      Fibronectin glomerulopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/18/33064?source=related_link\">",
"      Glomerular diseases due to nonamyloid fibrillar deposits",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/34/11817?source=related_link\">",
"      Glycemic control and vascular complications in type 1 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/25/7578?source=related_link\">",
"      Glycemic control and vascular complications in type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/58/11174?source=related_link\">",
"      Hypertensive complications in blacks",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/61/22484?source=related_link\">",
"      Mechanisms of glomerular hyperfiltration in diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/49/42777?source=related_link\">",
"      Microalbuminuria in type 1 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/33/39449?source=related_link\">",
"      Microalbuminuria in type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?24/4/24644?source=related_link\">",
"      Patient information: Diabetic kidney disease (diabetic nephropathy) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/29/13784?source=related_link\">",
"      Renal amyloidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/60/19398?source=related_link\">",
"      Renal effects of ACE inhibitors in hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/4/5189?source=related_link\">",
"      Smoking and cardiovascular risk in diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/48/40714?source=related_link\">",
"      Treatment of diabetic nephropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/45/21210?source=related_link\">",
"      Treatment of hypertension in patients with diabetes mellitus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f29_63_30715="Assessment of older drivers";
var content_f29_63_30715=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F71095&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F71095&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Functional assessment of older drivers",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Function",
"       </td>",
"       <td class=\"subtitle1\">",
"        Test",
"       </td>",
"       <td class=\"subtitle1\">",
"        Acceptable findings",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Muscle strength, grip strength",
"       </td>",
"       <td>",
"        Dynamometer for hand grip",
"       </td>",
"       <td>",
"        &gt;35 lb grip strength in dominant hand",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mobility",
"       </td>",
"       <td>",
"        Get up and go test; functional reach test; range of motion in shoulder, neck, and wrist",
"       </td>",
"       <td>",
"        15 seconds; reach 6 inches from starting point; watch rise from chair, turn and use of arms, height of steps",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hearing",
"       </td>",
"       <td>",
"        Whisper test",
"       </td>",
"       <td>",
"        Able to distinguish sounds",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Visual acuity and attention, peripheral vision",
"       </td>",
"       <td>",
"        Snellen eye chart or Rosenbaum pocket vision card; useful field of view (UFOV); visual fields",
"       </td>",
"       <td>",
"        20/40 in better eye; &gt;120 degrees",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cognitive function, judgement, attention, visual-spatial",
"       </td>",
"       <td>",
"        Mini mental state exam (MMSE); hexagon drawing on MMSE",
"       </td>",
"       <td>",
"        23 out of 30, &lt;23 stop driving until further testing done; copy design with sides intersecting",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Abrams, WB, Beers, MH, Berkow, R, The Merck Manual of Geriatrics, Second Edition, 1995, Whitehouse Station, NJ.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_63_30715=[""].join("\n");
var outline_f29_63_30715=null;
var title_f29_63_30716="Evaluation of cirrhosis";
var content_f29_63_30716=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F55647&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F55647&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Evaluation of the patient with cirrhosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Disease",
"      </td>",
"      <td class=\"subtitle1\">",
"       Tests and findings",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"2\">",
"       Alcoholic liver disease",
"      </td>",
"      <td>",
"       History of alcohol abuse",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       AST/ALT &gt;2 with both being less than 500 IU/mL if alcoholic hepatitis is present",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"2\">",
"       Chronic hepatitis C",
"      </td>",
"      <td>",
"       ELISA assay for anti-HCV",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       PCR for HCV RNA if confirmatory test is necessary",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Primary biliary cirrhosis",
"      </td>",
"      <td>",
"       Antimitochondrial antibodies as an isolated finding",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"3\">",
"       Primary sclerosing cholangitis",
"      </td>",
"      <td>",
"       Strong association with inflammatory bowel disease",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Contrastcholangiography to establish the diagnosis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Antinuclear and antismoothmuscle antibodies and ANCA; these are not diagnostic",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       Autoimmune hepatitis",
"      </td>",
"      <td>",
"       Hypergammaglobulinemia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Antinuclear and antismooth muscle antibodies and ANCA in type 1; anti-LKM-1 in type 2",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Chronic hepatitis B",
"      </td>",
"      <td>",
"       HBsAg and HBeAg and, in some cases, HBV DNA by hybridization or bDNA assay",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"3\">",
"       Hereditary hemochromatosis",
"      </td>",
"      <td>",
"       Family history of cirrhosis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Transferrin saturation and plasma ferritin should be performed but may be elevated by liver disease itself",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Diagnosis established by liver biopsy and calculation of hepatic iron index or by genetic testing",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"3\">",
"       Wilson disease",
"      </td>",
"      <td>",
"       Family or personal history of cirrhosis at a young age",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Serumceruloplasmin reduced in 95 percent of patients",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Liver biopsy showsincreased copper content which may also be seen in cholestatic liver diseases",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"2\">",
"       Alpha-1-antitrypsin deficiency",
"      </td>",
"      <td>",
"       Family or personal history of cirrhosis at a young age",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Serum AAT; phenotyping if low or borderline values",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"2\">",
"       Nonalcoholic fatty liver disease",
"      </td>",
"      <td>",
"       History of diabetes mellitus or metabolic syndrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Diagnosis maybe suspected by abnormal liver biochemical tests and hepatic imagingshowing fatty infiltration and is confirmed by liver biopsy",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_63_30716=[""].join("\n");
var outline_f29_63_30716=null;
var title_f29_63_30717="BAL fluid in smokers";
var content_f29_63_30717=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F66165&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F66165&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Expected values of BAL fluid constituents in healthy smokers",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Variable",
"       </td>",
"       <td class=\"subtitle1\">",
"        Mean &plusmn; SEM",
"       </td>",
"       <td class=\"subtitle1\">",
"        5th percentile*",
"       </td>",
"       <td class=\"subtitle1\">",
"        95th percentile",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Percent recovery of lavagate",
"       </td>",
"       <td>",
"        59.2 &plusmn; 1.4",
"       </td>",
"       <td>",
"        35.9",
"       </td>",
"       <td>",
"        74.9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Total cells, 10",
"        <sup>",
"         6&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        59.9 &plusmn; 7.3",
"       </td>",
"       <td>",
"        10.5",
"       </td>",
"       <td>",
"        176.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Total cells/ml, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        41.8 &plusmn; 4.5",
"       </td>",
"       <td>",
"        8.1",
"       </td>",
"       <td>",
"        117.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Macrophages, percent",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        92.5 &plusmn; 1.0",
"       </td>",
"       <td>",
"        79.5",
"       </td>",
"       <td>",
"        99.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Macrophages/mL, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        39.0 &plusmn; 4.3",
"       </td>",
"       <td>",
"        7.0",
"       </td>",
"       <td>",
"        108.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lymphocytes, percent",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        5.2 &plusmn; 0.9",
"       </td>",
"       <td>",
"        1.0",
"       </td>",
"       <td>",
"        18.6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lymphocytes/mL, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        1.74 &plusmn; 0.28",
"       </td>",
"       <td>",
"        0.1",
"       </td>",
"       <td>",
"        7.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neutrophils, percent",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        1.6 &plusmn; 0.2",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        7.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neutrophils/mL, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.82 &plusmn; 0.18",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        3.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Eosinophils, percent",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.56 &plusmn; 0.13&nbsp;",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        3.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Eosinophils/mL, 10",
"        <sup>",
"         4&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.28 &plusmn; 0.09",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        2.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T cells, percent",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        69.2 &plusmn; 4.32",
"       </td>",
"       <td>",
"        15.0",
"       </td>",
"       <td>",
"        95.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T-helper cells, percent",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        32.21 &plusmn; 2.71",
"       </td>",
"       <td>",
"        9.0",
"       </td>",
"       <td>",
"        65",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T-suppressor cells, percent",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        29.2 &plusmn; 3.0",
"       </td>",
"       <td>",
"        5.0",
"       </td>",
"       <td>",
"        58",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Helper/suppressor ratio",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        1.64 &plusmn; 0.29",
"       </td>",
"       <td>",
"        0.30",
"       </td>",
"       <td>",
"        6.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        B cells, percent",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        6.54 &plusmn; 1.54",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        28.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IgG, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        10.22 &plusmn; 0.90",
"       </td>",
"       <td>",
"        2.5",
"       </td>",
"       <td>",
"        22.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IgA, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        5.94 &plusmn; 0.53",
"       </td>",
"       <td>",
"        1.06",
"       </td>",
"       <td>",
"        15.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IgM, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        0.227 &plusmn; 0.05",
"       </td>",
"       <td>",
"        0.01",
"       </td>",
"       <td>",
"        1.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Albumin, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        42.92 &plusmn; 2.73",
"       </td>",
"       <td>",
"        14.0",
"       </td>",
"       <td>",
"        91.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Total protein, mcg/mL",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        95.39 &plusmn; 5.24",
"       </td>",
"       <td>",
"        37.8",
"       </td>",
"       <td>",
"        182.7",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     BAL: bronchoalveolar lavage.",
"     <br>",
"      * 5th percentile of the study population.",
"      <br>",
"       &bull; 95th percentile of the study population.",
"       <br>",
"        &Delta; n = 64.",
"        <br>",
"         &loz; n = 29.",
"         <br>",
"          &sect; n = 62.",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from: BAL Cooperative Group. Am Rev Respir Dis 1990; 141:S169 (BAL Cooperative Group, 1990 #261).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_63_30717=[""].join("\n");
var outline_f29_63_30717=null;
var title_f29_63_30718="Differences between clinical and pathological staging";
var content_f29_63_30718=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F87269&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F87269&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Correlation of clinical and pathological staging in pleural mesothelioma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 332px; height: 434px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Rusch VW, Giroux D, Kennedy C, et al. Initial Analysis of the International Association For the Study of Lung Cancer Mesothelioma Database. J Thorac Oncol 2012; 7:1631. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_63_30718=[""].join("\n");
var outline_f29_63_30718=null;
var title_f29_63_30719="Plagiocephaly comparison";
var content_f29_63_30719=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F60493&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F60493&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Common presentation of deformational plagiocephaly compared with synostotic plagiocephaly",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 312px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The ear is often anteriorly displaced on the affected side in deformational plagiocephaly, although this finding is not always consistent.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_63_30719=[""].join("\n");
var outline_f29_63_30719=null;
